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Eukaryotic DNA is packaged into chromatin, providing a physical and structural barrier for 
regulatory and effector proteins to access the DNA. It has been shown that linker histone 
variants inhibit the double strand break (DSB) repair pathway known as non-homologous 
end joining (NHEJ). NHEJ, in vivo, requires the KU complex, the DNA dependent protein 
kinase (DNA-PK) and the DNA ligase IV/XRCC4 (LX) complex. In vitro analysis has shown that 
H1.1, H1.3 and H1.X are all phosphorylated by DNA-PK. Importantly, H1.X contains and is 
phosphorylated at the DNA-PK consensus sequence. Depletion of H1.X protein levels by 
short interfering RNA renders cells radiosensitive and increases the levels of un-repaired 
DSBs following exposure to ionising radiation. H1.X interacts with both DNA ligase IV and 
XRCC4 in vivo, along with DNA-PK, the KU complex and nucleolin. Interestingly, the 
interaction with nucleolin only occurs in the presence of DNA damage following exposure to 
ionising radiation. In vitro analysis has shown that H1.X is able to form stable complexes in 
the presence of DNA and the LX complex, and very efficiently stimulates LX-mediated 
ligation of double stranded DNA. These findings establish a role for the linker histone variant 
H1.X in the NHEJ pathway.  
 
Page | III  
 
Acknowledgments 
I would like to thank all members of the Medical & Molecular Genetics Group at the 
University of Birmingham for their help and support throughout my time there. You’re a 
great bunch of people who always manage to make me laugh! Special thanks go to Chris 
Bruce, aka Yoda, for his general help with anything and everything. Special thanks also to 
both Ashraf Dallol and Luke Hesson for their help with protein purification and to Luke for 
taking the time to look over my thesis all the way down under. I would also like to thank 
Boris Kysela for allowing me to work in his lab and for his help and guidance supervising this 
project. The image of your little dance the day I told you H1.X was phosphorylated will bring 
a smile to my face for the rest of my life! Thanks also to Grant Stewart for his help with the 
in vivo work. 
Huge thanks to all my friends for their continued support. However, now I am in the real 
world of work, none of you can call me the “eternal student” anymore! 
None of this would have been possible if it was not for the support from my parents. To you 
both I am forever indebted. I know you have always been extremely proud of me and what I 
do, and for that I am grateful. It is a shame that it is all coming to end as I think you both 
finally understand what it is I do!! 
 
Last, but by no means least, Amy. I will be forever thankful for your love and support over 
these past 5 years, without you, I don’t think I would have got through it. Hopefully now the 
dreaded thesis is finished we can start and enjoy life again, which I am sure will inevitably 
mean me beating you at Wii Tennis!!  
 
Page | IV  
 
Table Of Contents 
 
List of Figures .............................................................................................. XI 
List of Tables ............................................................................................... XIV 
List of Abbreviations .................................................................................... XV 
CHAPTER ONE: INTRODUCTION .................................................................................. 1 
1.1 DNA Damage and Repair............................................................................................... 2 
1.1.1 DNA Damage Responses in Mammalian Cells ....................................................... 4 
1.1.1.1 G1 Phase Checkpoint ..................................................................................... 6 
1.1.1.2 S Phase Checkpoint ....................................................................................... 6 
1.1.1.3 G2 to M Phase Checkpoint ............................................................................ 7 
1.1.1.4 Apoptosis ....................................................................................................... 8 
1.1.2 DNA Double Strand Break Recognition ................................................................. 9 
1.1.2.1 MRE11 ......................................................................................................... 10 
1.1.2.2 RAD50 .......................................................................................................... 11 
1.1.2.3 NBS1 ............................................................................................................ 12 
1.1.2.4 ATM ............................................................................................................. 13 
1.1.2.5 MDC1 ........................................................................................................... 15 
1.1.2.6 53BP1 ........................................................................................................... 16 
1.1.2.7 BRCA1 .......................................................................................................... 17 
1.1.3 DNA Double Strand Break Repair Pathways ........................................................ 18 
1.1.3.1 Homologous Recombination ....................................................................... 18 
1.1.3.2 Non Homologous End Joining...................................................................... 21 
 
Page | V  
 
1.1.3.2.1 DNA-Dependent Protein Kinase Complex Formation ....................... 21 
1.1.3.2.2 End Processing ................................................................................... 23 
1.1.3.2.3 End Ligation ....................................................................................... 24 
1.1.3.3 DNA Double Strand Break Repair Pathway Choice ..................................... 25 
1.2 Chromatin ................................................................................................................... 28 
1.2.1 Core Histones ....................................................................................................... 36 
1.2.2 Linker Histones ..................................................................................................... 40 
1.2.3 Mammalian Linker Histone Variants ................................................................... 41 
1.3 Chromatin and the DNA Damage Response ............................................................... 47 
CHAPTER TWO: MATERIALS AND METHODS ............................................................. 50 
2.1 Suppliers ...................................................................................................................... 51 
2.2 Cells and Cell Culture .................................................................................................. 51 
2.2.1 MRC5VA Cells ....................................................................................................... 51 
2.2.2 Cell Maintenance ................................................................................................. 51 
2.2.3 Trypsinisation of Confluent Cells ......................................................................... 52 
2.2.4 Cell Reseeding ...................................................................................................... 53 
2.2.5 Cell Cryopreservation........................................................................................... 53 
2.2.6 Short Interfering RNA Transfection ..................................................................... 53 
2.2.7 Stably Transfected Cell Line Generation .............................................................. 54 
2.3 Protein Harvesting and Quantification ....................................................................... 55 
2.3.1 Mammalian Protein Extraction ............................................................................ 55 
 
Page | VI  
 
2.3.2 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis .......................... 56 
2.3.3 Coomassie Staining and Drying of SDS-PAGE Gels .............................................. 57 
2.3.4 Protein Transfer from SDS-PAGE to Polyvinylidene Fluoride Membrane ........... 57 
2.3.5 Western Blotting .................................................................................................. 58 
2.4 Clonogenic Survival Assay ........................................................................................... 60 
2.5 Immuno-fluorescence ................................................................................................. 60 
2.5.1 Fixation of Cells .................................................................................................... 60 
2.5.2 Immuno-probing .................................................................................................. 61 
2.5.3 Mounting and Visualisation ................................................................................. 61 
2.6H2A.X Quantification ................................................................................................. 62 
2.7 Cytochalasin B Micronuclei Assay ............................................................................... 62 
2.8 Cell Cycle Flow Cytometry Assay ................................................................................ 63 
2.9 Plasmids ...................................................................................................................... 64 
2.10 Bacteria ..................................................................................................................... 65 
2.10.1 General Maintenance ........................................................................................ 65 
2.10.2 Image Clones ...................................................................................................... 65 
2.10.3 Transformation .................................................................................................. 65 
2.11 Agarose Gel Electrophoresis of DNA ........................................................................ 71 
2.12 DNA Extraction .......................................................................................................... 71 
 
Page | VII  
 
2.12.1 DNA Extraction from Agarose Gels .................................................................... 71 
2.12.2 Small Scale Purification of Plasmid DNA, Miniprep. .......................................... 72 
2.13 DNA Manipulation .................................................................................................... 73 
2.13.1 Polymerase Chain Reaction ............................................................................... 73 
2.13.2 Standard Polymerase Chain Reaction ................................................................ 73 
2.13.3 Cloning Polymerase Chain Reaction .................................................................. 74 
2.13.4 Colony Polymerase Chain Reaction ................................................................... 74 
2.13.5 Restriction Digests ............................................................................................. 77 
2.13.6 Ligation............................................................................................................... 77 
2.13.7 pGEM-T-Easy Cloning ......................................................................................... 77 
2.13.8 DNA Sequencing ................................................................................................ 78 
2.13.8.1 Sequencing Polymerase Chain Reaction ................................................... 78 
2.13.8.2 Ethanol Precipitation of DNA Products ..................................................... 78 
2.13.8.3 Sample Preparation for Sequencing Analysis ............................................ 79 
2.14 Protein Purification ................................................................................................... 79 
2.14.1 Cloning of Linker Histone Genes in to the pET28-b Vector ............................... 79 
2.14.2 Induction of Recombinant Proteins. .................................................................. 80 
2.14.3 Extraction and Purification of Recombinant Proteins. ...................................... 80 
2.14.4 Dialysis of Recombinant Proteins. ..................................................................... 81 
2.15 Protein Kinase Assay ................................................................................................. 82 
2.16 Phospho-peptide Mapping ....................................................................................... 82 
 
Page | VIII  
 
2.17 In Vitro Ligation ......................................................................................................... 83 
2.17.1 dsDNA End Labelling .......................................................................................... 83 
2.17.2 Ligation Assay .................................................................................................... 83 
2.18 Electrophoresis Mobility Shift Assay ......................................................................... 84 
2.19 Co-Immunoprecipitation .......................................................................................... 85 
2.19.1 Cloning of Linker Histone Genes in to the pFLAG-CMV-4 Vector ...................... 85 
2.19.2 Cloning of Linker Histone Genes in to the pEGFP Vector .................................. 86 
2.19.3 Protein Extraction .............................................................................................. 86 
2.19.4 Co-Immunoprecipitation ................................................................................... 87 
2.19.5 Interacting Protein Partners Determination...................................................... 88 
CHAPTER THREE: MAPPING PHOSPHORYLATION SITES IN THE SOMATIC LINKER HISTONE 
VARIANTS................................................................................................................. 89 
3.1 Introduction and Overview ......................................................................................... 90 
3.2 Aims ............................................................................................................................. 93 
3.3 Results ......................................................................................................................... 94 
3.3.1 Identification of putative ATM/DNA-PK phosphorylation sites. ......................... 94 
3.3.2 Phosphorylation mapping of linker histone variants. ......................................... 97 
3.3.3 Purification of individual linker histones variants from E.coli. .......................... 103 
3.3.4 Phosphorylation of linker histone variants by DNA-PK. .................................... 108 
3.4 Discussion .................................................................................................................. 110 
 
Page | IX  
 
CHAPTER FOUR: IN VIVO CHARACTERISATION OF H1.X’S ROLE IN DOUBLE STRAND BREAK 
REPAIR ................................................................................................................... 115 
4.1 Introduction and Overview ....................................................................................... 116 
4.2 Aims ........................................................................................................................... 119 
4.3 Results ....................................................................................................................... 119 
4.3.1 siRNA targeted knockdown of H1.X ................................................................... 119 
4.3.2 siRNA mediated depletion of H1.X renders cells sensitive to ionising radiation122 
4.3.3 siRNA depletion of H1.X leads to elevated levels of unrepaired double strand 
breaks as revealed by H2AX staining ................................................................ 124 
4.3.4 Cells depleted in H1.X show a delay in the G2 to M cell cycle progression 
following ionising radiation ................................................................................ 128 
4.3.5 siRNA depletion of H1.X leads to a delay in the appearance of micronuclei 
following ionising radiation ................................................................................ 132 
4.4 Discussion .................................................................................................................. 135 
4.4.1 H1.X depletion results in cellular sensitivity to IR ............................................. 135 
4.4.2 H1.X depletion invokes the G2 to M cell cycle checkpoint ............................... 137 
CHAPTER FIVE: THE ANALYSIS OF THE MECHANISM OF ACTION OF H1.X IN DSB REPAIR140 
5.1 Introduction and Overview ....................................................................................... 141 
5.2 Aims ........................................................................................................................... 142 
5.3 Results ....................................................................................................................... 143 
 
Page | X  
 
5.3.1 H1.X stimulates LX mediated ligation of double stranded DNA ........................ 143 
5.3.2 H1.X cannot rescue H1-mediated inhibition of ligation .................................... 147 
5.3.3 H1.X and DNA Ligase IV/XRCC4 form protein-DNA complexes. ........................ 149 
5.3.4 H1.X interacts with the DNA Ligase IV/XRCC4 complex .................................... 149 
5.3.5 H1.X interacts with nucleolin following exposure to IR..................................... 153 
5.4 Discussion .................................................................................................................. 156 
CHAPTER SIX: DISCUSSION ...................................................................................... 161 
6.1 Linker Histone Variant, H1.X, and its Role in Double Strand Break Repair .............. 162 
6.2 H1.X and the DSB Specific Interaction with Nucleolin .............................................. 167 
6.3 Future Experiments ................................................................................................... 167 
CHAPTER SEVEN: APPENDICES ................................................................................ 171 




Page | XI  
 
List of Figures 
 
 
Figure 1.1 - Cell Cycle Arrest Following DNA Damage ............................................................... 5 
Figure 1.2 - Domain structure of MRE11 ................................................................................. 10 
Figure 1.3 - Domain structure of RAD50 .................................................................................. 11 
Figure 1.4 - Domain structure of NBS1 .................................................................................... 13 
Figure 1.5 - Domain structure of ATM ..................................................................................... 15 
Figure 1.6 - Domain structure of MDC1 ................................................................................... 16 
Figure 1.7 - Homologous Recombination ................................................................................ 20 
Figure 1.8 – Model for deciding which pathway will repair DSBs. .......................................... 27 
Figure 1.9 - Crystal Structure of the Nucleosome at 2.8Ä ....................................................... 30 
Figure 1.10 - Chromatin - The Nucleosome, Chromatosome, Chromatin and the 
Chromosome .................................................................................................................... 31 
Figure 1.11 – Basic and crystal structure of a linker histone ................................................... 33 
Figure 1.12 - Molecular model of the linker histone within the nucleosome ......................... 34 
Figure 1.13 - Sequence alignment of H2A variants ................................................................. 39 
Figure 1.14 – Sequence alignment of all human linker histone variants ................................ 43 
Figure 2.1 – Plasmid map of pGEM-T-Easy .............................................................................. 67 
Figure 2.2 – Plasmid map of pFLAG-CMV-4 ............................................................................. 68 
Figure 2.3 – Plasmid map of pET28-b ...................................................................................... 69 
Figure 2.4 – Plasmid map of pEGFP ......................................................................................... 70 
Figure 3.1 – Amino acid sequence alignment of human linker histones. ................................ 95 
Figure 3.2 – Amino acid sequence alignment of H1.X putative SQ site in humans and the 
orthologues in different species. ..................................................................................... 96 
Figure 3.3 - Amino acid sequence alignment of H1.0 putative SQ site in humans and the 
orthologues in different species. ..................................................................................... 96 
 
Page | XII  
 
Figure 3.4 – Recombinant linker histone variant purification in E. Coli. ............................... 104 
Figure 3.5 – Elution of affinity purified linker histone variants. ............................................ 105 
Figure 3.6 – Purification of mammalian H1.2 from SF9 insect cells. ..................................... 107 
Figure 3.7 – DNA-PK phosphorylation of recombinant linker histone variants. ................... 109 
Figure 4.1 - Sequence alignment of linker histone variants .................................................. 118 
Figure 4.2 - siRNA depletion of H1.X, H1.2 and LUC .............................................................. 121 
Figure 4.3 - siRNA mediated depletion of H1.X renders cells sensitive to ionising radiation123 
Figure 4.4 - H2A.X foci are elevated following a 24 hour repair period in cells depleted 
for H1.X .......................................................................................................................... 126 
Figure 4.5 - Residual H2A.X foci 24 hours post-irradiation .................................................. 127 
Figure 4.6 – Measurement of G2/M delay over 24 hours ..................................................... 130 
Figure 4.7 - Measurement of G2/M delay over 48 hours ...................................................... 131 
Figure 4.8 – Cells depleted in H1.X have less micronuclei 24 hours post-irradiation ........... 133 
Figure 4.9 - Micronuclei seen at 24 and 48 hour post-irradiation ......................................... 134 
Figure 5.1 – Recombinant linker histone H1.X stimulates LX-mediated ligation. ................. 144 
Figure 5.2 – Linker histone H1.X does not possess DNA ligase activity. ................................ 146 
Figure 5.3 - H1X stimulates ligation under conditions previously shown to inhibit ligation . 146 
Figure 5.4 - H1.X does not have the ability to rescue H1 mediated inhibition of ligation. ... 148 
Figure 5.5 - H1.X stabilises LX on dsDNA ends. ...................................................................... 151 
Figure 5.6 - Co-immuno-precipitation of XRCC4 with GFP-H1.X ........................................... 151 
Figure 5.7 - Co-immuno-precipitation of DNA Ligase IV with endogenous H1.X .................. 152 
Figure 5.8 - Interaction between H1.X and DNA ligase IV is not disrupted with the 
addition of ethidium bromide. ....................................................................................... 152 
Figure 5.9 - Co-immuno-precipitation of nucleolin with GFP-H1.X ....................................... 155 
Figure 6.1 - Model for linker histone variants action during NHEJ ........................................ 166 
Figure 7.1 - Sample dot plot of flow cytometry data ............................................................. 175 
 
Page | XIII  
 
Figure 7.2 - Bivariate Cell Cycle Analysis of Un-Irradiated MRC5VA cells. ............................ 176 
Figure 7.3 - Bivariate Cell Cycle Analysis of Un-Irradiated MRC5VA cells depleted of LUC. . 177 
Figure 7.4 - Bivariate Cell Cycle Analysis of Un-Irradiated MRC5VA cells depleted of H1.X. 178 
Figure 7.5 - Bivariate Cell Cycle Analysis of Irradiated MRC5VA cells. .................................. 179 
Figure 7.6 - Bivariate Cell Cycle Analysis of Irradiated MRC5VA cells depleted of LUC. ....... 180 




Page | XIV  
 
List of Tables 
 
Table 1.1 - Core histones and histone variants ....................................................................... 36 
Table 2.1 - siRNA Transfection Details ..................................................................................... 54 
Table 2.2. List of siRNA oligonucleotides used for siRNA transfection. ................................... 54 
Table 2.3 - Table of antibodies, their dilutions and incubation times ..................................... 59 
Table 2.4 - List of plasmids used in this study. ........................................................................ 66 
Table 2.5 - Antibiotics used in this study. ................................................................................ 66 
Table 2.6 - List of Image Clones used in this study .................................................................. 66 
Table 2.7 - Standard PCR Cycle ................................................................................................ 73 
Table 2.8 - List of primers used in this thesis. .......................................................................... 76 
Table 2.9 - Standard Sequencing PCR Cycle ............................................................................. 78 
Table 3.1 – Phosphorylation Mapping of Linker Histones identified in this chapter, 
compared to published results. ..................................................................................... 102 




Page | XV  
 
List of Abbreviations 
 
APS – Ammonium PerSulphate 
ATM – Ataxia Telangiectasia Mutated 
ATP – Adenosine TriPhosphate 
ATR – Ataxia Telangiectasia mutated and Rad-3 related 
Backup Non-Homologous End Joining – B-NHEJ 
BrdU – BRomoDeoxyUridine 
BRCA1 – BReast and ovarian Cancer type 1 susceptibility protein 
BRCT – BReast and ovarian cancer type 1 susceptibility protein Carboxyl Terminus motif 
BSA – Bovine Serum Albumin 
CDK – Cyclin Dependent Kinase 
CTD – Carboxyl Terminal Domain 
DAPI - 4',6-DiAmidino-2-PhenylIndole 
DMEM – Dulbecco’s Modified Eagles Medium 
DNA-PK – DNA dependent Protein Kinase 
DNA-PKCS – DNA dependent Protein Kinase Catalytic Subunit 
DSB – Double Strand Break 
dsDNA – Double Stranded DNA 
DTT – DiThioThreitol 
EDTA – EthyleneDiamineTetraAcetic Acid 
EGTA – EthyleneGlycolTetraAcetic acid 
EMSA – Electrophoresis Mobility Shift Assay 
 
Page | XVI  
 
FBS – Foetal Bovine Serum 
FHA – Fork Head Associated 
FRAP - Flourescence Recovery After Photobleaching 
GFP – Green Fluorescent Protein 
HP1 – Heterchromatin Protein 1 
HR – Homologous Recombination 
IPTG – IsoPropyl ThioGalactoside 
IR – Ionising Radiation 
LUC – Luciferase gene 
LX – DNA Ligase IV / XRCC4 complex 
MDC1 – Mediator of the DNA damage Checkpoint 1 
MMS – Methyl MethaneSulfonate 
MRN – Mre11/Rad50/Nbs1 
NHEJ – Non-Homologous End Joining 
NTD – Amino Terminal Domain 
PBS – Phosphate Buffered Saline 
PCR – Polymerase Chain Reaction 
PIKK – Phosphatidyl Inositol-3-Kinase related Kinases 
PMSF – PhenylMethylSulfonylFluoride 
PTM – Post Translational Modification 
PVDF – PolyVinyliDene Fluoride 
RPA – Replication Protein A 
SDS – Sodium Dodecyl Sulfate 
 
Page | XVII  
 
SDS-PAGE - Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis 
siRNA – Short Interfering RNA 
SMC – Structural maintenance of chromosomes 
ssDNA – Single Stranded DNA 
TEMED – TEtraMethylEthyleneDiamine 
UV – Ultra Violet 
H2A.X – phosphorylated H2A.X 
 













CHAPTER ONE: INTRODUCTION 
  
 
Page | 2  
 
1.1 DNA Damage and Repair 
DNA damage arises from environmental factors, along with metabolic processes within the 
cell. It is estimated that there are between 1,000 and 1,000,000 lesions induced per cell 
genome per day (Lodish et al., 2007). Whilst this may seem alarmingly high, it is only a very 
small fraction of the 6 billion DNA bases in each cell. However, mutations in genes involved 
with DNA repair itself (P. C. Chen et al., 2005c, Miki et al., 1994, Prolla et al., 1998), cell cycle 
regulation (DeLeo et al., 1979) and apoptosis (Irvin et al., 2003) can ultimately lead to 
tumour formation. 
 
DNA damage affects the primary structure of the DNA. The normally regular structure of the 
double-helix is altered by the addition or removal of chemical bonds, the introduction of 
bulky lesions, or by single and double strand breaks (DSB). 
 
Damage can arise from endogenous and exogenous sources. Endogenous sources include 
replication errors where the incorrect base is inserted, resulting in a mis-match and a stalled 
replication fork, and base modifications such as oxidation, alkylation and the hydrolysis of 
bases. Oxidation arises from reactive oxygen species produced in the mitochondrial electron 
transport chain. An estimated 105 oxidative hits per day occur in every cell in the human 
body (Valko et al., 2004). 
 
Exogenous sources include: ultra-violet (UV) irradiation from the sun resulting in lesions such 
as cyclobutane pyrimidine dimers and pyrimidine (6-4) pyrimidone photoproducts, resulting 
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in the bonding of two adjacent bases; ionizing radiation (IR), including X-rays and gamma 
rays from cosmic radiation and radioactive decay which result in DSB formation; and many 
mutagenic chemicals such as ethidium bromide which intercalates between the DNA base 
pairs. 
 
DNA DSBs are the most lethal form of DNA damage and are generated when complimentary 
strands of the DNA double helix are broken simultaneously. These breaks are produced by 
exogenous damaging agents such as IR, or radiomimetic molecules such as bleomycin, 
neocarzinostatin and etoposide. DSBs can also occur endogenously as a consequence of 
oxidative metabolism, and in lymphocytes during gene rearrangement, a process known as 
V(D)J recombination (Bassing et al., 2002). It has been estimated that a typical mammalian 
cell will incur at least 10 spontaneous DSBs per day (Pastwa and Blasiak, 2003). If left 
unrepaired, DSBs can lead to a wide array of problems including chromosome translocation, 
cancer predisposition and the induction of cell death.  
 
There are evolutionary conserved pathways to deal with DNA damages. DNA base 
modifications, including deamination, base loss, oxygen free radical attack and methylation 
are predominantly repaired by the base excision repair pathway (for review, Robertson et 
al., 2009). Those base modifications which are unable to be repaired by this pathway, along 
with UV induced (6-4) photoproducts and cyclobutane pyrimidine dimers are repaired by the 
nucleotide excision repair pathway (for review, Fousteri and Mullenders, 2008, Shuck et al., 
2008). Mis-incorporated bases are removed by the mismatch repair pathway (G. M. Li, 
2008), and for the removal of DSBs there are two evolutionary conserved pathways, 
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homologous recombination (HR; Section 1.1.3.1) and the non-homologous end joining 
(NHEJ; Section 1.1.3.2) pathway. 
 
1.1.1 DNA Damage Responses in Mammalian Cells 
Upon sensing DNA damage or a stalled replication fork, it is essential that the cell responds 
to halt the cell cycle so that potential deleterious mutations are not passed on to daughter 
cells. Along with the activation of cell cycle checkpoints, DNA repair pathways are initiated, 
and if the damage is too severe, apoptosis is initiated (B. B. Zhou and Elledge, 2000). Cell 
cycle checkpoints exist to ensure that each phase of the cell cycle has been executed 
properly. The three checkpoints exist in the G1 and S phases of the cell cycle, and the G2 to 
M transition (Figure 1.1). 
 
The key regulators of the cell cycle checkpoints in mammalian cells are the ataxia 
telangiectasia mutated (ATM) and ATM and RAD3 -related (ATR) protein kinases (Kastan et 
al., 1992, Paulovich and Hartwell, 1995). These proteins belong to a family of proteins, the 
phosphatidylinositol-3-kinase related kinases (PIKKs), characterised by a phosphatidylinositol 
3-kinase domain in their carboxyl terminal domain (CTD). Although ATM and ATR are able to 
phosphorylate the same targets, it depends on the type of damage incurred as to which 
kinase is activated. ATM is primarily involved in DSB repair in response to IR, whereas ATR 
acts as a backup for ATM in response to IR, and also deals with UV irradiation and stalled 
replication forks. 
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Figure 1.1 - Cell Cycle Arrest Following DNA Damage 
Upon DNA damage the ATM and ATR kinases are activated. During G1, phosphorylation by ATM/ATR and CHK2 activates p53 leading to the transcription of p21. p21 
suppresses CDK2/Cyclin E activity resulting in G1 arrest. During S phase, CHK1 and CHK2 will phosphorylate CDC25A targeting it for proteosomal degradation, therefore the 
CDK2/Cyclin A/E complexes remain inactive, preventing DNA synthesis. During G2, CDC25C is phosphorylated by CHK1/CHK2, allowing the binding of 14-3-3 proteins. This 
subsequently targets CDC25C for nuclear export, therefore the CDC2/Cyclin B1 complex remains inactive, resulting in G2 arrest. 
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1.1.1.1 G1 Phase Checkpoint 
The G1 checkpoint is currently the most understood checkpoint in mammalian cells and 
prevents damaged DNA from being replicated. Central to this checkpoint is the accumulation 
of the tumour suppressor protein, p53 (Kastan et al., 1991). Under normal conditions, p53 is 
bound by MDM2 which targets p53 for nuclear export and ultimately proteosomal 
degradation (Inoue et al., 2001, Y. Zhang and Xiong, 2001). Following IR, ATM activates CHK2 
by phosphorylation (threonine 68; Matsuoka et al., 2000). CHK2 then phosphorylates p53 
(serine 20), blocking the p53-MDM2 interaction, allowing p53 to accumulate in the nucleus 
(Chehab et al., 2000, Unger et al., 1999). ATM can also directly phosphorylate MDM2 (serine 
395) which, although allowing the p53-MDM2 interaction to occur, does not allow p53 to be 
targeted for nuclear export (Maya et al., 2001). ATM and/or ATR are also able to 
phosphorylate p53 directly (serine 15) in response to IR (ATM and ATR), UV (ATR) and stalled 
replication forks (ATR), resulting in the activation of p53 (Banin et al., 1998, Canman et al., 
1998, Zhao et al., 2008). The nuclear accumulation and activation of p53 allows it to up-
regulate a number of genes including p21 (Waldman et al., 1995). p21 is a cyclin dependent 
kinase (CDK) inhibitor and suppresses the CDK2/cyclin E activity resulting in G1 arrest (el-
Deiry et al., 1993, Gu et al., 1993, Harper et al., 1993; Figure 1.1) 
 
1.1.1.2 S Phase Checkpoint 
The S phase checkpoint monitors DNA synthesis during cell cycle progression and will slow 
the rate of DNA synthesis following DNA damage. There are two branches which will activate 
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the S phase checkpoint (Figure 1.1). The first branch is initiated by the phosphorylation of 
CHK2 (threonine 68) by ATM (Matsuoka et al., 2000). CHK2, once activated by 
phosphorylation, is able to phosphorylate CDC25A (serine 123) which will target it for 
ubiquitin-dependant degradation (Matsuoka et al., 1998). CDC25A is therefore no longer 
able to remove the inhibitory phosphate groups from CDK2 (threonine 14 and tyrosine 15), 
therefore the CDK2/cyclin E and CDK2/cyclin A complexes remain inactive, preventing DNA 
synthesis (Falck et al., 2001, Gu et al., 1992). 
 
The second branch of the S phase checkpoint, involves the direct phosphorylation of NBS1 
(serine 343), breast and ovarian cancer type 1 susceptibility protein (BRCA1, serine 1387) 
and structural maintenance of chromosomes 1 (SMC1; serine 957 and serine 966) by ATM. 
All of these proteins are needed for the activation of the S phase checkpoint, however, the 
exact function of these proteins in the checkpoint remains to be elucidated (S. T. Kim et al., 
2002, Lim et al., 2000, Xu et al., 2001, Xu et al., 2002). 
  
1.1.1.3 G2 to M Phase Checkpoint 
The G2 to M phase checkpoint is extremely important as it regulates cell cycle progression 
prior to chromosome segregation. The G2/M checkpoint is initiated by the phosphorylation 
of CHK1 and CHK2 by ATR and ATM respectively, thus activating them (Q. Liu et al., 2000, 
Matsuoka et al., 2000, Zhao and Piwnica-Worms, 2001). Once activated CHK1 and CHK2 can 
phosphorylate CDC25C (serine 216), enabling the binding of 14-3-3 proteins (Ogg et al., 
1994, Peng et al., 1997, Sanchez et al., 1997). CDC25C/14-3-3 complexes are then 
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sequestered to the cytoplasm, stopping CDC25C from removing the inhibitory phosphate 
groups from CDC2 (Dalal et al., 1999). The CDC2/cyclin B1 complex therefore remains 
inactive, halting the progression into mitosis (Figure 1.1). 
 
1.1.1.4 Apoptosis 
If DNA repair is unsuccessful and the damage persists, the cell has to be removed from the 
population by death in a process known as apoptosis. DNA damage activates the ATM and 
ATR kinases which stabilise p53 (Section 1.1.1.1; Banin et al., 1998, Canman et al., 1998, 
Zhao et al., 2008). p53 is then able to up-regulate the expression of several genes involved in 
apoptosis, specifically members of the BCL-2 family (Miyashita et al., 1994, Miyashita and 
Reed, 1995). This family consists of both pro- and anti-apoptotic proteins which regulate the 
permeability of the mitochondrial membrane (Chipuk et al., 2010). Pro-apoptotic members 
of the BCL-2 family, including BAX and BID, function to permeabilise the mitochondrial 
membrane resulting in the release of cytochrome c from the mitochondria to the cytoplasm 
(Kluck et al., 1997, J. Yang et al., 1997). Once in the cytoplasm, cytochrome c is able to 
activate caspase 9 (Hakem et al., 1998, Kuida et al., 1998). Caspases are aspartate specific 
proteases which are responsible for the disassembly of the cell in a controlled manner. 
Caspase 9 then activates other caspases causing a caspase cascade, ultimately resulting in 
the controlled destruction of the cell (T. J. Fan et al., 2005). 
 
There are also reports of p53-independent apoptosis pathways including the activation of 
the JNK pathway (McNamee and Brodsky, 2009), the interaction between p19ARF and BAX 
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(Suzuki et al., 2003) and by the transcriptional up-regulation of PUMA by p73 (Melino et al., 
2004). PUMA binds to BCL-2 and BCL-XL, translocates to the mitochondria, resulting in 
cytochrome c release and the caspase cascade (Nakano and Vousden, 2001, Yu et al., 2003a, 
Yu et al., 2001).  
 
1.1.2 DNA Double Strand Break Recognition 
Currently, the primary sensor of a DSB is unknown. One branch of evidence suggests the 
MRE11 (Section 1.1.2.1)/RAD50 (Section 1.1.2.2)/NBS1 (Section 1.1.2.3) (MRN) complex 
recognises the damage (Uziel et al., 2003). Whereas another branch of evidence suggests 
localised perturbations of the chromatin structure following IR cause the activation of ATM 
(Bakkenist and Kastan, 2003, Y. C. Kim et al., 2009). 
 
MRN is able to tether damaged DNA which increases the local concentration of DSBs 
promoting the recruitment, monomerisation and activation of ATM, which exists in 
unstressed cells as inactive dimers (Dupre et al., 2006). Along with tethering the damaged 
DNA, NBS1 as part of the MRN complex, is also capable of unwinding DNA at the ends of the 
breaks which also promotes ATM monomerisation and activation (J. H. Lee and Paull, 2005, 
Paull and Gellert, 1999). 
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1.1.2.1 MRE11 
MRE11 is known to exist as a dimer which is essential for cellular survival against DSBs 
(Hopfner et al., 2001, R. S. Williams et al., 2008). Dimerisation occurs via two N-terminal 
dimerisation motifs which overlap the NBS1 interacting domain (Figure 1.2). In vitro, MRE11 
has been shown to exhibit single stranded DNA (ssDNA) endonuclease, 3’->5’ ssDNA 
exonuclease, double stranded DNA (dsDNA) exonuclease and hairpin opening activities. 
These are enhanced when MRE11 is in a heterotetrameric structure with RAD50 and in the 
presence of adenosine triphosphate (ATP; Figure 1.2; Furuse et al., 1998, Paull and Gellert, 
1998, Trujillo and Sung, 2001, Trujillo et al., 1998). Mutations in MRE11 give rise to the 
human disorder ataxia-telangiectasia-like disorder (ATLD). Patients with ATLD have 
radiosensitivity along with other chromosomal abnormalities (Stewart et al., 1999). Patients 
with ATLD have mutations which occur within the NBS1 interacting domain (Figure 1.2) 




Figure 1.2 - Domain structure of MRE11 
The amino terminus of MRE11 contains the nuclease domain, capable of endonuclease and exonuclease 
activity. Contained within the nuclease domain are two dimerisation domains and two NBS1 interacting 
domains (ID). MRE11 is capable of binding DNA by its two DNA binding domains, one central, one at the 
carboxyl terminus. In between the two DNA binding domains there is a RAD50 interacting domain. Adapted 
from Rupnik et al., 2010. 
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1.1.2.2 RAD50 
RAD50 is a member of the SMC family of proteins which are involved in sister-chromatid 
cohesion and chromosome condensation in eukaryotes (Sharples and Leach, 1995). RAD50 
contains two Walker domains which are required for its ATPase activity (Figure 1.3; J. E. 
Walker et al., 1982). Mutations in the Walker A domain confer the same radiosensitivity as 
RAD50 deletion mutants. Defects are seen in both HR and NHEJ, suggesting the Walker 
domains are crucial for RAD50’s role in DSB repair. Defects are also seen in RAD50’s ATPase 
activity, ATP-dependent DNA unwinding and ATP-stimulated endonuclease activity, 
however, DNA end-bridging does still occur (L. Chen et al., 2005b, de Jager et al., 2002). 
Scanning force microscopy revealed that RAD50 consists of two highly flexible 
intramolecular coiled coils protruding from a central globular DNA binding domain. The ends 
of the coils contain a zinc hook which allows the protein to fold back upon itself. The zinc 
hook also allows dimerisation and facilitates the end bridging of broken DNA ends (Figure 
1.3; de Jager et al., 2001, Hopfner et al., 2002). 
 
 
Figure 1.3 - Domain structure of RAD50 
At the carboxyl and amino termini are Walker domains which are essential for ATPase activity. RAD50 interacts 
with MRE11 by two MRE11 interacting domains (ID) which are located at the carboxyl and amino termini of the 
protein. In the centre of the protein there is a “hinged” zinc hook which allows the protein to fold back upon 
itself and also allow RAD50 dimerisation. Adapted from Rupnik et al., 2010. 
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1.1.2.3 NBS1 
Although there is no enzymatic activity associated with NBS1, it contains many interacting 
regions which are crucial for its role in DNA repair (Figure 1.4). The fork head-associated 
(FHA) domain is a phospho-peptide recognition domain which was originally identified in 
protein kinases and transcription factors (Durocher et al., 1999, Hofmann and Bucher, 1995). 
NBS1 also contains tandem BRCA1 carboxyl terminus motifs (BRCT), which are known to 
have affinity towards phospho-peptides in proteins involved in DNA repair (Yu et al., 2003b). 
Both the BRCT domains and the FHA domain are needed to allow NBS1 to bind to the sites of 
DBS’s following DNA damage (di Masi et al., 2008, Kobayashi et al., 2002). 
 
NBS1 contains an MRE11 interacting domain at its carboxyl terminus (Figure 1.4). Deletion 
mutants lacking the MRE11 interacting domain still permitted NBS1 to localise to the nucleus 
and to form IR-induced foci. However the mutant protein could not complement the 
radiosensitivity of NBS1 deficient cells suggesting the NBS1-MRE11 interaction is essential to 
survive IR (Desai-Mehta et al., 2001). An ATM interacting domain contained in the carboxyl 
terminus is crucial to recruit ATM to DNA in vitro, and for ATM recruitment to DSBs following 
IR in vivo (Figure 1.4; Falck et al., 2005). 
 
Mutations in the NBS1 gene give rise to Nijmegen breakage syndrome, a disorder similar to 
ataxia telangiectasia which results in immunodeficiency and radiosensitivity (Carney et al., 
1998, Varon et al., 1998).  
 
 




Figure 1.4 - Domain structure of NBS1 
At the amino terminus is an FHA domain which mediates NBS1’s interaction with phosphopeptides. Also 
contained at the amino terminus are 2 BRCT motifs which also interact with phosphopeptides, specifically 
those involved in the DNA damage response. At the carboxyl terminus are three interacting domains (ID) 
mediating its interaction with the PI3-kinase (PI3K), MRE11 and ATM. Adapted from Rupnik et al., 2010. 
 
1.1.2.4 ATM 
ATM, ATR and the DNA-dependent protein kinase catalytic subunit (DNA-PKCS; Section 
1.1.3.2.1) are all members of the PIKK family due to their phosphatidylinositol 3-kinase 
domain (Figure 1.5). Mutations in ATM cause the disorder ataxia telangiectasia, causing 
cerebella degeneration, chromosomal instability, cancer predisposition, immunodeficiency, 
radiation sensitivity, and cell cycle abnormalities (Savitsky et al., 1995). 
 
Following its activation by DSB induction and MRN foci formation, ATM rapidly 
phosphorylates the highly conserved serine 139 residue on the histone variant H2A.X (Burma 
et al., 2001, Rogakou et al., 1998). This phosphorylation signal is propagated to the 
surrounding H2A.X histones, stretching up to 1 mega base of DNA from the break (Rogakou 
et al., 1998). This phosphorylation event was originally hypothesised to aid the recruitment 
of the repair proteins to the site of the break, however, recent evidence suggests that it 
actually functions to concentrate and stabilise repair proteins in the vicinity of the break 
(Celeste et al., 2003). 
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Recent evidence also suggests that phosphorylated H2A.X (H2A.X) inhibits linker histone 
binding and therefore the 30nm fiber formation, aiding in relaxing the chromatin structure 
to allow the repair machinery to access the DNA (A. Li et al., 2010). H2A.X has also been 
shown to recruit chromatin remodelling factors including NUA4 (Downs et al., 2004) and 
INO80 (Morrison et al., 2004, van Attikum et al., 2004) in budding yeast, and TIP60 (Kusch et 
al., 2004) in Drosophila melanogaster. 
 
TIP60 driven chromatin remodelling has also been seen to activate ATM. TIP60 replaces 
HP1 bound to tri-methylated core histone H3 on lysine 9, activating TIP60s acetyl 
transferase activity. Once activated, TIP60 will acetylate ATM via its interaction with ATMs 
FATC domain (Figure 1.5), enhancing ATM’s activation (Sun et al., 2005, Sun et al., 2009). 
 
Following the successful repair of the DSB serine 139 is either dephosphorylated or the 
whole H2A.X histone is replaced. There are numerous reports of proteins which have been 
implicated in this dephosphorylation step, including protein phosphatase 2A, protein 
phosphatase 6 and p53-induced phosphatase 1 (Cha et al., 2010, Chowdhury et al., 2005, 
Douglas et al., 2010). There is also growing evidence for histone exchange following 
successful DSB repair. In D. melanogaster, TIP60 will acetylate H2A.X and replace it with 
normal H2A.X (Kusch et al., 2004). 
 
 
Page | 15  
 
 
Figure 1.5 - Domain structure of ATM 
ATM contains a FAT domain which is a domain found in FRAP (F), ATM (A) and TRRAP (T) proteins. The 
phosphatidylinositol 3-kinase (PI3K) domain is the catalytic kinase domain which is found in all the PIKKs. The 




Mediator of the DNA Damage Checkpoint 1 (MDC1) is an adapter protein which forms a 
scaffold upon which other repair proteins are supported. MDC1 is initially recruited to the 
DSB site due to its high affinity for H2A.X, mediated by its carboxyl terminal tandem BRCT 
domains (Figure 1.6; M. S. Lee et al., 2005, Shang et al., 2003). Knock-down of MDC1, 
followed by exposure to IR shows normal formation of H2A.X foci, however, these foci 
disappeared much quicker than in the control cells. This suggests that MDC1 creates the 
initial scaffold at the site of the DSB and spreads out from it, allowing the propagation of the 
H2A.X signal (Lou et al., 2006, Stucki et al., 2005). MDC1 has also been shown to recruit and 
stabilise several other repair proteins including BRCA1, 53BP1, ATM and CHK2 (Goldberg et 
al., 2003, Stewart et al., 2003). MDC1 has also been shown to interact with the FHA domain 
of NBS1 in a phosphorylation dependent manner. This occurs via its SDT domain enabling 
the accumulation of MRN at the sites of DSBs (Figure 1.4 & Figure 1.6; Melander et al., 2008, 
Spycher et al., 2008). 
 
 
Page | 16  
 
MDC1 is also phosphorylated by ATM on “TQXF” motifs which promote the recruitment of 
RNF8, an E3 ubiquitin ligase, to the site of repair (Figure 1.6; Huen et al., 2007, Kolas et al., 
2007). RNF8, in conjunction with the E2 ubiquitin conjugating enzyme UBC13, catalyses the 
ubiquitylation of histones, suspected to make the chromatin more accessible to repair 
factors (Huen et al., 2007, Kolas et al., 2007, Mailand et al., 2007, B. Wang and Elledge, 
2007). Depletion studies of RNF8 show increased sensitivity to IR suggesting it plays a key 
role in chromatin remodelling during DSB repair (Mailand et al., 2007). RNF8 also recruits 
both 53BP1 and BRCA1 to the sites of DSBs (Kolas et al., 2007, B. Wang and Elledge, 2007). 
RNF168 is also recruited to sites of DSBs and binds to ubiquitylated H2A where it enhances 
the ubiquitylation signal, poly-ubiquitylating H2A histones (Stewart et al., 2009). 
 
 
Figure 1.6 - Domain structure of MDC1 
At the amino terminus of MDC1 there is an FHA domain promoting its interaction with phosphopeptides, along 
with 2 BRCT domains at the carboxyl terminus which also promote its interaction with phosphopeptides, 
specifically those involved in the DNA damage response. The SDT motif consists of a small patch of serine and 
threonine residues separated by an aspartate residue and are responsible for MDC1’s interaction with the MRN 
complex. The TQXF motif is a cluster of ATM phosphorylation consensus sites, which are phosphorylated by 
ATM following a DSB, and promote the recruitment of RNF8 to the site of damage. The PST motif is a region 
which contains proline-serine-threonine repeats, although the function of this motif is unknown. Adapted from 
Jungmichel and Stucki, 2010. 
 
1.1.2.6 53BP1 
The 53BP1 protein was initially isolated as a binding partner of p53 and was shown to be 
recruited early to the site of DSBs (Bork et al., 1997, Iwabuchi et al., 1994, Schultz et al., 
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2000). Its precise role in the damage response is still uncertain, however it has been 
implicated in regulating the activation of the G2 to M phase checkpoint (DiTullio et al., 2002, 
B. Wang et al., 2002) and the repair of a subset of DSBs in NHEJ (Difilippantonio et al., 2008). 
More recently, 53BP1 has been shown to prevent the resection of DNA ends to produce a 
single stranded overhang at one end, the preliminary step required for HR (Section 1.1.3.1), 




BRCA1 was the first cloned breast cancer susceptibility gene and was quickly linked to a role 
in DNA repair (Miki et al., 1994, Moynahan et al., 1999, Moynahan et al., 2001, Scully et al., 
1997a). Evidence for its role in DNA repair came from its association with RAD51, a key 
protein in HR (Section 1.1.3.1; Scully et al., 1997b). Subsequently, BRCA1 has also been 
shown to interact with the MRN complex and co-localise with MRN foci (Wu et al., 2000a, 
Zhong et al., 1999). H2A.X deficient mice are unable to recruit BRCA1 to the sites of DSBs 
suggesting a physical link between BRCA1 and H2A.X (Celeste et al., 2002). 
 
A complex containing BRCA1, named BRCA1A, has been shown to co-localise to sites of DSB 
repair (X. Chen et al., 2006, Feng et al., 2009, H. Kim et al., 2007a, H. Kim et al., 2007b, Z. Liu 
et al., 2007, Shao et al., 2009, Sobhian et al., 2007, B. Wang et al., 2007). The recruitment of 
the BRCA1A complex to the sites of DSB repair is mediated through the ubiquitylation of 
chromatin in the immediate vicinity of the DSB by the aforementioned RNF8/UBC13 
partnership and two ubiquitin interacting domains contained within RAP-80, a member of 
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the BRCA1A complex (H. Kim et al., 2007a, B. Wang and Elledge, 2007). Recruitment is also 
dependent on ATM mediated phosphorylation of RAP-80 following exposure to IR (J. Yan et 
al., 2008). BRCA1 also forms a complex with BARD1 which is recruited to the sites of DSB 
repair where they are able to further ubiquitylate chromatin and activate the G2 to M phase 
checkpoint (H. Kim et al., 2007a, Polanowska et al., 2006). 
 
1.1.3 DNA Double Strand Break Repair Pathways 
1.1.3.1 Homologous Recombination 
HR is the primary pathway in repairing DSBs during the late S and G2 phases of the cell cycle. 
During this period there is an identical genetic copy available to the repair machinery which 
enables high fidelity repair of DSBs. HR utilises the RAD52 epistasis group of proteins 
originally identified in S. cerevisiae, which includes RAD50, RAD51, RAD52, RAD54, RAD55, 
RAD57, RAD59, MRE11 and XRS2 (homologue of eukaryotic NBS1; Section 1.1.2.3; Game and 
Mortimer, 1974). 
 
Following DSB recognition, the initial stage of HR is the resection of DNA to generate 3’ 
ssDNA tails (Figure 1.7c). Resection is achieved through the nuclease activity of MRE11, 
which is enhanced by CTIP, both of which are crucial for efficient HR (Paull and Gellert, 1998, 
Sartori et al., 2007, Trujillo et al., 1998). The exposed ssDNA tails are then bound by the 
replication protein A (RPA), a heterotrimeric protein consisting of three subunits (70 kDa, 32 
kDa and 14 kDa; Longhese et al., 1994, Moore et al., 1991). RPA is not unique to HR, having 
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roles in replication along with nucleotide excision repair and base excision repair (Binz et al., 
2004). 
 
RAD52 subsequently targets RAD51 to ssDNA specifically loaded with RPA, exchanging RPA 
for RAD51 to form the RAD51 nucleoprotein filament (Benson et al., 1998, New et al., 1998, 
Shinohara and Ogawa, 1998). BRCA2 has also been implicated in loading RAD51 onto ssDNA 
(Shivji et al., 2006, H. Yang et al., 2002, H. Yang et al., 2005). RAD51 has significant homology 
with the bacterial recombinase RECA, specifically in those areas that are crucial for 
recombination, DNA binding and ATP hydrolysis (Aboussekhra et al., 1992, Basile et al., 1992, 
Shinohara et al., 1992). The RAD51 nucleoprotein filament is then stabilised by RAD54, which 
also promotes strand invasion and increases the rate of pairing between homologous ssDNA 
and dsDNA (Clever et al., 1997, Petukhova et al., 1998; Figure 1.7d-e).  
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Figure 1.7 - Homologous Recombination 
Following a DNA DSB (b), the DNA ends are resected to create 3’ ssDNA tails by the MRN complex (c). RAD51 is 
loaded on to the ssDNA to form the RAD51 nucleoprotein filament (d). The subsequent binding of RAD54 
promotes strand invasion and DNA pairing (e). Following pairing, RAD51 is removed from the DNA (f) and new 
DNA is synthesised (g). Two potential outcomes are resolution whereby there is an exchange of genetic 
information, and dissolution where there is not (h).  
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Following pairing, RAD51 and RAD54 need to be removed from the DNA (Figure 1.7f). Recent 
work in C. elegans has shown that the HELQ-1 and RFS-1 proteins are both independently 
able to remove RAD51 from dsDNA, not ssDNA (Ward et al., 2010). Once the DNA is devoid 
of RAD51 and RAD54, DNA helicases and DNA polymerases are able to unwind and 
synthesize new DNA respectively (Figure 1.7g). At this point two DNA crossover structures 
are created, referred to as Holliday junctions (Holliday, 1964). There are two potential 
outcomes of the Holliday junctions: dissolution, whereby no exchange of genetic information 
occurs and resolution where there is an exchange of genetic information (Figure 1.7h). 
Dissolution is facilitated by BLM, an RECQ helicase, topoisomerase III, and BLAP75 (Raynard 
et al., 2006, Wu et al., 2006, Wu and Hickson, 2003). Resolution involves the resolvase GEN1 
which will symmetrically cleave the DNA at the Holliday junction, which is then ligated by 
DNA ligase I (Goetz et al., 2005, Ip et al., 2008). 
 
1.1.3.2 Non Homologous End Joining 
NHEJ is the predominant pathway for the repair of DSBs and is more active during the G1 
phase of the cell cycle. Due to the lack of a sister chromatid, repair by this pathway can be 
deleterious as nucleotides are often removed or added prior to ligation of the broken ends. 
 
1.1.3.2.1 DNA-Dependent Protein Kinase Complex Formation 
The first NHEJ protein to bind the DSB is the KU protein complex, a heterodimer consisting of 
a 73kDa subunit (KU70) and an 83kDa subunit (KU80, also known as KU86; Lieber, 1999). KU 
has been implicated in many cellular processes including telomere maintenance (Baumann 
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and Cech, 2000), apoptosis (Sawada et al., 2003) and transcription (Downs and Jackson, 
2004). 
 
The crystal structure of the KU complex associated with DNA shows it forms a doughnut 
shape with a positively charged central hole which is large enough to accommodate DNA (J. 
R. Walker et al., 2001). KU is able to bind to DSBs in a non structural manner, i.e. binding 
occurs to blunt ends, to ends with 5’ and 3’ overhangs, and to hairpin ends, and is largely 
independent of DNA sequence (Mimori and Hardin, 1986, Paillard and Strauss, 1991). UV 
cross-linking experiments have shown that KU70 binds tightly to DNA protecting a 5’-end 
label from nuclease degradation (W. W. Zhang and Yaneva, 1992). Similar experiments with 
KU80 suggest it does not offer this protection but is able to protect an internal label, 
suggesting KU80 may bind distal to the DSB (W. W. Zhang and Yaneva, 1992). 
 
KU is the most abundant non-histone nuclear protein, with an estimated 400,000 molecules 
per cell compared to a typical housekeeping protein having 10,000 molecules (Lieber, 1999). 
Due to its abundance and affinity for DNA ends, KU has been shown to be recruited to laser 
induced DSBs within a few seconds, suggesting it could either sense DNA damage, or prevent 
the nucleolytic degradation of DNA ends (Mari et al., 2006). 
 
Once bound to the DSB the KU complex is able to move freely, without energy input, inward 
along DNA and recruit DNA-PKCS (de Vries et al., 1989, Dvir et al., 1992, Dynan and Yoo, 
1998, Gottlieb and Jackson, 1993). Inhibition of KU translocation by cisplatin–DNA adducts 
results in the failure to recruit DNA-PKCS and therefore failure to repair the DSB (Kysela et al., 
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2003, Turchi et al., 2000). The recruitment of DNA-PKCS is facilitated by the CTD of the KU80 
subunit, specifically the last 12 amino acids (Gell and Jackson, 1999, Singleton et al., 1999). 
Deletion of this region does not affect the ability of KU80 to bind DSBs, however DNA-PKCS 
will not be recruited to the site of the DSB (Singleton et al., 1999).  
 
DNA-PKCS, a 469kDa protein, has a carboxyl terminal catalytic domain which bears amino 
acid similarity to the catalytic domain of phosphoinositide-3,4-kinase family of lipid kinases, 
placing DNA-PKCS in the PIKK family (Hartley et al., 1995, Poltoratsky et al., 1995). Upon 
recruitment to DNA by the KU complex, DNA-PKCS requires the ends of the DSB as a cofactor 
to become activated, a characteristic biologically unique to this ligase (Anderson and Carter, 
1996). Bound and activated DNA-PKCS along with the KU complex, referred to as DNA-PK, 
subsequently exhibits serine/threonine protein kinase activity (discussed in more detail in 
Section 3.1). It is believed that the formation of this complex aids in the spatial coupling of 
the DNA ends thus allowing DNA end processing (Section 1.1.3.2.2) and finally ligation 
(Section 1.1.3.2.3; Hefferin and Tomkinson, 2005). 
 
1.1.3.2.2 End Processing 
Due to the random nature of the DSBs, DNA overhangs and hairpins may need to be 
removed to allow the final ligation step. A protein believed to be involved in DNA end 
processing is Artemis (Moshous et al., 2001, Moshous et al., 2000). Cells deficient in Artemis 
exhibit radiosensitivity and defective V(D)J recombination, although the sensitivity is not as 
severe as cells deficient in other components of NHEJ (Rooney et al., 2003, J. Wang et al., 
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2005b). Artemis alone has 5’-3’ exonuclease activity which is converted to endonuclease 
activity following phosphorylation by DNA-PKCS. Once activated, Artemis is also available to 
accommodate more substrates including 5’ and 3’ overhangs and hairpins (Ma et al., 2002). 
DNA-PKCS is implicated twice in Artemis mediated end processing, it is suggested that 
conformational changes in DNA-PKCS following IR allow Artemis access to the DSB (Goodarzi 
et al., 2006). Also, the CTD of Artemis is a target of phosphorylation by DNA-PKCS following 
IR. It is suggested that Artemis’ unmodified CTD stops it binding to DNA substrates as some 
DNA structures created during replication and transcription mimic Artemis substrates. 
Phosphorylation of the CTD of Artemis subsequently alleviates this inhibition allowing it to 
bind DNA substrates involved in DNA repair (Ma et al., 2005). Artemis has also been shown 
to interact with the MRN complex when phosphorylated having a role in the G2 to M cell 
cycle checkpoint control (L. Chen et al., 2005a, X. Zhang et al., 2004). Another nuclease has 
been implicated in NHEJ, knockout of FEN-1 in S. cerevisiae leads to a 4.4 fold reduction of 
end joining which requires the removal of 5’ flaps (Wu et al., 1999). 
 
1.1.3.2.3 End Ligation 
One DNA ends have been processed, the final step of NHEJ is ligation which is mediated by 
the protein complex of XRCC4 and DNA Ligase IV (LX; Critchlow et al., 1997, Grawunder et 
al., 1997, Wilson et al., 1997). Deletion of either of these components leads to embryonic 
lethality in mice due to neuronal apoptosis (Barnes et al., 1998, Z. Li et al., 1995), and 
patients with mutations in DNA Ligase IV are radiosensitive and have developmental delay 
(Girard et al., 2004). 
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XRCC4 has been shown to interact with DNA, DNA-PKCS and the KU complex suggesting they 
aid the recruitment of LX to the site of the DSB (Hsu et al., 2002, Modesti et al., 1999, Nick 
McElhinny et al., 2000). Effective ligation will only occur however, in the presence of both 
the KU complex and DNA-PKCS, however DNA- PKCS mediated phosphorylation of LX seems 
dispensable for its ligation activity (Calsou et al., 2003). Should the DNA ends not be fully 
compatible and need the addition of extra bases, DNA polymerase mu has been shown to 
add nucleotides in a template independent manner (Gu et al., 2007a). 
 
More recently another protein has been identified which interacts and aids the LX complex. 
It was originally isolated in a patient who exhibited radio-sensitivity symptoms which could 
not be complemented with any known NHEJ factors (Dai et al., 2003). In 2006, two 
independent groups published their results on this protein and its role in NHEJ and it was 
given the name XLF (Ahnesorg et al., 2006, Buck et al., 2006). XLF has weak sequence 
homology with XRCC4 but is predicted to be structurally similar. Its suggested role in NHEJ is 
to act as a heteromultimer with XRCC4 to promote and stimulate the ligase activity of DNA 
Ligase IV (Ahnesorg et al., 2006).  
 
1.1.3.3 DNA Double Strand Break Repair Pathway Choice 
As NHEJ is active throughout the cell cycle, both the HR and NHEJ pathways are available for 
DSB repair during the late S to G2 phases of the cell cycle. Studies in avian cells suggest the 
protein CTIP, which is present in both pathways, controls the choice between the two 
pathways. As cells enter S-phase of the cell cycle, phosphorylation of CTIP at serine 327, a 
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weak CDK consensus site, results in the recruitment of BRCA1 (Yu and Chen, 2004, Yun and 
Hiom, 2009). Studies with BRCA1 deficient human cancer cells lines show an inability to 
repair breaks by HR, which can be fully complemented with the addition of wild-type BRCA1 
protein (Moynahan et al., 1999, Scully et al., 1999). This evidence suggests that the 
recruitment of BRCA1 could be the key decider in favouring HR. 
 
53BP1 has been shown to prevent the resection of DNA to form ssDNA tails which is an 
absolute requirement for HR, demonstrating that 53BP1 favours NHEJ (Bunting et al., 2010). 
This suggests a model whereby 53BP1 is able to prevent HR and favour NHEJ. However, 
during the late S and G2 phases of the cell cycle, phosphorylated CTIP is able to recruit 
BRCA1 to the sites of DSBs. BRCA1 is then able to promote HR, potentially by alleviating 
53BP1’s inhibitory effect (Figure 1.8; Boulton, 2010). These interactions however, are 
unconfirmed in mammalian systems. 
 
Incidentally, there are conflicting reports about the involvement of BRCA1 during NHEJ. In 
vitro studies using cellular extracts depleted in BRCA1 by targeted antibodies, show 
inhibition of DNA end-joining, as do BRCA1-deficient mouse embryonic fibroblast cellular 
extracts (Zhong et al., 2002). However, in vivo studies using pulse field gel electrophoresis 
show no difference between wild type cells and a human breast cancer cell line expressing a 
non-functional BRCA1 protein (H. Wang et al., 2001).  
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Figure 1.8 – Model for deciding which pathway will repair DSBs. 
a. Under normal circumstances, during late S to G2 phases of the cell cycle, BRCA1 is recruited to the sites of 
DSB by phosphorylated CTIP. BRCA1 is able to then promote repair by HR and potentially inhibit 53BP1’s ability 
to prevent DNA resection. 
b. When BRCA1 is not present at the site of a DSB, during any stage of the cell cycle excluding late S to G2, 
53BP1 prevents the resection of DNA to produce ssDNA, therefore repair of the DSB is by the NHEJ pathway. 
Image modified from Boulton, 2010. 
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1.2 Chromatin 
In eukaryotic genomes, DNA is organised in a nucleoprotein complex known as chromatin. 
The fundamental repeating unit of eukaryotic chromatin is the nucleosome (Kornberg and 
Thomas, 1974, Olins and Olins, 1974, Oudet et al., 1975). A nucleosome is the packaging of 
145bp – 147bp of DNA wrapped around an octamer of histone proteins, occurring every 200 
± 40bp throughout all eukaryotic genomes (Figure 1.9). The histone octamer consists of 2 
copies of the H2A, H2B, H3 and H4 histones. Inter-nucleosomal DNA, termed the linker DNA, 
is bound by members of the linker histone family, also known as H1. The combination of the 
nucleosome, the linker DNA and the linker histone forms a structure known as the 
chromatosome (Simpson, 1978; Figure 1.10). It is believed that a more compact DNA 
structure, known as the 30nm fibre, is stabilised by the addition of linker histones, although 
there is currently no data to support this theory (Davey et al., 2002, Syed et al., 2010, 
Tremethick, 2007).  
 
Core histone proteins, H2A, H2B, H3 and H4, are very small proteins ranging from 10-22kDa 
in size and are the most naturally occurring basic proteins known (Lindner, 2008). Their 
structure consists of folded globular domains, known as the histone fold domain. The 
histone fold domain consists of three alpha helices connected by two loops which interact 
with DNA and are required for the structural organisation of the nucleosome. The histone 
fold domains account directly for the organisation of 121bp of DNA, with approximately 27-
28bp of DNA per histone fold (Luger et al., 1997). Binding to the DNA occurs via the 
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phosphodiester backbone, with each helical turn providing two consecutive phosphate 
groups to hydrogen bond with the histone fold pairs. 
 
Core histones also consist of amino-terminal tails which extend from the nucleosome (Davey 
et al., 2002, Hacques et al., 1990, Luger et al., 1997). The amino-terminal tails are extremely 
basic due to their high numbers of lysine and arginine residues, and are subject to post 
translational modifications (PTM). For example, lysine residues can be acetylated, lysine and 
arginine residues can be methylated, serine, threonine and tyrosine residues can be 
phosphorylated and lysine residues can be ubiquitylated. These modifications rarely occur 
singularly and solely, with different types and multiple modifications typically occurring, 
making up what is known as the epigenetic code (for review, see Turner, 2007) 
 
The epigenetic code is extremely complex as the number of modifications per nucleosome 
can be very large. A single chromosome can contain up to as many as 500,000 nucleosomes 
which can lead to many epigenetic permutations (Luger and Richmond, 1998). The 
epigenetic code is also not as straightforward as the genetic code, where it is known exactly 
which DNA triplet codes for which amino acid (Lodish et al., 2007). There are conflicting 
arguments for the exact purpose of the modifications. Some evidence suggests that the 
modifications themselves alter the conformation of the nucleosome, allowing proteins to 
access the otherwise restricted DNA (Ruthenburg et al., 2007). Alternatively it is thought that 
the DNA is always accessible but proteins have nothing to bind to, and it is these 
modifications which provide that docking station (Ruthenburg et al., 2007). 
 
 




Figure 1.9 - Crystal Structure of the Nucleosome at 2.8Ä 
The crystal structure of the nucleosome particle at a resolution of 2.8Ä. The phosphodiester backbones is highlighted in brown and turquoise, core histone H3 
coloured blue, H4 coloured green, H2A coloured yellow and H2B coloured red. Image taken from Luger et al., 1997.  
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Figure 1.10 - Chromatin - The Nucleosome, Chromatosome, Chromatin and the Chromosome 
146bp of DNA is bound by an octamer of core histones, two of the H2A, H2B, H3 and H4 histones, to form the 
nucleosome of 11 nm. The elusive 30 nm fibre is formed when the linker DNA is bound by the linker histones 
which are believed to compact the DNA further. Binding of the 30 nm fibre to a chromosomal scaffold aids the 
further condensation to achieve the metaphase chromosome, the ultimate condensed form of DNA (Taken 
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Linker histones bind the inter-nucleosomal DNA and are believed to mediate 30nm 
chromatin fibre formation (Sinha and Shogren-Knaak, 2010). Linker histones have a tripartite 
structure consisting of an unstructured amino terminal domain (NTD) and CTD of sizes 13-40 
amino acids and ~100 amino acids respectively, and a well folded central globular domain of 
about 80 amino acids (Hartman et al., 1977; Figure 1.11). 
 
The globular domain of the linker histone is expected to interact with DNA as it contains at 
least 2 separate DNA binding sites: a classical winged helix motif (Figure 1.11, site 1) and a 
cluster of conserved basic residues (Figure 1.11, site 2; Ramakrishnan et al., 1993). Binding of 
the globular domain to the DNA occurs at, or near to, the nucleosomal dyad contacting with 
at least two strands of DNA (Figure 1.12; Duggan and Thomas, 2000, Goytisolo et al., 1996). 
Site 1 of the globular domain interacts with DNA close to the nucleosomal dyad. Lysine69, 
lysine71 and arginine74, contained within site 1, are suggested to fit in to the major groove 
of the DNA, with histidine25, lysine47 and lysine85 positioned to interact with the DNA 
backbone (Figure 1.11 & Figure 1.12; Brown et al., 2006). Site 2 of the globular domain 
interacts with one of the entering-and-exiting strands of linker DNA (Figure 1.11 & Figure 
1.12; Brown et al., 2006). The globular domain also protects the chromatosome from 
nuclease digestion, with crucial residues likely to influence the condensation of chromatin 











Figure 1.11 – Basic and crystal structure of a linker histone 
Top. The basic structure of a linker histone consists of a short amino terminal domain (NTD) of 13-40 amino 
acids long, a central globular domain of about 80 amino acids long, and a carboxyl terminal domain (CTD) of 
approximately 100 amino acids long. 
Bottom. The crystal structure of the globular domain of histone H5 with crucial residues mapped. The green 
cluster represents binding residues in site 1, the green cluster represents binding residues in site 2. The blue 
cluster represents those residues not contributing to binding affinity, and is positioned on the opposite side of 
the globular domain to sites 1 and 2. Image taken from Brown et al., 2006. 
 
 




Figure 1.12 - Molecular model of the linker histone within the nucleosome 
Molecular model showing the positioning of the linker histone within the nucleosome, along with its contacts 
with DNA. Nucleosomal DNA shown in blue, nucleosome dyad shown in yellow, globular domain of linker 
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Linker histones in chromatin determine the trajectory of the entering-and-exiting DNA, and 
are also likely to direct the position of successive nucleosomes, along with nucleosome-
nucleosome interactions (Sivolob and Prunell, 2003). The structure of the 30nm fibre is hotly 
debated, with two potential models proposed: the one-start solenoidal helix, where a linear 
array of nucleosomes are coiled (Finch and Klug, 1976); and the two-start helix, where 
nucleosomes are assembled in a zig-zag ribbon (S. P. Williams et al., 1986, Woodcock et al., 
1984). 
 
Recent crystal structure data of a tetranucleosome has provided evidence of a two-start 
helix, although the crystals produced in the study were devoid of the linker histones (Schalch 
et al., 2005). Another study using arrays capable of holding over 50 nucleosomes with 
varying repeat lengths of 177-207bp and in the presence of one linker histone per 
nucleosome revealed fibres of diameter 33-34nm, with a nucleosome packaging ratio  of ~11 
nucleosomes per 11nm (Robinson and Rhodes, 2006). The data presented supports the one-
start solenoidal helix, the alternative model to that seen by Richmond and colleagues, 
although the differences seen by Richmond and colleagues could be due to the absence of 
the linker histone in their studies (Robinson and Rhodes, 2006, Schalch et al., 2005). 
 
The CTD of the linker histone, which is extremely rich in lysine residues, has also been shown 
to bind the linker DNA and facilitate the higher order packaging of the 30nm fibre (Allan et 
al., 1986). There has been no direct function associated with the NTD of the linker histones, 
however it is hypothesised that the NTD can facilitate protein-protein interactions through 
PTMs (McBryant et al., 2010). Evidence for this is seen in the NTD of human H1.4 where 
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lysine 26 can be methylated. Once methylated it can be recognised by HP1, however, this 
interaction can be blocked by the phosphorylation of the adjacent serine residue (serine 27) 
creating what the authors call a “phospho switch” model (Daujat et al., 2005). 
 
1.2.1 Core Histones 
Although the core histones are often referred to as H2A, H2B, H3 and H4, there are many 
variants which have very specific roles within the cell (Table 1.1).  
 
 
Core Histone Histone Variants 
H2A H2A.1 




















Table 1.1 - Core histones and histone variants 
List of core histones and the variants associated with each of the core histones. Adapted from Lindner, 2008 
and the NCBI database. 
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There are 18 H2A variants, with only slight differences seen between them (Table 1.1). 
H2A.1, H2A.1A-E, H2A.1H, H2A.2A-C, H2A.3, and H2A.J are all very similar with only a few 
amino acid differences between them (Figure 1.13). H2A.X, although being very similar to 
the previous mentioned group, has a carboxyl-terminal extension of 10 amino acids 
containing a conserved serine residue which is rapidly phosphorylated following DSB 
induction (Figure 1.13, red box; Section 1.1.2.4).  H2A.X makes up approximately 10% of the 
total H2A within chromatin, which suggests that it is present in at least one in every 5 
nucleosomes (West and Bonner, 1980). H2A.V and H2A.Z have more differences compared 
to the previously mentioned H2A variants, however between them they share very similar 
sequences (Figure 1.13). H2A.Bbd was originally identified due to its exclusion from the 
inactive X chromosome (known as the Barr body) and is associated with active areas of 
chromatin. The H2A.Bbd variant is very different from all other H2A variants, and is the 
shortest of all with 115 amino acids, compared to 128-143 for the other variants (Figure 
1.13). There are also two exceptionally large H2A variants, macro-H2A.1 & 2, which are both 
three times the size of the other H2A variants, however, sequences are conserved around 
the globular domain (Figure 1.13). 
 
H2A variants have a region which is postulated to interact with the amino terminal tail of 
histone H4 to promote chromatin condensation and 30nm fibre formation, this region is 
known as the acidic patch (Sinha and Shogren-Knaak, 2010; Figure 1.13, region highlighted 
a). H2A.Z has a small but noticeable extension of this acidic patch which results in the tighter 
compaction of chromatin. This is reflected in the deposition of H2A.Z into areas that are 
transcriptionally inactive, namely heterochromatin (J. Y. Fan et al., 2004). H2A.Bbd lacks the 
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acidic patch, resulting in less tightly bound chromatin, and is postulated to inhibit the 30nm 
fibre formation (J. Zhou et al., 2007). The H2A-H4 interaction can also be abolished by the 
acetylation of H4 lysine16, leading to fibre unfolding (Shogren-Knaak et al., 2006). 
 
H2A.Bbd is significantly shorter than the other H2A variants, containing a shorter docking 
domain lacking the residues which interact with H3 (Y. Bao et al., 2004, Chadwick and 
Willard, 2001). H2A.Bbd also has an NTD differing from the other H2A variants, containing a 
row of 6 arginine residues and no lysine residues whatsoever (Y. Bao et al., 2004, Gautier et 
al., 2004). Studies show H2A.Bbd co-localises with regions of H4 acetylation during 
interphase and metaphase, a mark prominently seen in transcriptionally active euchromatin 
(Chadwick and Willard, 2001). Further evidence for H2A.Bbd’s presence in relaxed chromatin 
includes GFP tagged H2A.Bbd being exchanged more quickly than GFP tagged H2A in vivo 
(Gautier et al., 2004) and DNAse I digestion of nucleosomes containing H2A.Bbd exhibiting 
more frequent random cutting compared to canonical nucleosomes (Okuwaki et al., 2005). 
Nucleosomes containing H2A.Bbd were also found to bind 130bp DNA, in contrast to the 
147bp bound in canonical nucleosomes, allowing a free 10bp of DNA at each end of the 
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Figure 1.13 - Sequence alignment of H2A variants 
H2A variants were aligned to show both similarities and differences. H2A.1 to H2A.J show striking similarities, with only the occasional differences seen. H2A.V and H2A.Z 
are similar to each other, but less similar to the previous group. H2A.Z shows an extension to the acidic patch (highlighted with red a). H2A.X is very similar to the first 
group of H2A variants, however has an extension of the CTD which contains a conserved phosphorylation site (boxed in red). Both H2A.Bbd variants are much smaller than 
the other H2A variants and also display little sequence conservation. Both macro-H2A variants also display low levels of sequence conservation, but are over twice the size 
of all other H2A variants. Sequences were aligned using ClustalW program (www.ebi.ac.uk). Key - Alanine, Tyrosine and Phenylalanine, Glycine, Proline, Serine and 
Threonine, Aspartic acid and Glutamine acid, Tryptophan, Histidine, Lysine and Arginine, Isoleucine, Leucine, Methionine and Valine, Asparagine and Glutamine and 
Cysteine 
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H2A.Z is a highly evolutionary conserved variant of H2A which is reflected in its requirement 
for viability in a range of species including the ciliated protozoan Tetrahymena thermophila 
and Mus musculus (Faast et al., 2001, X. Liu et al., 1996). H2A.Z is incorporated into 
heterochromatic nucleosomes and aids the compaction of DNA. However, contrasting 
reports state that H2A.Z is also deposited into nucleosomes at the sites of transcription, 
typically euchromatin, where it efficiently promotes RNA polymerase 2 recruitment (Adam 
et al., 2001). A comprehensive review on the complex roles of H2A.Z is reported in Draker 
and Cheung, 2009. 
 
1.2.2 Linker Histones 
The number of linker histone variants, varies between species, for example, Saccharomyces 
cerevisiae and T. thermophila have only one linker histone whereas humans have 11 variants 
((Johmann and Gorovsky, 1976, Landsman, 1996 and Section 1.2.3). Knocking out the linker 
histone in T. thermophila shows no effect on viability or growth, just a slightly enlarged 
nucleus (Shen et al., 1995). S. cerevisiae strains with a disruptive mutation in the linker 
histone gene HHO1 also showed no detectable defects in chromatin structure, 
transcriptional silencing or growth rates compared to the wild type, however they were 
shown to have a reduced life span (Downs et al., 2003, Patterton et al., 1998, Ushinsky et al., 
1997). Wild type strains did show that the linker histone is inhibitory to HR in S. cerevisiae, 
potentially by occluding binding sites for HR proteins. Inhibition of HR impacts on the 
recombination-dependent mechanism of telomere maintenance, which could explain the 
reduced life span (Downs et al., 2003). Genome-wide microarray studies in the HHO1 mutant 
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yeast showed that expression of only 27 out of 6216 genes tested were affected significantly 
(Hellauer et al., 2001). Surprisingly all of these genes were down-regulated, contradicting the 
typical view of histone proteins repressing transcription.  
 
1.2.3 Mammalian Linker Histone Variants 
In mammals there are 11 H1 variants (Figure 1.14). One of these variants, H1.Foo, is oocyte 
specific (Tanaka et al., 2001), and 3 variants are testis-specific, H1.t (Drabent et al., 1993), 
H1.t2 (Martianov et al., 2005) and HILS1 (W. Yan et al., 2003). Gamete-specific linker histone 
variants replace the somatic linker histone variants during meiotic prophase and are 
replaced with transition proteins after meiosis (Pradeepa and Rao, 2007). Knockout studies 
of H1.Foo suggest they are crucial for oocyte maturation (Furuya et al., 2007), however H1.t 
null sperm remained viable with H1.1 compensating for its absence (Lin et al., 2004). 
 
The remainder of the linker histone variants, the somatic linker histone variants, can further 
be subdivided into those which are replication-dependent and those which are replication-
independent. The former is made up of H1.1, H1.2, H1.3, H1.4 and H1.5 (Albig et al., 1997) 
and are expressed in S-phase of the cell cycle, the latter is made up of H1.0 (Panyim and 
Chalkley, 1969) and H1.X (Happel et al., 2005) which are expressed during the whole cell 
cycle. 
 
Alignment of the linker histone protein sequences shows that the gamete-specific linker 
histone variants are very different from one another with the greatest similarity score of 
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22% between H1.Foo and H1.t (Appendix A). The gamete-specific linker histone variants also 
share very little similarity to the somatic linker histone variants, with the exception of H1.t 
which has a slightly higher similarity score represented by its greater conservation of the 
globular domain compared to the other gamete-specific linker histone variants (Appendix A 
and Figure 1.14). 
 
Replication dependent linker histone variants are all very similar to each other and have high 
similarity scores with extremely high conservation in their globular domains. The variation 
between them however, is seen in the CTD and NTDs (Appendix A and Figure 1.14). 
Similarities between the replication dependent and replication independent linker histone 
variants are low due to reduced conservation of the globular domain (Appendix A and Figure 
1.14). 
 
Linker histones are often collectively referred to in the literature as H1. However, the 
variants are structurally very different to one another, and it is these differences which allow 
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Figure 1.14 – Sequence alignment of all human linker histone variants 
Mammalian linker histone variants were aligned to show sequence similarities and differences. H1.1 through to H1.5 are very highly conserved over the globular domain, 
underlined in purple. There is a low level of sequence conservation amongst this group and the rest of the linker histones, with HILS1 being the least similar. Sequences 
were aligned using ClustalW program (www.ebi.ac.uk). Accession numbers are in Appendix B. Key - Alanine, Tyrosine and Phenylalanine, Glycine, Proline, Serine and 
Threonine, Aspartic acid and Glutamine acid, Tryptophan, Histidine, Lysine and Arginine, Isoleucine, Leucine, Methionine and Valine, Asparagine and Glutamine and 
Cysteine.
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Linker histone H1.1 has been shown to be crucial for Caenorhabditis elegans germline 
proliferation and differentiation in the hermaphrodite, whilst depletion of other linker 
histone variants were shown to have no effect (Jedrusik and Schulze, 2001). In humans, H1.1 
also has the most restrictive tissue specificity, only being found in the thymus, spleen, 
lymphocytes, neuronal cells and the testis (Godde and Ura, 2008). Although being classed as 
a somatic linker histone, this variant is also predominant in germ cell chromatin during early 
spermatogenesis, being replaced by the gamete specific linker histone H1.t during meiosis 
(Franke et al., 1998). 
 
H1.2 has been shown to induce apoptosis following exposure to IR due to the p53-mediated 
release of H1.2 into the cytoplasm leading to cytochrome c release and mitochondria 
mediated apoptosis (Section 1.1.1.4). Although all linker histone variants are released into 
the cytoplasm following IR, it is specifically H1.2 which induces this apoptotic response. It is 
suggested that this could possibly be to a lack of a KXXKP motif in the CTD (Konishi et al., 
2003). However, analysis of the CTD of H1.2 and the other linker histone variants shows that 
H1.1, H1.2 and H1.5 have 4 KXXKP motifs, H1.3 has 5 and H1.4 has 6, although the 
penultimate KXXKP motif is absent in H1.2 (Figure 1.14). 
 
Studies in a human breast cancer cell line, T47D, show that H1.2 depletion causes cell cycle 
arrest at the G1 phase of the cell cycle, along with the reduced expression of selected cell 
cycle genes including CDC2, CDC23 and AURKB (Sancho et al., 2008). Further studies in the 
same cells highlight the importance of a single linker histone variant, H1.4, on the survival of 
the breast cancer cell line. A high level of mortality was seen in these knock-down cells, 
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however, this was not attributable to apoptosis (Sancho et al., 2008). Interestingly, mouse 
embryonic stem cells deficient in H1.2, H1.3 and H1.4 (H234) show an increased resistance to 
IR and the alkylating agent methyl methanesulfonate (MMS; Murga et al., 2007). 
 
Linker histones, like core histones, can harbour a range of PTMs (Wisniewski et al., 2007) 
resulting in their own linker histone code (reviewed in (Godde and Ura, 2008)). The most 
studied of the linker histone PTMs is phosphorylation. During mitosis, linker histones are 
progressively phosphorylated with the peak phosphorylation at the G2/M phase of the cell 
cycle, however the exact function of these phosphorylation marks remains elusive (Talasz et 
al., 1996). Phosphorylation of linker histones occurs at (S/T)PXK motifs which are recognised 
by the cyclin dependent kinases (CDKs; Deterding et al., 2008). A novel phosphorylation site 
was recently found on H1.5 which undergoes 5 phosphorylation events during mitosis, of 
which 4 are at known CDK sites (Sarg et al., 2006). The novel site, TPAP, was found to be 
phosphorylated by glycogen synthase kinase-3 which has been shown to phosphorylate 
other targets involved in the cell cycle (Happel et al., 2009). 
 
H1.0 was originally identified in terminally differentiated cells (Panyim and Chalkley, 1969). It 
can however, be detected in mice oocytes and embryos up to the four-cell stage. At this 
point the levels of H1.0 become undetectable and it is replaced by other somatic linker 
histone variants (Fu et al., 2003). Knockout studies in mice have also shown that although it 
is the predominant linker histone in early embryogenesis, it is not essential for 
embryogenesis with viable offspring having other linker histones compensating for its loss (Y. 
Fan et al., 2001, Sirotkin et al., 1995). H1.0 shares very little sequence homology with the 
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other linker histone variants, in fact, it is more homologous to the avian histone H5 
((Zlatanova and Doenecke, 1994, Appendix A and Figure 1.14).  
 
The most recently identified linker histone is H1.X (Happel et al., 2005). This histone shuttles 
between nuclear compartments during the cell cycle. During the G1 phase of the cell cycle, 
H1.X resides predominantly in the nucleoli, whereas at the end of the G1 phase, H1.X 
spreads to the nucleoplasm (Stoldt et al., 2007). Experiments depleting the levels of H1.X 
have suggested that it is required for correct mitotic progression with defects seen in 
chromosome alignment, chromosome segregation and spindle morphology (Takata et al., 
2007). Interestingly, H1.X has been found to be over-expressed in human neuroendocrine 
tumours, although the authors do not suggest a reason for these elevated levels 
(Warneboldt et al., 2008). 
 
Viability studies in mice have shown that individual linker histone variants are dispensable 
for survival with only subtle changes in gene expression (Y. Fan et al., 2001). Examination of 
the chromatin in these knock-out mice showed that other linker histone variants 
compensate for individual loss, maintaining a normal H1 to nucleosome stoichiometry. 
Double knockout mice showed the same effects as the single knockouts, however after three 
histone genes were knocked out (H1.2, H1.3 and H1.4) no embryos survived past embryonic 
day E11.5 (Y. Fan et al., 2003, Y. Fan et al., 2001). Furthermore, embryonic stem cells taken 
from these embryos exhibit a massive reduction in the total amount of linker histone, ~50% 
of the normal ratio of linker histones to nucleosomes (Y. Fan et al., 2003). 
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Chromatin binding studies have shown that H1.2, H1.3 and H1.4 linker histone variants 
extracted from mouse liver tissue have the highest binding affinities to DNA which could 
explain their necessity in mice (Talasz et al., 1998). However, studies from different species 
show differences in the DNA binding affinities. H1.3 and H1.4 have the highest binding, 
followed by H1.5 and H1.2 with intermediate binding and H1.1 with the lowest binding to 
nucleosomal arrays of linker histone variants extracted from rat brain tissue (Orrego et al., 
2007). Whereas, in vivo studies in human cells using GFP tagged linker histone variants and 
Fluorescence Recovery After Photobleaching (FRAP) show that H1.4 and H1.5 have the 
highest DNA binding, H1.3 has intermediate DNA binding and H1.1 and H1.2 have the lowest 
DNA binding (Th'ng et al., 2005). 
 
1.3 Chromatin and the DNA Damage Response 
It is widely accepted that DNA recombination, DNA replication, mitotic condensation, 
transcription and DNA repair all involve the interaction with chromatin, and are ultimately 
affected by its structure (Cairns, 2009, Mendez-Acuna et al., 2010, Ransom et al., 2010, van 
Attikum and Gasser, 2005, L. Zhang et al., 2009). All of these processes require the 
chromatin structure to be temporarily removed, allowing the required proteins access to the 
DNA. 
 
It is currently unclear as to how the condensed chromatin structure becomes relaxed upon 
events such as DNA repair. A model proposed by Stewart (2009) suggests that following the 
poly-ubiquitylation of H2A histones by RNF8 and RNF168, other ‘hidden’ epigenetic marks on 
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chromatin become visible (Stewart, 2009). One of these marks, di-methylation of the core 
histone H4 on lysine 20 is proposed to be inaccessible in condensed chromatin. Following 
DNA damage by IR and the subsequent chromatin relaxation around the break, these marks 
are thought to become accessible. One protein, 53BP1 (Section 1.1.2.6), has a very high 
affinity for di-methylated lysine 20 on histone H4 and plays a part in the stabilisation of 
53BP1 at the sites of DSBs (Botuyan et al., 2006). 
 
Three recent studies have highlighted the importance of linker histone variants during DNA 
repair, specifically DSB repair. A linker histone mix, extracted from calf thymus tissue, was 
shown to strongly inhibit DNA end joining in vitro (Kysela et al., 2005). Following 
phosphorylation of the linker histone mix, however, DNA end joining is restored, possibly 
due to the reduced affinity of linker histones for DNA (Dou et al., 2002, Green et al., 1993, 
Kysela et al., 2005, Roque et al., 2008, Th'ng et al., 1994). Another study showed that a linker 
histone mix could mildly stimulate DNA end joining when used at lower levels to the 
previous study. However, when using DNA ligase III, DNA end stimulation was significantly 
higher. Further work in this study showed that H1.2 was the linker histone responsible for 
the stimulation (Rosidi et al., 2008). Another study using chicken DT40 cells with individual 
linker histones knocked out shows a crucial role for H1.R in survival following MMS 
treatment. Results in the study fail to ascertain exactly how H1.R is involved in DNA repair, 
however the authors suggest that it may be required for accessibility or efficiency of repair 
proteins (Hashimoto et al., 2007). 
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The data presented by Kysela et. al. highlights the importance of linker histones during LX-
mediated DNA ligation, and specifically as a target of DNA phosphorylation by DNA-PK, both 
important processes of the NHEJ pathway (Kysela et al., 2005). This highlights the necessity 
to ascertain the role the linker histone family have during DNA repair, and specifically NHEJ. 
  
 












CHAPTER TWO: MATERIALS AND METHODS 
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2.1 Suppliers 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich. Restriction 
endonucleases were purchased from New England Biolabs or Fermentas. Tissue culture 
plastics were ordered from Corning. Tissue culture reagents were ordered from PAA Labs. 
Radionucleotides were ordered from Perkin Elmer, oligodeoxyribonucleotides were ordered 
from Invitrogen and oligoribonucleotides were ordered from Eurofins-MWG. Antibodies 
were purchased from Abcam, Invitrogen, Sigma or Santa Cruz. 
 
2.2 Cells and Cell Culture 
2.2.1 MRC5VA Cells 
MRC5VA cells were used throughout this thesis, they are an embryonic lung fibroblastic cell 
line immortalised by SV40 transformation. 
 
2.2.2 Cell Maintenance 
All solutions and equipment used in cell maintenance were either obtained sterile or 
autoclaved, where appropriate, prior to use. All cell culture work was undertaken in sterile 
conditions in a class 2 tissue culture hood (Holten LaminAir). 
 
Cells were maintained in a humidified chamber (37oC, 5% CO2, 95%; MCO-15AC, Sanyo) in 
75cm2 cell culture flasks containing 10mL Dulbecco’s Modified Eagle’s Medium (DMEM; 
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containing 1000mg/L glucose) supplemented with 10% (v/v) foetal bovine serum (FBS), 2mM 
L-glutamine, 1mM sodium pyruvate and 1% non-essential amino acids (Sigma-Aldrich) 
(supplemented DMEM), and where applicable with an additional 600g/mL G418 (G418 
DMEM). Cells were seeded at a density of 1x106 cells/flask and routinely passaged on day 3. 
 
2.2.3 Trypsinisation of Confluent Cells 
Upon confluency of the cells, media was aspirated from the flask using a sterile pipette. Cells 
were washed with 10mL of phosphate buffered saline (PBS; 2.7mM KCl, 137mM NaCl, 10mM 
phosphate buffer, pH 7.4). PBS was aspirated and replaced with 3mL of trypsin- 
ethylenediaminetetraacetic acid (EDTA; 0.25%:0.02%, 37oC). Flasks were placed in a 
humidified chamber until the cells detached from the bottom (~3 minutes), sometimes 
requiring gentle agitation. Following detachment, 7mL of supplemented DMEM was added 
and the cell suspension gently mixed using a sterile pipette. The suspension was 
subsequently transferred into a 15mL centrifuge tube (Falcon, Becton Dickinson Labware) 
and centrifuged at 1,200 rpm for 5 minutes at 20oC. The supernatant was carefully aspirated 
without disturbing the pellet, the subsequent pellet was either reseeded (Section 2.2.4), 
frozen (Section 2.2.5), transfected (Sections 2.2.6 and 2.2.7), or used for protein 
quantification (Section 2.3). 
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2.2.4 Cell Reseeding 
For routine cell maintenance, trypsinised cell pellets were resuspended in 10mL of 
supplemented DMEM and 1x106 cells were transferred to a 75cm2 cell culture flask 
containing 10mL of supplemented DMEM, or G418 DMEM where necessary. The flask was 
gently agitated to ensure an even distribution of the cells, and then placed in a humidified 
chamber and allowed to grow to confluency (~3 days). 
 
2.2.5 Cell Cryopreservation 
Trypsinised cell pellets were resuspended in 1mL FBS containing 10% (v/v) dimethyl 
sulphoxide as a cryoprotectant. The cell suspension was transferred into a 2mL cryovial 
(Nunc) and placed in a cryogenic freezing vessel (Mr. Frostie, Nalgene). The container was 
stored at -80oC overnight, after which the cryovials were removed and placed into liquid 
nitrogen for long-term storage. 
 
2.2.6 Short Interfering RNA Transfection 
Trypsinised cell pellets were resuspended in 10mL of supplemented DMEM, cells were 
counted and seeded according to manufacturer’s instructions (Table 2.1). Twenty four hours 
later cells were transfected according to the manufacturer’s instructions (Summarised in 
Table 2.1). Briefly, serum free DMEM was added to a sterile, RNAse free, labelled 1.5mL 
microcentrifuge tube. Short interfering RNA (siRNA) oligonucleotides (Table 2.2) were added 
to the serum free DMEM to a final concentration of 10M and the tube was vortexed gently. 
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INTERFERin (Polyplus transfection; Table 2.1) was added to the siRNA duplex solution and 
vortexed immediately for 10 seconds. The microcentrifuge tube was left at room 
temperature for 10 minutes before being added to the cells with replenished supplemented 
DMEM. Alongside targeted knockdowns, a negative control targeted towards the Photinus 
pyralis Luciferase (LUC) gene and an un-transfected negative control were also used. 
 
Vessel Seeding density Serum free DMEM INTERFERin Final Volume 
6-well dish 150,000 200L 8L 2.2mL 
25cm2 Cell 
Culture Flask 
400,000 400L 15L 4.4mL 
75cm2 Cell 
Culture Flask 
1,000,000 500L 40L 10.5mL 
Table 2.1 - siRNA Transfection Details 
The three culture vessels used for all transfections are listed with the required initial seeding densities of the 
cells, the amount of serum free DMEM the siRNA oligonucleotides are diluted into and the amount of 
INTERFERin used per reaction. 
 
Target Gene Sequence 
H1.2 5’-AAGAGCGUAGCGGAGUUUCUCTT-3’ (21mer) 
H1.X 5’-CCAAGAAGGUUCCGUGGUUTT-3’ (19mer) 
LUC 5’-CGUACGCGGAAUACUUCGATT-3’ (19mer) 
Table 2.2. List of siRNA oligonucleotides used for siRNA transfection. 
 
2.2.7 Stably Transfected Cell Line Generation 
To a labelled 1.5mL microcentrifuge tube, 98L serum free DMEM and 3L Fugene 6 
transfection reagent (Roche) was added and mixed by gentle tapping. To this solution, 1g 
of DNA was added and mixed gently by tapping, and left at room temperature for 15 
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minutes. This mixture was added to a well of a 6-well-plate containing 90% confluent cells in 
2mL supplemented DMEM and placed in a humidified chamber. After 48 hours the cells 
were trypsinised as outlined in Section 2.2.3, the pellet resuspended in 10mL G418 DMEM 
and spread over three 10cm2 Petri dishes containing G418 DMEM. The plates remained in a 
humidified chamber, with frequent media changes, for ~2 weeks to allow stably transfected 
isolated colonies to grow. Once colonies had begun to grow and contained ~150 cells they 
were scraped from the bottom of the Petri dish with a sterile 200L pipette tip and 
transferred to a separate well in a 6-well plate containing G418 DMEM. The plates were 
placed in a humidified chamber and allowed to grow to 90% confluency before being 
transferred to a 75cm2 cell culture flask. Individual colonies were assessed for transfection 
by Western blotting (Section 2.3) and immunofluorescence (Section 2.5) The flasks were 
kept in G418 DMEM to maintain a stable transfected population. 
 
2.3 Protein Harvesting and Quantification 
2.3.1 Mammalian Protein Extraction 
Trypsinised cell pellets were washed with 5mL PBS and the resulting pellet resuspended in 
twice the cell pellet volume of RIPA buffer (50mM Tris/HCl pH7.5, 1mM EDTA, 150mM NaCl, 
0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholic acid, 1% Igepal CA-360 (Mammalian 
Cell Lysis Kit, Sigma), and protease inhibitor cocktail (Roche)) and placed on ice for 20 
minutes. The suspension was centrifuged at 13,000 rpm for 5 minutes at 4oC. The 
supernatant was carefully removed and placed into a fresh 1.5mL microcentrifuge tube. 
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Protein concentration was determined by the method of Bradford (Bradford, 1976), briefly, 
1mL of 0.5x Bradford reagent was placed into a cuvette, to which 5L of sample was added. 
Absorbance was read at 595nm using a Genova spectrophotometer against a standard curve 
(5-30g bovine serum albumin (BSA)). 
 
2.3.2 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gels for immuno-blotting were prepared 
with a resolving gel segment and an overlaying 3% stacking gel segment.  The percentage of 
the resolving gel segment was 9%, 13% or 15% dependant on the molecular weight of the 
proteins to be resolved. The resolving gel was made up from 30% acrylamide Protogel 
(National Diagnostics), 375mM Tris/HCl pH8.8, 0.1% SDS, made to 5mL with water, and 
polymerised with 10% ammonium persulphate (APS) and tetramethylethylenediamine 
(TEMED). Four fifths of the resolving gel was poured and covered with isopropanol whilst the 
gel set. The isopropanol was removed and replaced with a stacking gel (3% polyacrylamide, 
50mM Tris pH6.8, 0.1% SDS, made to 5mL with water and polymerised with 10% APS and 
TEMED). Combs were immediately added to the stacker gel and allowed to set. Once set, the 
gels were placed into an electrophoresis tank (BIORAD Mini), part filled with SDS running 
buffer (25mM Tris, 192mM glycine, 0.1% SDS) and the combs removed. Protein samples, 
typically 15g, were diluted with 5x SDS loading buffer (65mM Tris/HCl pH8, 10% (v/v) 
glycerol, 2.3% (w/v) SDS, 0.01 bromophenol blue, 1% dithiothreitol (DTT)), denatured at 
100oC for 5 minutes and placed immediately on ice. The samples, including a protein ladder 
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were loaded into the wells of the gel and resolved at 150V for ~60 minutes until the loading 
dye approached the bottom of the gel. 
 
2.3.3 Coomassie Staining and Drying of SDS-PAGE Gels 
SDS-PAGE gels were stained using PageBlue (Fermentas). Briefly, the gel was placed in 20mL 
distilled water and heated until boiling point, the water was removed and replaced with 
fresh water. This was repeated twice more with the gel finally being boiled in 20mL PageBlue 
reagent. The gel was left on a rocker for approximately 20 minutes until banding had 
become clear, it was destained with several washes of distilled water. 
 
The gel was dried by sandwiching it between filter paper and Saran wrap and vacuum dried 
at 80oC for 60 minutes on a Gel Master Gel Dryer Vacuum System (Welch).  
 
2.3.4 Protein Transfer from SDS-PAGE to Polyvinylidene Fluoride Membrane 
The SDS-PAGE gel was transferred to an adequately sized piece of polyvinylidene fluoride 
(PVDF) transfer membrane which had been activated by brief immersion in methanol. The 
membrane and gel were sandwiched between two sponges and filter paper and clamped 
into a transfer device which was placed into a transfer unit (Amersham). This was filled to 
the top with CAPS buffer (10mM CAPS pH 11, 10% methanol) and run at 230mA for 90 
minutes at 4oC. The membrane was subsequently blocked using 5mL of 5% milk protein in 
PBS + 0.1% Tween (PBS/Tween) overnight at 4oC. 
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2.3.5 Western Blotting 
The PVDF membrane was placed into a 50mL centrifuge tube (Falcon), with the protein 
bound side of the membrane facing inwards, containing 5mL of 5% milk protein in 
PBS/Tween and the primary antibody diluted as appropriate (Table 2.3). The centrifuge tube 
was placed on a tube rotator and incubated as appropriate (Table 2.3). The membrane was 
removed from the centrifuge tube and subjected to 3 x 5 minute washes in PBS/Tween. The 
membrane was again placed inside another 50mL centrifuge tube containing 5mL of 5% milk 
protein in PBS/Tween and the secondary antibody (Table 2.3) and placed on a tube rotator 
and incubated at room temperature for one hour. The membrane was removed from the 
centrifuge tube and subjected to a further 3 x 5 minute washes in PBS/Tween. After the 
washes the membrane was overlaid with ECLPlus reagent (Amersham Biosciences) for 5 
minutes. Excess ECLPlus reagent was removed from the membrane and it was wrapped in 
Saran wrap, before exposure to autoradiography film (Kodak) for 30 seconds to 5 minutes 
dependant on the strength of the signal. Autoradiography films were then developed in an 
X-ray film developer (Konica Minolta). 
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Antibody Species Dilution Application Operating Conditions 
Anti-H1.X1 Rabbit 1:1000 Western Blotting 1hr, room temp, 5% milk 
Anti-H1.X1 Rabbit 4g Immunoprecipitation Standard Protocol (2.19.4) 
Anti-H1.21 Rabbit 1:1000 Western Blotting 1hr, room temp, 5% milk 
Anti-H2A.X2 Mouse 1:1000 Immunofluorescence 1hr, room temp, 2% FCS 
Anti- 
bromodeoxyuridine3 
Mouse 1:50 Flow Cytometry 0.5% normal goat serum, 
0.5% Tween 20 
Anti-FLAG4 Mouse 1:1000 Western Blotting 1hr, room temp, 5% milk 
 
Anti-FLAG4 Mouse 1:1000 Immunofluorescence 1hr, room temp, 2% FCS 
Anti-his2 Mouse 1:1000 Western Blotting 1hr, room temp, 5% milk 
Anti--tubulin1 Rabbit 1:10000 Western Blotting 30 minutes, room temp, 5% 
milk 
Anti-GFP1 Mouse 1:1000 Western Blotting 1hr, room temp, 5% milk 
Anti-GFP1 Mouse 4g Immunoprecipitation Standard Protocol (2.19.4) 
Anti-H2A5 Rabbit 1:5000 Western Blotting Overnight, 4oC, 5% milk 
Anti-XRCC45 Rabbit 1:1000 Western Blotting 1hr, room temp, 5% milk 
Anti-DNA Ligase IV6 Goat 1:200 Western Blotting 1hr, room temp, 5% milk 
Anti-Mouse-HRP3 Rabbit 1:5000 Western Blotting 1hr, room temp, 5% milk 
Anti-Rabbit-HRP3 Goat 1:5000 Western Blotting 1hr, room temp, 5% milk 
AlexaFluor 5947 Goat 1:1000 Immunofluorescence 1hr, room temp, 2% FCS 
AlexaFluor 4887 Goat 1:50 Flow Cytometry 0.5% normal goat serum, 
0.5% Tween 20 
     
Table 2.3 - Table of antibodies, their dilutions and incubation times 
Listed are all the antibodies used in this thesis. Other information provided includes the species the antibody 
was raised in, along with the specific application the antibody was used in, including the dilution for that 
application and the operating conditions. Antibody Sources. 1 – Abcam, 2 – Upstate, 3 – Dako, 4 – Sigma 
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2.4 Clonogenic Survival Assay 
Transfected cells were grown in 75cm2 cell culture flasks, as explained in 2.2.6, trypsinised as 
outlined in 2.2.3, counted using a haemocytometer and reseeded at 1x105 cells/mL. Cells 
were irradiated with 2, 4, 6 and 8 Gy of IR (Caesium 137 source), with one sample left un-
irradiated. Cells were seeded out at 50, 100, 500, 1000, 5000 and 10000 cells per well into a 
6-well plate for 0, 2, 4 and 6 Gy exposure. For 8 Gy exposure, 10000, 50000, 100000, 500000 
and 1000000 cells were seeded out. The 6-well plate was placed in a humidified chamber 
and left for ~2 weeks until colonies of ~50 cells were visible. The media was aspirated and a 
few drops of crystal violet (0.4% crystal violet, 50% Methanol) were added to each well. This 
was agitated for a few seconds and washed off with distilled water. Colonies were counted 
in the wells that contained between 50 and 100 cells. The experiment was repeated in 
triplicate and the data statistically analysed using the students’ two-tailed t-test. 
 
2.5 Immuno-fluorescence 
2.5.1 Fixation of Cells 
Cells were grown in 6-well dishes containing a 22mm x 22mm coverslip (VWR, UK), sterilised 
under UV light for 30 minutes. At the point of fixation, the media was aspirated and the 
coverslip washed with PBS. To each coverslip 1mL of immuno-fluorescence lysis buffer was 
added (10mM PIPES pH 6.8, 300mM sucrose, 20mM NaCl, 3mM MgCl2, 0.5% Triton X-100) 
and incubated on ice for 7 minutes. The slides were washed in PBS, and 1mL of 4% 
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paraformaldehyde (diluted in PBS) was added and left on ice for 10 minutes. The 
paraformaldehyde was aspirated and washed 3 times with PBS. 
 
2.5.2 Immuno-probing 
Ten percent FBS was added to the slides and incubated on a rocking platform for 1 hour at 
room temperature to aid blocking of non-specific proteins. FBS was removed and the slides 
washed with PBS. Subsequently, 100L PBS supplemented with 2% FBS and primary 
antibody (Table 2.3) was added and incubated at 37oC for 1 hour on a rocking platform. The 
coverslip was washed with 3 x 5 minute PBS washes and replaced with 100L PBS 
supplemented with 2% FBS and a fluorescently tagged secondary antibody (Table 2.3) and 
incubated at 37oC for 1 hour in the dark on a rocking platform. The coverslip was again 
washed with 3 x 5 minute PBS washes in the dark. 
 
2.5.3 Mounting and Visualisation 
The slides were mounted in Vectashield (Vector Laboratories, CA, USA) mounting media, 
containing 4',6-diamidino-2-phenylindole (DAPI), onto microscope slides (VWR). The slides 
were sealed with clear nail varnish and left at 4oC overnight before analysis. Slides were 
analysed with a Carl Zeiss microscope using a 100x objective and Smart Capture2 software. 
 
 
Page | 62  
 
2.6 H2A.X Quantification 
Transfected cells (Section 2.2.6) were grown in 6-well dishes containing a 22mmx22mm 
coverslip (VWR, UK), sterilised under UV light for 30 minutes. Cells were irradiated with 5 Gy 
of IR and placed in a humidified chamber. At 30 minutes and 24 hours post-irradiation the 
cells were fixed as outlined in Section 2.5.1, along with un-irradiated controls. Cells were 
immuno-probed as described in Section 2.5.2 with an antibody targeted towards H2A.X. 
After mounting and visualisation (Section 2.5.3), a minimum of 50 nuclei per time point per 
sample were examined and H2A.X foci per nuclei were counted using Photoshop Software 
(Adobe). The experiment was repeated in triplicate and the data statistically analysed using 
the students’ two-tailed t-test.  
 
2.7 Cytochalasin B Micronuclei Assay  
The cytochalasin B micronuclei assay was adapted slightly from published protocols (Fenech, 
2007, Fenech and Morley, 1985). Transfected cells (Section 2.2.6) were grown in 6-well 
dishes (Corning) containing a 22mmx22mm coverslip (VWR International, Lutterworth, UK), 
sterilised under UV light for 30 mins. Cells were irradiated with 5 Gy of IR and placed in a 
humidified chamber for 5 hours, along with un-irradiated controls. After 5 hours, 
cytochalasin B was added to the cells at 2g/mL per well. At 24 and 48 hours post-
irradiation, slides were fixed as outlined in 2.5.1. The slides were mounted as described in 
2.5.3, 100 binucleate cells per time point per sample were examined and total nuclei and 
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total micronuclei were counted. The experiment was repeated in triplicate and the data 
statistically analysed using the students’ two-tailed t-test. 
 
2.8 Cell Cycle Flow Cytometry Assay 
Transfected cells were grown in 75cm2 cell culture flasks to ~60% confluency, as explained in 
2.2.6. At this point 20M bromodeoxyuridine (BrdU) was added to the flasks and left for 20 
minutes in a humidified chamber. The cells were trypsinised as explained in Section 2.2.3 
and resuspended in 10mL supplemented DMEM. This suspension was counted using a 
haemocytometer and the cells resuspended at a cell density of 3x105/mL with 2 aliquots for 
each cell line. One of each of these suspensions was irradiated with 5 Gy of IR, the other left 
un-irradiated as a control. One millilitre of this suspension was seeded out into 25cm2 cell 
culture flasks allowing 4 hour time points over a 24 hour period. The flasks were placed in a 
humidified chamber until the designated time point. At each time point, including the cell 
suspension for time point zero, cells were trypsinised as explained in Section 2.2.3. The cell 
pellet was resuspended in 5mL PBS and centrifuged at 1,200 rpm for 5 minutes. The 
supernatant was removed and the cells resuspended in 2mL ice-cold ethanol whilst being 
vortexed to avoid cell clumping. The suspension was left at -20oC for at least 48 hours. The 
suspension was centrifuged at 1,200 rpm for 5 minutes, the pellet resuspended in 3mL PBS, 
followed by centrifugation at 1,200 rpm for 5 minutes and the pellet resuspended in 2mL 2M 
HCl containing 0.1% pepsin and left at room temperature for 20 minutes. Two millilitres PBS 
was added to the suspension and centrifuged at 1,200 rpm for 5 minutes. The pellet was 
resuspended in 3mL PBS and centrifuged at 1,200 rpm for 5 minutes, this PBS wash was 
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repeated a second time. The pellet was resuspended in 100L PNT (PBS containing 0.5% 
normal goat serum and 0.5% tween) and anti-BrdU antibody (Table 2.3). This was left at 
room temperature for 60 minutes, after which 3mL PBS was added and the suspension 
vortexed, it was then centrifuged at 1,200 rpm for 5 minutes. The pellet was resuspended in 
3mL PBS and centrifuged at 1,200 rpm for 5 minutes. The pellet was resuspended in 100L 
PNT containing the secondary antibody, AlexaFluor 488 conjugated goat-anti-mouse 
secondary antibody (Table 2.3) and left in the dark for 60 minutes. Three millilitres PBS was 
added and the suspension vortexed, it was centrifuged at 1,200 rpm for 5 minutes. The 
pellet was resuspended in 3mL PBS and centrifuged at 1,200 rpm for 5 minutes. The pellet 
was resuspended in 0.5mL PBS containing 20L/mL proidium iodide and analysed using a 
Coulter Elite flow cytometer using UV and 488nm lasers for excitation. The data obtained 
was analysed using FlowJo Flow Cytometry Analysis Software (Tree Star, Inc). 
 
2.9 Plasmids 
All plasmids used in this study are listed in Table 2.4. Their corresponding maps are shown in 
Figure 2.1 to Figure 2.4.  
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2.10 Bacteria 
2.10.1 General Maintenance 
Bacterial strains were maintained as glycerol stocks kept at -80oC, and were re-streaked onto 
fresh LB agar, supplemented with antibiotics as appropriate (Table 2.5), and incubated at 
37oC overnight. Overnight cultures were grown by inoculating a single fresh colony into 5mL 
of LB broth, supplemented with antibiotics as appropriate (Table 2.5), and incubated in an 
orbital shaker at 37oC/220 rpm for 12-16 hours. 
 
2.10.2 Image Clones 
All image clones were ordered from Geneservice and are listed in Table 2.6. 
 
2.10.3 Transformation 
Typically, 2L of ligation products were added to 20L competent Escherichia coli, and left 
on ice for an hour. The mixture was placed at exactly 42oC for 1 minute, and then placed on 
ice for 2 minutes. SOC media (Invitrogen) was added to the mixture and placed in an orbital 
shaker, 220 rpm at 37oC, for 60 minutes. Following this recovery period, 125L of this 
mixture was spread onto an LB agar plate supplemented with the appropriate antibiotic 
(Table 2.5) and incubated at 37°C overnight. 
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Plasmid Description Source 
pGEM-T-Easy Cloning of PCR generated DNA fragments. (Figure 
2.1) 
Promega 
pFLAG-CMV-4 Generation of flag-tagged recombinant proteins 
for in vivo studies. (Figure 2.2) 
Invitrogen 
pET28-b Generation of his-tagged recombinant proteins 
for use in protein purification. (Figure 2.3) 
Novagen 
pEGFP Generation of EGFP-tagged recombinant proteins 
for in vivo studies. (Figure 2.4) 
Clontech 
Table 2.4 - List of plasmids used in this study. 
All the plasmids used in this thesis are listed, along with their purpose of use and where the material was 
sourced from. 
 
Antibiotic Stock Concentration Working Concentration Plasmids 
Ampicillin 50mg/mL in H2O 50g/mL pGEM-T-Easy, pFLAG-CMV-4, 
pPCR-Script AMP SK (+) 
Kanamycin 25mg/mL in H2O 25g/mL pET28-b, pEGFP, pCR4-TOPO, 
pCR-BluntII-TOPO 
Chloramphenicol 34mg/mL in ethanol 25g/mL pOTB7 
Table 2.5 - Antibiotics used in this study. 
The antibiotics used in this thesis are listed, along with the stock and working concentrations, along with the 
plasmids which carried the antibiotic resistance gene. 
 
Gene Name Accession Number Source Source Plasmid 
H1.1 BC069492 Geneservice pPCR-Script AMP SK (+) 
H1.2 BC002649 Geneservice pOTB7 
H1.3 BC104874 Geneservice pCR4-TOPO 
H1.4 BC099632 Geneservice pCR-BluntII-TOPO 
H1.5 BC101581 Geneservice pCR4-TOPO 
H1.X BC010435 Geneservice pOTB7 
Table 2.6 - List of Image Clones used in this study 
Image clones were obtained for all linker histone genes used in this thesis. This table described where each 
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Figure 2.1 – Plasmid map of pGEM-T-Easy 
pGEM-T-Easy is a plasmid used to clone A-tailed PCR fragments. The plasmid is supplied linear, and becomes 
circularised upon insertion and ligation of PCR products. The multiple cloning site (MCS) contains many 
restriction sites, including the double EcoRI site which, using a single digest will reveal any inserted DNA. 
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Figure 2.2 – Plasmid map of pFLAG-CMV-4 
pFLAG-CMV-4 is a mammalian expression vector which adds the FLAG peptide sequence (DYKDDDDK, red filled 
box) at the amino terminus of the cloned gene. Linker histones were cloned into pFLAG-CMV-4 via the multiple 
cloning site (MCS) via the BglII and XbaI restriction sites. pFLAG-CMV-4 contains both an ampicillin resistance 
gene and a neomycin resistance gene for selection in both bacteria and mammalian cells respectively. 
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Figure 2.3 – Plasmid map of pET28-b 
pET28-b is a protein expression plasmid. Linker histone genes were cloned into the cloning/expression region 
(blue box on plasmid map, sequence data below). Highlighted are the T7 promoter and terminator regions (red 
box), the LacI operator (blue box), the ATG start site (red ATG), and the poly histidine tags (underlined). Note, 
linker histones were cloned so that the latter (3’) his-tag was not expressed. 
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Figure 2.4 – Plasmid map of pEGFP 
pEGFP is a mammalian expression vector which adds the GFP protein at the amino terminus of the cloned 
gene. Linker histone genes were cloned in to pEGFP via the multiple cloning site (MCS) and the EcoRI and 
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2.11 Agarose Gel Electrophoresis of DNA 
Samples were typically resolved on an 1.5% agarose (Bioline), TBE (89 mM Tris-Base, 89 mM 
boric acid, 2mM EDTA) gel. This was heated until all the agarose had dissolved, allowed to 
cool before the addition of 0.5μg/mL ethidium bromide and poured into an electrophoresis 
tray (Anachem). The electrophoresis tray was placed inside an electrophoresis tank and the 
samples were loaded into the wells, each sample was loaded containing x10 DNA loading 
buffer (50% glycerol, 0.05% bromophenol blue). To determine the size of the fragments, 
20μL of a 1kbPlus DNA ladder (Invitrogen) was also added to the gel. The products were 
resolved by applying 180V across the electrophoresis tank until the products had migrated 
10 cm. Products were viewed and photographed under UV light. 
 
2.12 DNA Extraction 
2.12.1 DNA Extraction from Agarose Gels 
DNA bands for extraction were excised from the agarose gel using a sharp scalpel and placed 
into a 1.5mL microcentrifuge tube. Excised bands were purified using the Qiagen QIAquick 
gel extraction kit following manufacturer instructions. Briefly, 300l of QG buffer was added 
and heated to 60oC until the agarose fragment had dissolved. One hundred microlitres of 
isopropanol was added, after 1 minute the sample was transferred to a spin column 
provided and centrifuged at 13,000 rpm for 1 minute. The column was then washed twice 
with 750L PE buffer and finally eluted with 50L EB buffer (1.25M NaCl, 50mM Tris/HCl pH 
8.5, 15% isopropanol (v/v)). 
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2.12.2 Small Scale Purification of Plasmid DNA, Miniprep. 
Plasmid DNA was extracted from an overnight culture using the QIAprep Miniprep kit. 
Briefly, the bacterial cells from the overnight culture were pelleted by centrifugation at 
13,000 rpm for 5 minutes in a 1.5mL microcentrifuge tube. The cells were resuspended in 
250L resuspension buffer P1 before the addition of 250L of lysis buffer P2. The solution 
was mixed by several inversions and allowed to stand for 5 minutes. After lysis, 350L 
neutralisation buffer, N3, was added and the solution mixed immediately by several 
inversions until the solution became cloudy. Cellular debris, including genomic DNA, was 
pelleted by centrifugation at 13,000 rpm for 10 minutes. The supernatant was aspirated and 
placed into a labelled QIAprep spin column and centrifuged for 1 minute at 13,000 rpm. The 
flow through was discarded and 500L wash solution PB was added to the column and 
centrifuged for a further 1 minute at 13,000 rpm with the flow through being discarded. A 
second wash using 750L of PE buffer was passed through the column by centrifugation at 
13,000 rpm for 1 minute. The flow through was discarded and any residual buffer was 
washed away from the column by centrifugation at 13,000 rpm for 1 minute. The QIAprep 
column was then transferred to a labelled 1.5mL microcentrifuge tube, 50L of elution 
buffer was added to the centre of the column and left to stand for 1 minute. The DNA was 
eluted by centrifugation at 13,000 rpm for 1 minute. 
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2.13 DNA Manipulation 
2.13.1 Polymerase Chain Reaction 
2.13.2 Standard Polymerase Chain Reaction 
All polymerase chain reactions (PCR) were performed on a GeneAmp 9700 thermocycler 
(Perkin Elmer) using 2 units Taq DNA polymerase (Invitrogen), 1mM dNTP mix (Roche), 
1.5mM MgCl2, 1mM forward and reverse primer (See Table 2.8 for primer list) and the 
appropriate amount of 10  PCR buffer (Invitrogen) unless otherwise stated.  The amount of 
DNA template and PCR program used are listed in the relevant sections.   A general PCR 
program is shown in Table 2.7. In all cases an identical PCR reaction using distilled water 
instead of DNA was used as a negative control.  Positive controls, which vary for each 
application, were always included.  
 
Temperature Time Purpose 
95oC 4 minute  Initial Melting 
95oC 1 minute  Melting 
TA
oC 1 minute 35 cycles Annealing 
68oC x minute  Extension 
68oC 4 minute  Final Extension 
 
Table 2.7 - Standard PCR Cycle 
An annealing temperature (TA°C) of 3-5°C below the melting temperature of the primers was used.  The 
extension time (x minute) was calculated based on PCR product length and rate of extension of the polymerase 
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2.13.3 Cloning Polymerase Chain Reaction 
Cloning PCR reactions were performed on a GeneAmp 9700 thermocycler using 2.5 units 
FailsafeTM DNA polymerase (CamBio), 2x buffer D (containing dNTPs and MgCl2), 1mM 
forward and reverse primer (Table 2.8), 1G plasmid DNA and topped to 50L with nuclease 
free water. A general PCR program is shown in Table 2.7. 
 
2.13.4 Colony Polymerase Chain Reaction 
Colony PCR reactions were setup as outlined in Section 2.13.2 with the addition of 5L of a 
fresh overnight bacterial culture. The PCR program used is shown in Table 2.7 with the initial 
melting step extended to 5 minutes to aid bacterial lysis. 
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H1.1 Forward All plasmids GCAGAGATCTGATGTCTGAAACAGTGCCTCCCGCC 55oC 1 minute 
H1.1 Reverse All plasmids GCAGTCTAGACTCGAGTTACTTTTTCTTGGGTGCCGC 55oC 1 minute 
H1.2 Forward All plasmids GCAGAGATCTGATGTCCGAGACTGCTCCTGC 55oC 1 minute 
H1.2 Reverse All plasmids GCAGTCTAGACTCGAGCTATTTCTTCTTGGGCGCCG 55oC 1 minute 
H1.3 Forward All plasmids GCAGAGATCTGATGTCGGAGACTGCTCCACTTGCTCC 55oC 1 minute 
H1.3 Reverse All plasmids GCAGTCTAGACTCGAGTCACTTTTTCTTCGGAGCTGCC 55oC 1 minute 
H1.4 Forward All plasmids GCAGAGATCTGATGTCCGAGACTGCGCCTGCCGCG 55oC 1 minute 
H1.4 Reverse All plasmids GCAGTCTAGACTCGAGCTACTTTTTCTTGGCTGCCGCCTTCTTTGGCTTGGCTG 55oC 1 minute 
H1.5 Forward All plasmids GCAGAGATCTGATGTCGGAAACCGCTCCTGCCGAGA 55oC 1 minute 
H1.5 Reverse All plasmids GCAGTCTAGACTCGAGCTACTTCTTTTTGGCAGCCG 55oC 1 minute 
H1.X Forward pFLAG Cloning GCAGAGATCTGATGTCCGTGGAGCTCGAGGAGGCCC 55oC 1 minute 
H1.X Reverse pFLAG Cloning GCAGTCTAGACTCGAGTCACTTGCGGCCCTTGGGCAC 55oC 1 minute 
H1.X Forward pET Cloning GCAGGAATTCGATGTCCGTGGAGCTCGAGGAGGCCC 55oC 1 minute 
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AGCGGATAACAATTTCACACAGG 50oC 10 seconds 
 
Table 2.8 - List of primers used in this thesis. 
Primers sequences used in this thesis along with the application for the primers, their melting temperature and extension times. 
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2.13.5 Restriction Digests 
Restriction digestions were routinely set up in 25L reaction volumes which consisted of 
18g miniprep DNA, 20 units of each restriction endonuclease, 10x buffer and where 
applicable 10x BSA, topped up with distilled water. Reactions were left at 37oC for 4 hours to 
allow complete digestion. Digested products were then visualised on an agarose gel as 
explained in Section 2.11. 
 
2.13.6 Ligation 
Ligation reactions were routinely set up in 10L reaction volumes using the LigaFast Rapid 
Ligation System (Promega). Briefly, 1g vector DNA, 3g insert DNA, 3 units T4 DNA Ligase 
and 2X rapid ligation buffer, made up to 10L with distilled water was incubated overnight 
at room temperature. 
 
2.13.7 pGEM-T-Easy Cloning 
Primers were designed to accommodate restriction sites either side of the linker histone 
genes allowing direct in-frame sub-cloning into expression vectors (Table 2.8). DNA was 
amplified from miniprep DNA (Section 2.12.2) obtained from linker histone image clones 
(Section 2.10.2) using PCR (2.13.1). PCR products were ligated into the pGEM-T-Easy 
(Promega) vector following manufacturer’s instructions. This involved mixing 1g PCR 
product, 3 units T4 DNA Ligase, 50ng pGEM-T-Easy linear vector, 2x ligation buffer and made 
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up to 10L with distilled water. The ligation mix was left overnight at room temperature. The 
ligation products were transformed into E. coli bacteria as described in Section 2.10.3 and 
spread onto an LB agar plate supplemented with the appropriate antibiotic (Table 2.5) along 
with 0.1M isopropyl thiogalactoside (IPTG) and 40g/L 5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside and incubated overnight at 37oC. 
 
2.13.8 DNA Sequencing 
2.13.8.1 Sequencing Polymerase Chain Reaction 
Sequencing PCR was routinely set up in 20L reaction volumes, consisting of 1L Big Dye 
(Applied Biosystems), 1mM sequencing primer (Table 2.8), 2g plasmid DNA and 5x 
sequencing buffer. PCR reaction conditions are shown in Table 2.9. 
 
Temperature Time Purpose 
95oC 4 minutes  Initial Melting 
95oC 20 seconds  Melting 
50oC 10 seconds 35 cycles Annealing 
60oC 4 minutes  Extension 
60oC 7 minutes  Final Extension 
 
Table 2.9 - Standard Sequencing PCR Cycle 
 
 
2.13.8.2 Ethanol Precipitation of DNA Products 
Ethanol precipitation was used to purify the DNA from the sequencing reaction. To the PCR 
reaction, 3L 1.5M Sodium Acetate – EDTA and 100L 95% ethanol were added and allowed 
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to stand at room temperature in the dark for 20 minutes. DNA products were then pelleted 
by centrifugation at 14,000 rpm at 4oC for 30 minutes. The supernatant was carefully 
removed by inversion, before the addition of 200L 100% ethanol. This was again 
centrifuged at 14,000 rpm for 30 minutes at 4oC. The supernatant was again carefully 
removed by inversion and the DNA pellet allowed to air dry for 30 minutes. 
 
2.13.8.3 Sample Preparation for Sequencing Analysis 
The DNA pellet was resuspended in 10L Hi-Di formamide loading buffer (Applied 
Biosystems). The DNA was denatured at 95oC for 4 minutes before being placed on ice for 2 
minutes. Samples were loaded on to the ABI Prism 3700 according to manufacturers’ 
instructions. DNA sequences were analysed by using BioEdit Sequence Alignment Editor. 
 
2.14 Protein Purification 
2.14.1 Cloning of Linker Histone Genes in to the pET28-b Vector 
Genes coding for the linker histone variants with ligateable ends were excised from pGEM-T-
Easy vector (H1.X, Figure 2.1) or from pFLAG-CMV-4 (H1.1 to H1.5, Figure 2.2, Section 2.19.1) 
using EcoRI/HindIII and EcoRI/XhoI restriction enzymes respectively (Section 2.13.5). 
Products were resolved on an agarose gel (Section 2.11), the relevant products were excised 
and the DNA extracted from the agarose (Section 2.12.1). These products were ligated into 
pET28-b expression vector (Section 2.13.6) which had been linearised with the same 
restriction enzymes listed above to allow compatible ends and the genes to be inserted in-
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frame and with an amino-terminal poly-histidine tag. Ligated products were transformed 
into competent E. coli (Section 2.10.3) capable of protein expression (BL21(DE3)pLysS; 
Promega) and plated out onto LB agar containing kanamycin and left at 37oC overnight 
(Section 2.10.1). Overnight cultures were obtained from individual colonies and these were 
assessed for the presence of the inserted gene by colony PCR (Section 2.13.4). Those positive 
colonies were used to generate recombinant protein.  
 
2.14.2 Induction of Recombinant Proteins. 
An overnight culture was transferred into 50mL of LB broth containing kanamycin (Table 2.5) 
and incubated at 37oC in an orbital shaker until the OD600 reached 0.6-1.0. Protein 
expression was typically induced by the addition of 1.0mM IPTG and was allowed to 
continue for 3 hours. The bacterial culture was pelleted by centrifugation at 4,000 rpm for 10 
minutes, this pellet was placed at -20oC overnight. Where necessary, the amount of IPTG 
used for induction, along with the induction time was changed. 
 
2.14.3 Extraction and Purification of Recombinant Proteins. 
The pellet was thawed with the addition of his-tag lysis buffer (50mM Tris/HCl pH 7.5, 
750mM NaCl, 0.02mM EDTA, 0.02mM ethylene glycol tetraacetic acid (EGTA), 1% Triton, 
0.06% ß-mercaptoethanol, 1mM benzamidine, 0.2mM phenylmethylsulfonyl fluoride (PMSF) 
and  protease inhibitor cocktail (Roche)). Bacteria were further lysed by sonication, three 15 
second pulses whilst on ice, followed by end-over-end rotation at 4oC for 30 minutes. The 
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lysate was centrifuged at 15,000 rpm at 4oC for 30 minutes and the soluble fraction 
(supernatant) was mixed with TALON metal affinity resin (Clontech), pre-equilibrated in his-
tag lysis buffer, by end-over-end rotation for 30 minutes to allow the his-tagged proteins to 
bind the beads. The flow-through was discarded as this contained unbound proteins and the 
column was washed with 10x column volumes of his-tag high salt buffer (50mM Tris/HCl pH 
7.5, 500mM NaCl, 0.02mM EDTA, 0.02mM EGTA, 0.03% Brij 35, 20mM imidazole, 0.06% ß-
mercaptoethanol, 1mM benzamidine, 0.2mM PMSF). The column was subsequently washed 
with 10x column volumes of his-tag low salt buffer buffer (50mM Tris/HCl pH 7.5, 150mM 
NaCl, 0.02mM EDTA, 0.02mM EGTA, 0.03% Brij 35, 20mM imidazole, 0.06% ß-
mercaptoethanol, 1mM benzamidine, 0.2mM PMSF). Proteins were then eluted in his-tag 
elution buffer (his-tag low salt buffer + 300mM imidazole, pH 7.5) in 250l fractions, each 
fraction was then analysed by SDS-PAGE (Section 2.3.2) and the fraction containing the 
protein of interest was used for further experimentation. 
 
Where necessary, the NaCl concentration of the his-tag lysis buffer and subsequent washes 
was changed. 
 
2.14.4 Dialysis of Recombinant Proteins. 
Protein solutions were placed inside a dialysis chamber of a custom made dialysis apparatus. 
Proteins were dialysed against TNB buffer (10 mM Tris, 50mM NaCl, 1mM -
mercaptoethanol, pH 8.0) overnight at 4oC. 
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2.15 Protein Kinase Assay 
Typically, 5g purified DNA-PK (Promega) was incubated with kinase buffer (25mM HEPES 
pH 7.5, 10mM MgCl2, 1mM DTT, 0.1% Nonidet P-40, 20% glycerol) in the presence of 5mg 
dsDNA cellulose (Amersham Bioscience) and incubated at 4oC for 30 minutes with end-over-
end rotation. The dsDNA cellulose was washed to remove any unbound DNA-PK with kinase 
buffer. Purified calf thymus linker histone H1 (Roche) or individually purified linker histone 
variants (Section 2.14) were added to the reaction mixture along with 4mM ATP, and 30nCi 
of [-32P]ATP and incubated for 20 minutes at 30oC. The reaction was terminated by the 
addition of 5x SDS loading buffer. Products were resolved on an SDS-PAGE gel as described 
in Section 2.3.2. The gel was stained and dried as detailed in Section 2.3.3. The gel was 
exposed to a storage phosphor screen (Molecular Dynamics) for 60 minutes, the screen was 
scanned using a STORM Phosphorimager (Molecular Dynamics) and the images analysed 
using ImageQuant software (GE Healthcare). 
 
2.16 Phospho-peptide Mapping 
Purified recombinant linker histone variants were phosphorylated as described in Section 
2.15, with the exclusion of [-32P]ATP. Products were resolved on an SDS-PAGE gel as 
explained in Section 2.3.2 using pre cast 4-20% gradient gels (Bio-Rad). The gel was stained 
as explained in Section 2.3.3, but not dried, and bands of interest were excised and analysed 
by mass spectrometry to identify proteins, and any post translational modifications. Mass 
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spectrometry analysis was carried out by Functional Genomics Unit, University of 
Birmingham and the results returned in Microsoft Excel format. 
 
2.17 In Vitro Ligation 
2.17.1 dsDNA End Labelling  
Two micrograms of DNA was incubated with 20 Units of shrimp alkaline phosphatase and 
10X buffer in a total reaction mix of 20L at 37oC for 1 hour. The reaction was terminated 
with a 5 minute incubation at 65oC and placed on ice for a further 5 minutes. To this mixture, 
5mM DTT and 5% polyethylene glycol were added, heated at 75oC for 10 minutes and chilled 
on ice for 5 minutes. Following this, 10 units of T4 polynucleotide kinase, 10X buffer and 
60Ci [-32P]-ATP were added and incubated at 37oC for 2 hours. The DNA products were 
then precipitated from the reaction mix with Pellet Paint CoPrecipitant (Novagen). DNA was 
pelleted by centrifugation at 13,000 rpm for 10 minutes and the supernatant was removed 
carefully. The DNA pellet was washed twice with 70% ethanol and finally dissolved in 100L 
elution buffer (Qiagen). 
 
2.17.2 Ligation Assay 
Reactions were set up in 20L reaction volumes consisting of 70fmol [-32P]-ATP labelled 
DNA, x10 ligation buffer (66 mM Tris/HCl pH 7.5, 5 mM MgCl2, 1 mM DTT, 1mM ATP, 
0.5mg/mL BSA) and the stated amount of purified linker histone. This mixture was incubated 
on ice for 10 minutes before the addition of 200ng recombinant purified LX complex 
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(purified in house by Dr. Boris Kysela). Reactions were placed inside a Thermomixer 
(Eppendorf), mixed briefly then incubated at 37oC for 10 minutes, before being placed on ice 
for 5 minutes. The reaction was terminated by the addition of 0.6mg/mL Proteinase K in 
0.6% SDS at 37oC for 15 minutes. The DNA products were then precipitated from the 
reaction mix with Pellet Paint CoPrecipitant. DNA was pelleted by centrifugation at 13,000 
rpm for 10 minutes and the supernatant was removed carefully and the remaining DNA 
pellet allowed to air dry. The products were dissolved in elution buffer and non-specific DNA 
products were separated by a 3 minute period at 95oC followed by a 3 minute period on ice. 
DNA loading buffer was added to the samples and they were loaded on a 0.8% agarose gel 
without the addition of ethidium bromide, outlined in Section 2.11, and resolved by applying 
150V across the gel for 45 minutes. The gel was vacuum dried at 50oC for 120 minutes, then 
exposed to a storage phosphor screen for 60 minutes. The screen was scanned using a 
STORM Phosphorimager and the images analysed using ImageQuant software. 
 
2.18 Electrophoresis Mobility Shift Assay 
Electrophoresis mobility shift assay (EMSA) reactions were set up in 20L reaction volumes 
consisting of 70fmol [-32P]-ATP labelled DNA, x10 EMSA buffer (66 mM Tris/HCl pH 7.5, 1 
mM DTT, 1mM ATP, 0.5mg/mL BSA) and the required amount of purified linker histone, and 
incubated on ice for 10 minutes. Where appropriate, 200ng purified LX complex was added 
and incubated for a further 10 minutes on ice. DNA loading buffer (excl bromophenol blue) 
was added to the samples and they were loaded on a 0.8% agarose gel without the addition 
of ethidium bromide, outlined in Section 2.11, and resolved by applying 30mA across the gel 
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for 3 hours. The gel was vacuum dried at 50oC for 120 minutes, then exposed to a storage 
phosphor screen for 60 minutes. The screen was scanned using a STORM Phosphorimager 
and the images analysed using ImageQuant software.  
 
2.19 Co-Immunoprecipitation 
2.19.1 Cloning of Linker Histone Genes in to the pFLAG-CMV-4 Vector 
Genes coding for the linker histone variants with ligateable ends were excised from the 
pGEM-T-Easy vector (Section 2.13.7) using XbaI/BglII (H1.2) or XbaI/EcoRI (H1.X) restriction 
enzymes (Section 2.13.5) along with empty pFLAG-CMV-4 vector (Figure 2.2). Products were 
resolved on an agarose gel (Section 2.11), the relevant products were excised and the DNA 
extracted from the agarose (Section 2.12.1). Excised gene fragments along with linearised 
pFLAG-CMV-4 vector were ligated together (Section 2.13.6) enabling the linker histone genes 
to be inserted in-frame and with an amino-terminal FLAG peptide sequence (Asp-Tyr-Lys-
Asp-Asp-Asp-Asp-Lys). Ligated products were transformed into competent E. coli (Section 
2.10.3) and plated out onto LB agar containing ampicillin and left at 37oC overnight (Section 
2.10.1). Overnight cultures were obtained from individual colonies and these were assessed 
for the presence of the inserted gene by colony PCR (Section 2.13.4). From the positive 
colonies, mini-prep DNA was extracted (Section 2.12.2) which was used to generate stably 
transfected cell lines (Section 2.2.7). 
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2.19.2 Cloning of Linker Histone Genes in to the pEGFP Vector 
Genes coding for the linker histone variants with ligateable ends were excised from the 
pFLAG-CMV-4 vector (Figure 2.2) using BamHI/EcoRI restriction enzymes (Section 2.13.5) 
along with empty pEGFP vector (Figure 2.4). Products were resolved on an agarose gel 
(Section 2.11), the relevant products were excised and the DNA extracted from the agarose 
(Section 2.12.1). Excised gene fragments along with linearised pEGFP vector were ligated 
together (Section 2.13.6) enabling the linker histone genes to be inserted in-frame and with 
an amino-terminal GFP fusion protein. Ligated products were transformed into competent E. 
coli (Section 2.10.3) and plated out onto LB agar containing ampicillin and left at 37oC 
overnight (Section 2.10.1). Overnight cultures were obtained from individual colonies and 
these were assessed for the presence of the inserted gene by colony PCR (Section 2.13.4). 
From the positive colonies mini-prep DNA was extracted (Section 2.12.2) which was used to 
generate stably transfected cell lines (Section 2.2.7). 
 
2.19.3 Protein Extraction 
Trypsinised cell pellets were washed with 5mL PBS and the resulting pellet resuspended in 
300L ice-cold IP lysis buffer (50mM Tris/HCl pH 7.5, 1mM EGTA, 1mM EDTA, 50mM sodium 
fluoride, 5mM sodium pyrophosphate, 1mM sodium orthovanadate, 0.27M sucrose, 1% 
Triton X-100, 0.1% -mercaptoethanol, and protease inhibitor cocktail), vortexed for 10 
seconds and placed on ice for 10 minutes. Cellular debris was pelleted by centrifugation at 
13,000 rpm for 10 minutes at 4oC. The supernatant was carefully removed and placed into a 
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Protein G slurry (10L) was washed twice with ice-cold IP wash buffer (IP lysis buffer 
excluding protease inhibitor cocktail). Extracted protein, typically 500g, was added to the 
protein G beads and left for one hour with end-over-end rotation. Protein G beads were 
pelleted by centrifugation at 3,000 rpm for 2 minutes and the supernatant was removed and 
placed in a fresh 1.5mL microcentrifuge tube. Primary antibodies (Table 2.5) were added to 
the protein lysate and placed in a Thermomixer at max speed overnight at 4oC. A further 
10L protein G slurry was washed twice in ice-cold IP wash buffer, the lysate/antibody 
mixture was added, and the mixture placed in a Thermomixer at max speed for 3 hours at 
4oC. Protein G beads were pelleted by centrifugation at 3,000 rpm for 2 minutes and the 
supernatant discarded. The beads were resuspended in 250L ice-cold IP wash buffer and 
transferred to a labelled spinX centrifuge tube filter (Costar, 0.45m pore size). The spinX 
column was centrifuged at 7,000 rpm for 1 minute and the flow through discarded. A further 
250L ice-cold IP wash buffer was added, centrifuged and discarded. Proteins were eluted 
with the addition of 35L 1X sample buffer (Biorad) and placed at 70oC for 5 minutes, 
followed by centrifugation at 7,000 rpm for 1 minute. 
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2.19.5 Interacting Protein Partners Determination 
To discover interacting partners following co-immunoprecipitation, the co-
immunoprecipitation eluate was resolved on an SDS-PAGE gel as explained in Section 2.3.2 
using pre cast 4-20% gradient gels (Bio-Rad). The gel was stained as explained in Section 
2.3.3, but not dried, and bands of interest were excised and analysed by mass spectrometry 
to identify proteins. Mass spectrometry analysis was carried out by Functional Genomics 
Unit, University of Birmingham and the results returned in Microsoft Excel format 
 
To confirm protein interactions, co-immunoprecipitation eluates were resolved on an SDS-
PAGE gel and transferred to PVDF membrane as outlined in Section 2.3.4. Antibodies raised 

















CHAPTER THREE: MAPPING PHOSPHORYLATION SITES IN 
THE SOMATIC LINKER HISTONE VARIANTS 
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3.1 Introduction and Overview 
Vast networks of signal transduction cascades amplify and relay signals from the site of a 
DSB to the repair, cell-cycle and apoptotic machineries. The most heavily studied of these 
cascades is that of phosphorylation, however interesting data is surfacing on other 
modifications such as acetylation (Sun et al., 2009) and ubiquitylation (Stewart et al., 2009). 
Following a DSB there is a rapid phosphorylation of ATM on serine 1981, activating it and 
enabling it to phosphorylate its many targets (Bakkenist and Kastan, 2003). Some of these 
targets include p53 (serine 15), MDM2 (serine 395) and CHK2 (threonine 68), and 
phosphorylation of these proteins and subsequent effects leads to cell cycle arrest in the G1 
phase of the cell cycle (Banin et al., 1998, Canman et al., 1998, Chehab et al., 2000, 
Matsuoka et al., 2000, Maya et al., 2001). Phosphorylation of BRCA1 (serine 1387) , FANCD2 
(serine 222), NBS1 (serines 343, 397 and 615) and SMC1 (serines 957 and 966) by ATM leads 
to S-phase arrest (Cortez et al., 1999, S. T. Kim et al., 2002, Lim et al., 2000, Taniguchi et al., 
2002, Wu et al., 2000b, Xu et al., 2002, B. B. Zhou et al., 2000), whereas cell cycle arrest at 
the G2 to M checkpoint can involve phosphorylation of hRAD17 (serines 635 and 645) and 
BRCA1 (serine 1423) (S. Bao et al., 2001, Xu et al., 2001). Phosphorylation of these targets is 
important in halting the cell cycle to allow the DNA damage to be correctly repaired. 
 
Another target of ATM is the histone variant H2A.X which is specifically phosphorylated on a 
highly conserved residue, serine 139. Histone H2A.X is a crucial phosphorylation target in the 
repair of DSB with its phosphorylation status widely being used as a marker for sites of DSBs. 
Following DSBs, H2A.X molecules are phosphorylated anywhere up to 1Mb from the site of 
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the DSB (Burma et al., 2001). This propagation amplifies the signal which is expected to aid 
the recruitment and retention of DNA repair proteins. 
 
DNA-PK also plays an active part in the phosphorylation cascade induced by a DSB, although 
many targets remain to be validated in vivo. DNA-PK phosphorylates p53 on serine 15 and 
serine 37 following IR, disrupting its interaction with MDM2 (Lees-Miller et al., 1992, Shieh 
et al., 1997). MDM2 itself is also phosphorylated on serine 17 by DNA-PK, further disrupting 
the p53-MDM2 interaction, although this phosphorylation event has only been studied in 
vitro (Mayo et al., 1997). Phosphorylation of poly(ADP-ribose) polymerase (PARP), a 
component of the base excision repair pathway, by DNA-PK has also been shown in vitro. 
This phosphorylation event does not seem to have any in vivo effect on its function however 
(Ariumi et al., 1999). 
 
DNA-PK has also been shown to phosphorylate several members of the NHEJ pathway 
including the KU complex, XRCC4, XLF and Artemis in vitro and in vivo (Cao et al., 1994, 
Douglas et al., 2005, Ma et al., 2002, Yu et al., 2008, Yu et al., 2003c). Using site directed 
mutagenesis, putative phosphorylation sites in XRCC4 and XLF were removed, however, 
there was no loss-of-NHEJ-function (Yu et al., 2008, Yu et al., 2003c). Interestingly however, 
the phosphorylation activity of DNA-PK has been shown to be crucial for NHEJ activity, 
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Autophosphorylation of DNA-PK has been shown to be the only crucial DNA-PK 
phosphorylation target for the rejoining of DSBs in vivo (Chan et al., 2002). Although there 
are many phosphorylation sites on DNA-PK, the phosphorylation of a cluster of residues 
around amino acid 2609 result in the dissociation of DNA-PK from DNA (Uematsu et al., 
2007). This cluster is a site of autophosphorylation, however, other kinases are reported to 
also phosphorylate this 2609 cluster. One study reports that the phosphorylation event is 
dependent on ATM (B. P. Chen et al., 2007), whereas another study shows there is no 
requirement for the presence of ATM, but that the cluster can be phosphorylated in the 
absence of a functional DNA-PKcs kinase, suggesting the involvement if other kinases (Meek 
et al., 2007). A third study has shown that the 2609 cluster can be phosphorylated by ATR 
following UV damage, although the involvement of ATR in NHEJ is still unclear (Yajima et al., 
2006). Either way, the phosphorylation of the 2609 cluster causes DNA-PKcs to leave the 
immediate site of the DSB allowing the processing and ligation of DNA ends (Uematsu et al., 
2007). 
 
Phosphorylation of p53, MDM2, CHK2, BRCA1, FANCD2, NBS1, SMC1, hRAD17 and H2A.X all 
occur at the ATM/DNA-PK consensus sequence (P/M/Y/G/F)-X-(S/A/D/E)-S/T-Q. The only 
strict requirement of the consensus sequence is that a glutamine residue is positioned 
directly after the phosphorylatable serine or threonine (S. T. Kim et al., 1999). Other proteins 
can be phosphorylated by DNA-PK at other regions, for example, RPA in response to UV 
irradiation (Zernik-Kobak et al., 1997). 
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DNA-PK can also phosphorylate the linker histone family in vitro. A commercially available 
mix of linker histones extracted from calf thymus tissue was phosphorylated by DNA-PK, in 
vitro, to a greater degree than the control p53 peptide. Purified phosphorylated linker 
histones were shown to remove the inhibition of LX mediated ligation which is seen with 
non-phosphorylated linker histones (Kysela et al., 2005).  
 
3.2 Aims 
In the previous published experiments, it was determined that the phosphorylation of linker 
histone variants has a functional impact on NHEJ (Kysela et al., 2005). The exact composition 
of the linker histone mix used in these studies is not known, therefore the exact target for 
DNA-PK phosphorylation could be any one or a combination of the 7 somatic linker histone 
variants (Section 1.2.3). 
 
This chapter aims to identify DNA-PK phosphorylation sites in the individual linker histone 
variants by: 
1. Identifying which individual linker histone variants are phosphorylated by the kinase 
DNA-PK, in vitro. 
2. Identifying the DNA-PK phosphorylation sites in the linker histone variants. 
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3.3 Results 
3.3.1 Identification of putative ATM/DNA-PK phosphorylation sites. 
As previously mentioned, the ATM/DNA-PK phosphorylation consensus sequence has been 
identified as S/T-Q (S. T. Kim et al., 1999). All somatic linker histone variants were examined 
by sequence analysis to determine if any of these contained putative S/T-Q sites. Only two of 
the linker histone variants, H1.0 and H1.X, contained an SQ motif (Figure 3.1, underlined in 
red). Interestingly, the serine residue of the SQ motif in H1.0 is conserved throughout all the 
linker histone variants with the exception of H1.X, whereas, the serine residue of the SQ 
motif in H1.X is conserved in all linker histones variants. In both cases the glutamine residue 
following the serine residue is not conserved at all. 
 
Conservation of these SQ sites in H1.X and H1.0 were then studied across different species. 
The SQ site in H1.X is conserved from Homo sapiens through to Gallas gallas, along with a 
surrounding 15 amino acid region (Figure 3.2). However, the site is not conserved in Danio 
rerio with the glutamine residue being replaced by a lysine residue. The full length H1.X 
protein is conserved 94% and 91% with Pan troglodytes and Bos taurus respectively, 
however it is much less conserved with other species (Figure 3.2). The SQ site in H1.0 is 
conserved in all species studied, excluding G. gallas where the serine residue is replaced 
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Figure 3.1 – Amino acid sequence alignment of human linker histones. 
Linker histones were analysed to see if they contained putative ATM/DNA-PK phosphorylation sites. Two 
possible sites were found, one in H1.0 and the other in H1.X (boxed in red and highlighted by an asterix). 
Alignment of the linker histones illustrates the conservation of these sites amongst the somatic linker histones. 
Sequences were aligned using ClustalW program (www.ebi.ac.uk). Genbank accession numbers for protein 
sequences used are given in Table 2.6 and Appendix B. Key - Alanine, Tyrosine and Phenylalanine, Glycine, 
Proline, Serine and Threonine, Aspartic acid and Glutamine acid, Tryptophan, Histidine, Lysine and Arginine, 








Figure 3.2 – Amino acid sequence alignment of H1.X putative SQ site in humans and the orthologues in 
different species. 
Amino acid sequences of H1.X, or similar to H1.X (P. troglodytes and B. taurus), aligned to show conservation of 
the putative SQ phosphorylation site. The SQ site is highlighted with a red box showing conservation in all 
species excluding D. rerio. Percentages shown in brackets represent the % identity to H. sapiens full length 
protein. Sequences were aligned using ClustalW program (www.ebi.ac.uk). Genbank accession numbers for 
protein sequences used are given in Appendix B. Key - Alanine, Tyrosine and Phenylalanine, Glycine, Proline, 
Serine and Threonine, Aspartic acid and Glutamine acid, Tryptophan, Histidine, Lysine and Arginine, Isoleucine, 




Figure 3.3 - Amino acid sequence alignment of H1.0 putative SQ site in humans and the orthologues in 
different species. 
Amino acid sequences of H1.0, or hypothetical sequence (P. troglodytes), aligned to show conservation of the 
putative SQ phosphorylation site. The SQ site is highlighted with a red box showing conservation in all species 
excluding G. gallus. Percentages shown in brackets represent the % identity to H. sapiens full length protein. 
Sequences were aligned using ClustalW program (www.ebi.ac.uk). Genbank accession numbers for protein 
sequences used are given in Appendix B. Key - Alanine, Tyrosine and Phenylalanine, Glycine, Proline, Serine and 
Threonine, Aspartic acid and Glutamine acid, Tryptophan, Histidine, Lysine and Arginine, Isoleucine, Leucine, 
Methionine and Valine, Asparagine and Glutamine and Cysteine. 
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3.3.2 Phosphorylation mapping of linker histone variants. 
To identify potential DNA-PK phosphorylation sites on linker histone variants, a linker 
histone mix from calf thymus was used as a substrate for DNA-PK in an in vitro kinase assay 
(Section 2.15). Proteins were resolved on an SDS-PAGE gel (Section 2.3.2) and stained with 
PageBlue (Section 2.3.3). The linker histone bands were excised from the SDS-PAGE gel and 
phospho-peptide mapped by Functional Genomics (University of Birmingham). The collision 
induced dissociation technique was used to isolate PTM’s of the linker histone variants. 
Whilst this technique confirms the presence of a modification, it does not necessarily 
determine which residue is modified (Sweet et al., 2006). Therefore all phosphorylatable 
residues within a peptide will be listed as a potential site of phosphorylation. 
 
Peptides from all of the somatic linker histone variants were identified (H1.0-H1.5 and H1.X). 
Phosphorylation sites were seen that correspond with sites previously reported for H1.1, 
H1.2, H1.3 and H1.4 (Garcia et al., 2004, Wisniewski et al., 2007; Table 3.1). These are 
typically serine 2 and threonine 4, or those that reside within the RKASGPPVSELITKA peptide. 
These sites were seen before phosphorylation by DNA-PK, suggesting that these are 
phosphorylated residues which have arisen in the calf thymus cells and not specifically by 
DNA-PK. Several novel non DNA-PK-mediated phosphorylated residues were also identified 
namely; serine 55 or serine 58 of H1.2, H1.3 (serine 56 and serine 59) and H1.4, along with 
threonine 77, threonine 78 or threonine 84 within H1.0.  
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All linker histone variants except H1.5 were phosphorylated by DNA-PK (Table 3.1). Novel 
phosphorylation by DNA-PK of serine 89, serine 92, threonine 85 or threonine 99 was found 
in H1.1. Phosphorylation of the same residues has already been identified in H1.2 and H1.3, 
however, since the matched peptide is the same across all three variants it is impossible to 
ascertain which of the three variants is actually phosphorylated (Garcia et al., 2004). Novel 
DNA-PK phosphorylation was also seen in: H1.1, serine 149 or threonine 152; H1.3, 
threonine 164 or threonine 168; H1.0 threonine 77, threonine 78 or threonine 84; and H1.X, 
tyrosine 48, serine 49 or threonine 55. 
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Protein Modification Peptide Source Cell Line or Tissue 
H1.1 pS-2 pSETVPPAPAASAAPEKPLAGK (Wisniewski et al., 
2007) 
HeLa, Mouse heart, kidney, seminal vesicle, testis. 
 pT-4 pSEpTAPVAQAASTATEKPAAAK (Wisniewski et al., 
2007) 
Mouse testis 
 pS-43 KPAGPSVpSELIVQAVSSSK (Wisniewski et al., 
2007) 
 
 pS-89, pS-92, pT-85 
or pT-99 
KpSLVpSKGpTLVQpTKG This Study  
 pS-149 or pT-152 KKpSVKpTPKK This Study  
H1.2 pS-2 pSETAPAAPAAAPPAEK (Wisniewski et al., 
2007) 
HeLa, Mouse heart, seminal vesicle  
 pS-2 or pT-4 MpSEpTAPAAPAAAPPAEKA This Study  
 pT-31 KAAKKAGGpTPR (Garcia et al., 2004) HeLa 
 pS-36 KApSGPPVSELITK (Garcia et al., 2004, 
Wisniewski et al., 
2007) 
MCF7, HeLa, Mouse brain, kidney, muscle, seminal 
vesicle, spleen 
 pS-36, pS-41 or pT-
45 
RKApSGPPVpSELIpTKA This Study  
 pS-41 ASGPPVpSELITK (Wisniewski et al., 
2007) 
Mouse spleen 
 pS-55 or pS-58 pSGVpSLAALK This Study  
 pS-86 LGLKpSLVSK (Wisniewski et al., 
2007) 
Mouse kidney 
 pS-86, pS-89 or pT-
92 
KpSLVpSKGpTLVQpTKG This Study  
 pT-146 KAAGGApTPKK (Garcia et al., 2004, 
Wisniewski et al., 
2007) 
HeLa, Mouse spleen 
 pT-154 KSAKKpTPK (Garcia et al., 2004) HeLa 
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 pT-165 KPAAApTVTKK (Wisniewski et al., 
2007) 
MCF7 
 pS-173 KVAKpSPK (Garcia et al., 2004, 
Sarg et al., 2006, 
Wisniewski et al., 
2007) 
HeLa, HLTC 
H1.3 pT-18 SETAPLAPTIPAPAEKpTPVK (Wisniewski et al., 
2007) 
MCF7, HeLa, Mouse testis, spleen 
 pS-37 KApSGPPVSELITK (Garcia et al., 2004, 
Wisniewski et al., 
2007) 
MCF7, HeLa, Mouse brain, kidney, muscle, seminal 
vesicle, spleen 
 pS-42 ASGPPVpSELITK (Wisniewski et al., 
2007) 
Mouse spleen 
 pS-37, pS-42 or pT-
46 
RKApSGPPVpSELIpTKA This Study  
 pS-56 or pS-59 pSGVpSLAALK This Study  
 pS-87 LGLKpSLVSK (Wisniewski et al., 
2007) 
Mouse kidney 
 pS-87, pS-90, pT-93 
or pT-97 
KpSLVpSKGpTLVQpTKG This Study  
 pT-147 KVAGAApTPKK (Garcia et al., 2004, 
Wisniewski et al., 
2007) 
MCF7, HeLa, Mouse spleen 
 pT-155 KSIKKpTPK (Garcia et al., 2004) HeLa 
 pT-164 or pT-168 KKVKKPApTAAGpTKK This Study  
 pT-180 KVKpTPQPK (Garcia et al., 2004) HeLa 
 pS-189 KAAKpSPAKAKAPKPK (Garcia et al., 2004, 
Sarg et al., 2006) 
HeLa, HLTC 
H1.4 pS-2 pSETAPAAPAAPAPAEK (Garcia et al., 2004, 
Wisniewski et al., 
HeLa, Mouse spleen, heart 
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2007) 
 pT-4 pSEpTAPAAPAAPAPAEKT (Garcia et al., 2004, 
Wisniewski et al., 
2007) 
HeLa, Mouse spleen 
 pT-18 SETAPAAPAAPAPAEKpTPVK (Garcia et al., 2004, 
Wisniewski et al., 
2007) 
MCF7, HeLa, Mouse testis, liver 
 pS-2, pT-4 or pT-18 pSEpTAPAAPAAPAPAEKpTPVK This Study  
 pS-27 KARKpSAGAAKR (Garcia et al., 2004) HeLa 
 pS-36 RKApSGPPVSELITKA (Wisniewski et al., 
2007) 
MCF7, HeLa, Mouse heart, lung, muscle, spleen 
 pS-41 TSGPPVpSELITK (Wisniewski et al., 
2007) 
Mouse kidney, lung 
 pS-36, pS-41, pT-45 RKApSGPPVpSELIpTKA This Study  
 pS-55 or pS-58 pSGVpSLAALK This Study  
 pS-86 LGLKpSLVSK (Wisniewski et al., 
2007) 
Mouse kidney 
 pT-146 KATGAApTPKK (Garcia et al., 2004) HeLa 
 pS-172 KAKpSPK (Garcia et al., 2004, 
Sarg et al., 2006) 
HeLa, HLTC 
 pS-187 KAPKpSPAK (Garcia et al., 2004, 
Sarg et al., 2006, 
Wisniewski et al., 
2007) 
MCF7, HeLa, HLTC, Mouse spleen 
H1.5 pS-2 pSETAPAETATPAPVEK (Wisniewski et al., 
2007) 
MCF7, Mouse heart, seminal vesicle 
 pT-4 pSEpTAPAETATPAPVEK (Wisniewski et al., 
2007) 
HeLa 
 pT-11 Not given (Sarg et al., 2006) HTLC 
 pS-18 SETAPAETATPAPVEKpSPAK (Sarg et al., 2006, MCF7, HeLa, Mouse brain, kidney, liver, muscle, 
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Wisniewski et al., 
2007) 
seminal vesicle, spleen, testis, HLTC 
 pT-138 KPAGApTPKK (Garcia et al., 2004, 
Sarg et al., 2006, 
Wisniewski et al., 
2007) 
MCF7, HeLa, HLTC 
 pT-155 KAVKKpTPK (Garcia et al., 2004, 
Sarg et al., 2006) 
HeLa, HLTC 
 pT-173 Not given (Sarg et al., 2006) HLTC 
 pS-188 Not given (Sarg et al., 2006) HLTC 
H1.X pS-31 AGGSAALpSPSK (Garcia et al., 2004, 
Wisniewski et al., 
2007) 
HeLa 
 pY-48, pS-49 or pT-
55 
KpYpSQLVVEpTIRRL This Study  
 pS-154 AKKAAPGAAGpSR This Study  
H1.0 pT-77, pT-78 or pT-
84 
LVpTpTGVLKQpTK This Study  
Table 3.1 – Phosphorylation Mapping of Linker Histones identified in this chapter, compared to published results. 
Linker histones were phosphorylated by DNA-PK and analysed by mass spectrometry. Due to the nature of the mass spectrometry only peptides, and not specific 
phosphorylation sites, were mapped. All phosphorylation sites are preceded with a lower case p, ambiguous phosphorylation sites are underlined and identified 
phosphorylation sites are listed in bold. Along with results identified in this chapter are previously published phosphorylated residues with the tissue/cell line they 
were isolated in. Red identifies phosphorylation sites in the absence of DNA-PK which have previously been recorded. Blue identifies novel phosphorylation sites in 
the absence of DNA-PK. Green identifies novel DNA-PK mediated phosphorylation sites. 
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3.3.3 Purification of individual linker histones variants from E.coli. 
To confirm whether the DNA-PK mediated phosphorylation sites seen in H1.X and H1.0 are 
phosphorylated in vitro, recombinant proteins were prepared in E. coli and reconstituted 
into the in vitro kinase assay (Section 2.15). Following induction of protein expression, 
prominent bands were clearly visible which represent the individual linker histone variants 
(Figure 3.4A, red boxes). Following lysis, the linker histone bands are still present, and in 
some cases, extremely prominent (Figure 3.4B). Eluates of the linker histone variants 
showed a prominent main band which corresponded to the predicted protein size (35kDa-
40kDa), however all but H1.X showed varying degrees of protein degradation (Figure 3.5).  
 
Attempts were made to reduce the amount of degradation seen in linker histone variants 
H1.1 to H1.5. These included changing the bacteria in which the proteins were produced, 
varying the amounts of IPTG used for induction and the induction time itself, varying the 
constituents of the lysis buffer, removing the sonication step and changing the wash 
conditions. All of these had no significant impact on the amount of degradation seen (data 
not shown).  
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Figure 3.4 – Recombinant linker histone variant purification in E. Coli. 
A. Bacteria containing the pET28-b expression vector with linker histone variant genes cloned into the multiple 
cloning site were induced to produce protein with the addition of IPTG. Linker histone variants H1.1-H1.5 and 
H1.X show a clear over-expressed protein band, boxed in red, compared to the un-induced controls. 
B. After salt lysis the over-expressed histone bands have been solubilised and are clearly visible. 
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Figure 3.5 – Elution of affinity purified linker histone variants. 
Each linker histone variant (A-H1.1, B-H1.5, C-H1.2, D-H1.3, E-H1.4, F-H1.X) was eluted in 250uL aliquots from affinity beads with imidazole. In the majority of cases the first 
elution provides the most protein, and where it does not then the second elution provides the most protein. Varying amounts of purified proteins can be seen, along with 
degradation products. After 4 elutions very little protein remained on the beads. 
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Attempts were also made to over-express and purify some of the linker histone variants in 
the baculovirus over-expression system. Cellular extracts of over expressed H1.2 protein 
from SF9 insect cells were produced (personal communication with Dr. Chris Bruce, 
procedure outlined in Riballo et al., 2001). Using the standard lysis buffer, H1.2 protein 
remained in the insoluble fraction (Figure 3.6A). The lysis buffer was subsequently changed 
to resemble that used in the bacterial cell lysis (Section 2.14.3), and this also was unable to 
solubilise H1.2 from insect cells (Figure 3.6B). 
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Figure 3.6 – Purification of mammalian H1.2 from SF9 insect cells. 
Over-expressed H1.2 protein was produced in SF9 insect cells. Under normal lysis conditions, the proteins 
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3.3.4 Phosphorylation of linker histone variants by DNA-PK. 
Purified recombinant linker histone variants H1.1, H1.2, H1.3, H1.4, H1.5, H1.X, and purified 
H1.0 (a gift from Prof. Jeffrey Hansen, Colorado State University) were examined using the in 
vitro kinase assay with DNA-PK as the kinase (Section 2.15). All the linker histone variants 
were phosphorylated by DNA-PK (Figure 3.7A). However, the linker histone variants which 
showed large amounts of degradation, H1.1-H1.5, also showed large amounts of 
phosphorylated degradation products (Figure 3.7A). Although H1.X and H1.0 both contain 
the ATM/DNA-PK SQ phosphorylation motif, H1.X was phosphorylated to a greater extent 
than H1.0 which has an extremely faint band. All linker histones were loaded equally (Figure 
3.7B).  
 
Page | 109  
 
 
Figure 3.7 – DNA-PK phosphorylation of recombinant linker histone variants. 
Recombinant linker histone proteins were incubated with DNA-PK and [-
32
P]ATP. Dried SDS-PAGE gels were 
exposed to a storage phosphor screen and imaged on a Typhoon Phosphorimager. Linker histone variants H1.1 
– H1.5 show phosphorylation of the full length protein, but also of the degraded protein. H1.0 shows extremely 
low phosphorylation, and H1.X exhibits good phosphorylation of the full length product. H1.X also displays the 
least amount of phosphorylated degradation products due to its cleaner purification. H1 Mix contains linker 
histone variants purified from calf thymus which shows phosphorylation. 
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3.4 Discussion 
The aim of this chapter was to identify potential phosphorylation sites on the linker histone 
variant proteins. Using in silica analysis we show that the replication dependent somatic 
linker histone variants do not contain a putative ATM/DNA-PK phosphorylation site. 
However, the less characterised H1.0 and H1.X both contain putative SQ sites. Aligning all 
somatic linker histone variants (Figure 3.1), we reveal significant homology surrounding 
these SQ sites but crucially, the required glutamine is absent. The SQ sites in both H1.0 and 
H1.X are also conserved in P. troglodytes, B. taurus, M. musculus and Rattus norvegicus. 
 
Table 3.1 shows that the phosphorylation of the H1.2, H1.3 and H1.4 proteins could be 
observed at the RKASGPPVSELITKA site prior to incubation with DNA-PK. This supports other 
studies in HeLa and MCF7 human cell lines, along with different mouse tissues, which 
suggest these phosphorylation events occur during normal cycling of the cell and are not 
limited to the response to DNA damage in the form of DSBs (Garcia et al., 2004, Wisniewski 
et al., 2007). Phosphorylation of serine 2 and threonine 4 in the amino terminus of H1.1 and 
H1.4 was also seen, which supports studies where it has been previously seen in mouse 
tissues and HeLa cells (Garcia et al., 2004, Wisniewski et al., 2007). It is suggested that 
phosphorylation of these residues occurs during the cell cycle. During interphase the CTD is 
primarily phosphorylated, and during mitosis the NTD also becomes phosphorylated (Gurley 
et al., 1995). As the linker histones were commercially sourced it is impossible to determine 
whether they were cycling or not. 
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Novel phosphorylation sites were identified prior to incubation with DNA-PK for H1.2, H1.3 
and H1.4 on the SGVSLAALK peptide. The first serine residue is not conserved in H1.1, H1.5, 
H1.X or H1.0, suggesting that it may be this residue that is preferentially phosphorylated as it 
is unique to H1.2, H1.3 and H1.4. This peptide is part of the central conserved domain of the 
linker histones and is conserved in mice. Novel phosphorylation was also seen in H1.X at 
serine-154, a residue not conserved in any other linker histone, nor in mouse H1.X. 
 
Of particular interest was the identification of novel DNA-PK phosphorylation sites. Several 
novel sites of phosphorylation in the linker histone variants H1.1, H1.3 and H1.X were 
identified following incubation with DNA-PK, none of which were detected in previous 
studies of HeLa, MCF7 or lymphoblastic T-cell human cell lines, or mouse tissue (Garcia et al., 
2004, Sarg et al., 2006, Wisniewski et al., 2007).  
 
Phosphorylation of the KKSVKTPKK peptide, identified in H1.1, is particularly interesting as it 
contains a residue, threonine 152, which is proposed to facilitate high affinity binding 
between the linker histone and the DNA. Mutations in this residue, and/or serine 183, result 
in the reduced mobility of the linker histone variant H1.1 on DNA, as measured by FRAP 
analysis (Hendzel et al., 2004). If threonine 152 is a target of DNA-PK phosphorylation, it 
would imply that following DNA damage, DNA-PK phosphorylates linker histone variant H1.1 
at threonine 152, and potentially the other replication dependent linker histone variants as 
this residue is conserved. This would result in weaker binding of the linker histone variants 
to the DNA, aiding their release from the DNA, allowing the NHEJ repair proteins access to 
the site of the DSB (Dou et al., 2002, Lever et al., 2000). 
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Phosphorylation of the KKVKKPATAAGTKK peptide at positions threonine 164 or threonine 
168, identified in H1.3, has not been shown before in cell lines or mouse tissue. These 
residues are very poorly conserved between the other linker histones with only threonine 
168 conserved in H1.2, and both threonine residues not being conserved at all in mouse 
H1.3. 
 
Phosphorylation of the KYSQLVVETIRRL peptide in H1.X contains three potential 
phosphorylatable residues. Conservation of these residues shows the tyrosine residue is only 
conserved in H1.0, the threonine residue is not conserved at all and the serine residue is 
conserved in all linker histones. The glutamine residue which immediately follows in H1.X 
conforms to the DNA-PK SQ consensus motif, this residue is not conserved amongst the 
somatic linker histones, suggesting it could be an important unique linker histone capable of 
phosphorylation by DNA-PK. 
 
Although the S/T-Q motif is generally thought to be the target for DNA-PK phosphorylation 
(Y. R. Chen et al., 1991), more recently proteins lacking these motifs have been shown to be 
phosphorylated by DNA-PK (Chan et al., 1999, Zernik-Kobak et al., 1997). Mass spectroscopy 
has shown that serine or threonine sites can be phosphorylated when immediately followed 
by a hydrophobic amino acid (Meek et al., 2004). This chapter demonstrates that the 
majority follow this rule but there is one exception where a threonine residue is followed by 
a glycine residue in H1.0 (Table 3.1). 
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To determine the importance of the potential individual phosphorylation sites identified 
they would have to be knocked out by site-directed mutagenesis and re-assessed using the 
in vitro kinase assay. However, the potential impact of these sites in vivo would also need to 
be tested. Studies knocking out DNA-PK phosphorylation sites in XRCC4 (Yu et al., 2003c) and 
XLF (Yu et al., 2008) have resulted in no impact on NHEJ. This suggests that although the 
native proteins can be phosphorylated, their phosphorylation has no detrimental effect on 
NHEJ. 
 
In order to study the phosphorylation sites in more detail, recombinant proteins were 
produced. Although linker histone variants were purified from E. coli using the pET vector 
system, with the exception of H1.X, they were highly degraded. A study which aimed to 
purify rat H1.3 also encountered similar problems and the authors suggest that the 
degradation is due to the high lysine and arginine content found in the CTD of the linker 
histone (Bharath et al., 1998). This group also tried to express the linker histone H1.3 as a 
fusion protein with GST using the pGEX-2T vector but the fusion protein was unable to bind 
the GST affinity matrix, something also observed when attempting to purify linker histone 
variants using this system (data not shown). To overcome the problem of degradation the 
group used an alternative vector, pTrc99A, which places the poly-histidine tag at the 
carboxyl-terminus of the protein, as opposed to the amino-terminus in the pET vector 
system. An alternative approach would be to tag the protein at each end and employ a 
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Another approach to purify linker histone H1.2 was to use the baculovirus expression 
system. Although the system adequately expressed linker histone H1.2, the protein was 
insoluble and remained insoluble despite using several different lysis buffers. Further work 
to find the correct lysis buffer to solubilise H1.2 is required. 
 
Using the purified linker histone variants reconstituted in the in vitro kinase assay, it was 
seen that H1.1, H1.2, H1.3, H1.4, H1.5 and H1.X are all phosphorylated and H1.0 had very 
minimal phosphorylation. As previously discussed, phosphorylation of H1.1 to H1.5 must be 
at a non-SQ site as these linker histone variants do not contain this site. As the products are 
also not pure, the possible phosphorylation of contamination products cannot be ruled out. 
H1.0 and H1.X are the only two linker histone variants to contain the SQ-site and of these 
two, H1.X is seen to be phosphorylated to a greater extent in vitro. 
  
 













CHAPTER FOUR: IN VIVO CHARACTERISATION OF H1.X’S 
ROLE IN DOUBLE STRAND BREAK REPAIR 
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4.1 Introduction and Overview 
H1.X is the most recently identified of the linker histone family (Yamamoto and Horikoshi, 
1996). The expression profile of H1.X demonstrates expression across many tissues in a non 
cell cycle dependant manner, in contrast to the rest of the linker histone variants H1.1, H1.2, 
H1.3, H1.4 and H1.5 (Happel et al., 2005).  
 
Structurally, H1.X contains the typical tripartite structure comprising of a central globular 
domain, flanked by a short basic NTD and a long basic CTD, as seen in other linker histone 
variants (Figure 1.11). However, H1.X shares much less sequence homology with the other 
linker histones. The globular domain (underlined in purple in Figure 4.1) shows striking 
conservation between linker histones H1.1 to H1.5, however, there is only 38% identity 
between H1.X and H1.1 to H1.5. Outside of the globular domain, in the basic NTD and CTD 
there is also little conservation. 
 
There are three key lysine residues (Figure 4.1, red asterisks) within the globular domain 
which are postulated to be important for contact with DNA. These three lysine residues are 
conserved between all linker histone variants. Two amino acids that are considered to be 
important for the high-affinity binding of linker histones to chromatin in vivo, threonine 152 
and serine 183 in H1.1, are not conserved in H1.X (Hendzel et al., 2004). The importance of 
these residues can be seen when comparing H1.2, which has these conserved sites, and 
H1.X, which does not. Using GFP-tagged linker histone proteins and analysing their binding 
kinetics using FRAP, H1.2 remains more tightly bound than H1.X (Takata et al., 2007). 
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H1.X also has a different localisation pattern to other linker histone variants which have an 
overall nuclear localisation and do not appear to be accumulated in the nucleoli. H1.X 
primarily locates to the nucleoli during the G1 phase of the cell cycle, however, it is not 
required for the maintenance of nucleolar structure (Stoldt et al., 2007, Takata et al., 2007). 
Olsen et. al. (2002) suggest a role for the nucleoli whereby it serves as a storage centre for 
the temporary inactivation of regulatory proteins (Olson et al., 2000). This theory seems 
even more interesting when considering some of the proteins which have been reported to 
be present in the nucleoli: RAD51, involved in HR (Section 1.1.3; De et al., 2006); BRCA1 
(Section 1.1.2.7), involved in HR, checkpoint control and DNA repair (De et al., 2006, Tulchin 
et al., 2010). 
 
Depletion of H1.X in HeLa cells results in defective spindle formation, leading to misaligned 
chromosomes and activation of the spindle checkpoint resulting in delayed mitosis (Takata 
et al., 2007). Interestingly, the presence of micronuclei following successful mitotic division 
was also detected. The presence of micronuclei can indicate that the protein may have an 
involvement in DNA repair. Micronuclei are unrepaired DSBs that result in an acentric 
chromosome fragment being created. Micronuclei are also seen when depleting the levels of 
KU70, or inhibiting the kinase function of DNA-PKCS (Chernikova et al., 1999, Y. Zhang et al., 
2008).  
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Figure 4.1 - Sequence alignment of linker histone variants 
Multiple alignment of the primary sequences of human somatic linker histone variants. The globular domain 
sequence is underlined in purple. Lysine residues thought to be important for contact with DNA are highlighted 
with red asterisks, and the two amino acids postulated to be important for chromatin interactions are 
highlighted with blue asterisks. Key - Alanine, Tyrosine and Phenylalanine, Glycine, Proline, Serine and 
Threonine, Aspartic acid and Glutamine acid, Tryptophan, Histidine, Lysine and Arginine, Isoleucine, Leucine, 









The previous chapter explains that although all the linker histone variants examined are able 
to be phosphorylated by DNA-PK in vitro, H1.X contains an SQ site which could be 
phosphorylated in vivo by DNA-PK. This observation suggests that H1.X might be a true 
physiological target for DNA-PK in vivo, and as such, it may be involved in DNA-PK mediated 
DNA damage responses in human cells. In order to investigate the functional role of H1.X in 
vivo this chapter will: 
1. Investigate H1.X function by depleting cells of H1.X protein and then: 
a. Assessing cell survival and growth using the clonogenic survival assay. 
b. Assessing the ability of cells to repair DSBs by the H2A.X foci assay. 
c. Assessing changes to cell cycle kinetics by flow sorting. 
2. Further characterise H1.X function by examining the localisation of H1.X following 
exposure to IR. 
 
4.3 Results 
4.3.1 siRNA targeted knockdown of H1.X 
Using small RNA oligonucleotides targeted towards the globular domain of H1.X, protein 
levels were reduced by 95% 24 hours post transfection, and lasted for a minimum of 5 days 
(Figure 4.2). -tubulin was used as a loading control, and immuno-probing for the linker 
histone variant H1.2 will assess the specificity of the siRNA. H1.2 does not contain an SQ 
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phosphorylation motif and has been reported as being the most highly expressed of all linker 
histones (Kratzmeier et al., 1999). Immuno-probing for the core histone H2A will also 
highlight any changes in core histone protein levels due to H1.X depletion. Levels of all of 
these proteins remain the same as the pre-siRNA samples (0 hours) showing that the 
depletion of H1.X had no effects on other linker histones nor core histones. Using siRNA 
targeted towards H1.2, H1.2 protein levels were reduced by 96% after 24 hours and the 
following 5 days. Levels of H1.X, H2A and -tubulin remained constant during this time 
course. siRNA targeted towards the firefly luciferase (LUC) gene was used a control for 
transfection. The -tubulin levels are constant and there is no noticeable reduction of H2A 
levels over the 5 day time course, however, after 24 hours both H1.X and H1.2 protein levels 
were reduced by 80% and 95% respectively. These levels do return to their un-transfected 
level after 48 hours however and remain at that for the next 72 hours. Due to this all 
experiments were carried out 48 hours post transfection when the levels of all un-targeted 
proteins are at their normal levels.  
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Figure 4.2 - siRNA depletion of H1.X, H1.2 and LUC 
MRC5VA cells were treated with siRNA targeted towards H1.X, H1.2 and LUC and examined over a 120 hour 
period. All siRNA transfections were assessed with antibodies directed towards H1.X, H1.2, H2A and -tubulin. 
H1.X siRNA reduced H1.X proteins levels by 95% over the 120 hour period with no significant changes seen in 
the expression levels of H2A and H1.2. H1.2 siRNA reduced H1.2 protein levels by 96% over the 120 hour period 
with no significant changes seen in the expression levels of H1.X and H2A. Control LUC siRNA reduced the 
protein levels of H1.X and H1.2 by 80% and 95% respectively after the first 24 hours. From 48 hours onwards 
the expression levels returned to pre-siRNA levels. Levels of H2A remained consistent throughout the 120 hour 
period. Protein quantification was determined with ImageJ imaging software (NIH). 
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4.3.2 siRNA mediated depletion of H1.X renders cells sensitive to ionising 
radiation 
To determine whether H1.X had a role in survival following exposure to IR, MRC5VA cells 
were exposed to increasing doses of IR and their survival rates analysed (Figure 4.3). Over 
the 8 Gy dose range H1.X siRNA cells are consistently more sensitive than the untransfected, 
LUC siRNA or H1.2 siRNA transfected cells (Figure 4.3). Using the students’ two tailed t-test, 
the difference between H1.X depleted cells and control cells is statistically significant with a 
p-value of at least < 0.05 for 2, 4 and 6 Gy (Figure 4.3, gold stars), at 8 Gy the p-value 
becomes < 0.001 (Figure 4.3, red star). Interestingly there is a slight resistance to IR for the 
H1.2 depleted cells when cells are exposed to 8 Gy (p < 0.05, Figure 4.3, black star).  
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Figure 4.3 - siRNA mediated depletion of H1.X renders cells sensitive to ionising radiation 
Over increasing doses of IR, cells depleted of H1.X by siRNA are more sensitive than the control un-transfected 
cells, LUC siRNA control cells and cells depleted of H1.2 by siRNA. At 8Gy, the difference between cells depleted 
in H1.X is at its greatest, it is also at this dose where cells depleted in H1.2 show a mild resistance to IR when 
compared to the un-transfected and LUC siRNA control cells. Gold and black stars represent a statistically 
significant difference of p<0.05 and red stars a difference of p<0.001 as measured by the students’ two tailed t-
test. (n=3 independent experiments, each in triplicate; error bars represent ± standard error of the mean)  
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4.3.3 siRNA depletion of H1.X leads to elevated levels of unrepaired double 
strand breaks as revealed by H2AX staining 
As cells depleted in H1.X are more radiosensitive, it would suggest that the repair of DSBs is 
compromised. To examine the effects of H1.X depletion on DSB repair, the levels of H2A.X 
were studied in un-irradiated cells to determine the background level, 30 minutes following 
IR to determine the maximum amount of DNA damage, and 24 hours post-irradiation when, 
under normal conditions, the majority of DSBs should be repaired (Section 1.1.2.4).  
 
Figure 4.4 shows the foci seen in the untransfected MRC5VA and LUC siRNA and H1.2 siRNA 
transfected control cells along with the H1.X siRNA transfected cells. At 0 hours the nuclei in 
all conditions contain comparably low amounts of H2A.X foci, MRC5VA, LUC siRNA and H1.X 
siRNA having 7, 5 and 6 foci (±3), and H1.2 siRNA having slightly more with 10 foci on 
average. At 30 minutes post IR they all contain comparably high amounts of H2A.X foci, an 
average of 60 per nuclei for MRC5VA, LUC siRNA and H1.X siRNA, and an average of 65 of 
H1.2 siRNA. Twenty four hours post-irradiation, the majority, if not all of the H2A.X foci 
have disappeared in the MRC5VA and LUC siRNA transfected control cells, with 10 and 8 foci 
on average respectively. Cells depleted in H1.2 again have a marginally higher amount of 
H2A.X foci after 24 hours, on average 13 foci remain. This suggests that depletion of H1.2 
has no effect on DSB repair. Cells depleted in H1.X have a greater number of H2A.X foci 
after 24 hours than seen in the controls, on average 19 foci remain. 
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Plotting the number of unrepaired breaks as a percentage of the total breaks seen at 30 
minutes, termed the residual foci, clearly shows the difference between cells depleted in 
H1.X and the controls (Figure 4.5). The control MRC5VA, LUC siRNA and H1.2 siRNA cells all 
display, on average, 5% residual foci, compared to H1.X siRNA which display 28% residual 
foci. The gold star representing a statistically significant difference between cells depleted in 
H1.X and the controls, MRC5VA, LUC siRNA and H1.2 siRNA (p<0.01, students’ two tailed t-
test). 
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Figure 4.4 - H2A.X foci are elevated following a 24 hour repair period in cells depleted for H1.X 
The panel labelled MRC5VA shows the un-transfected control cells. Un-IR (0h) cells show no, or very low, H2A.X foci which are representative of a DSB. The maximum 
H2A.X signal can be seen 30 minutes post IR, with the majority of these being repaired 24 hours post IR. A very similar story is seen in control LUC siRNA and cells depleted 








Figure 4.5 - Residual H2A.X foci 24 hours post-irradiation 
Foci counted at 30 minutes and 24 hours post -irradiation were normalised against the un-irradiated counts. 
Residual foci were calculated as the percentage of foci remaining after 24 hours against the foci counted at 30 
minutes post-irradiation. The un-transfected MRC5VA cells, control LUC siRNA cells and cells depleted in H1.2 
all displayed comparable levels of residual foci at, on average 5%. Cells depleted in H1.X displayed a much 
higher amount of residual foci at 28%. Gold star represents a statistically significant difference of p < 0.01 
compared to all controls, as measured by the students’ two tailed t-test. (n=3 independent experiments; error 
bars represent ± standard error of the mean)  
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4.3.4 Cells depleted in H1.X show a delay in the G2 to M cell cycle progression 
following ionising radiation 
Results described in Section 4.3.3 show that H2A.X foci persist in cells depleted in H1.X, 24 
hours post-irradiation. The elevated number of unrepaired breaks seen in H1.X siRNA cells is 
generally accompanied by a longer lasting G2 block, reflecting the presence of DNA damage 
(Walworth et al., 1993). To determine whether the delay in dephosphorylation of the H2A.X 
signal is linked to a delay in the cell cycle, cell cycle kinetics were examined using bivariate 
cell cycle analysis. Cells were examined over a 24 hour period with sampling every 4 hours. 
Following flow cytometry analysis, dot plots were plotted with DNA content on the 
horizontal axis, and BrdU content on the vertical axis. Each plot is representative of 70,000 
cells (Figure 7.2 - Figure 7.7, Appendix C). The BrdU labelled population of cells can be split in 
to specific defined regions (Figure 7.1, Appendix C): R1 is a measure of the total BrdU 
labelled population; R2 a measure of the BrdU labelled population in the G1 phase of the cell 
cycle having a DNA copy number of 1; R3 a measure of the BrdU labelled population 
currently synthesising DNA, the S-phase of the cell cycle; and R4 a measure of the BrdU 
labelled population in the G2/M phases of the cell cycle, having a DNA copy number of 2. 
 
Following the BrdU pulse-labelling in all samples, the majority of the cells are in S-phase (R3, 
Figure 7.1, Appendix C). At subsequent time points this population moves towards the G2/M 
phase of the cell cycle (R4, Figure 7.1, Appendix C). MRC5VA, LUC siRNA and H1.X siRNA un-
irradiated populations all show a re-appearance in G1 (R2, Figure 7.1, Appendix C) after 8 
hours (Figure 7.2 - Figure 7.4, red box, Appendix C). In contrast, following IR, MRC5VA and 
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LUC siRNA populations show a re-appearance in G1 after 12 hours, 4 hours longer than the 
corresponding un-irradiated samples (Figure 7.5 & Figure 7.6, red box, Appendix C). Cells 
depleted in H1.X show a re-appearance in G1 after 16 hours, 8 hours longer than the 
corresponding un-irradiated samples and 4 hours longer than the irradiated controls (Figure 
7.7, red box, Appendix C). 
 
The duration of the G2/M phase can be estimated by plotting the entry of BrdU positive cells 
into the G1 phase of the cell cycle (R2/R1, Figure 7.1, Appendix C). By extrapolating the 
regression line from the most linear part of the curve to the x-axis one can estimate the G2 
to M delay. All un-irradiated samples show a duration in G2/M of approximately 5 hours, 
with no differences seen between all samples (Figure 4.6 & Figure 4.7, filled markers). 
Irradiated MRC5VA and LUC siRNA samples show an extended duration in G2/M of 
approximately 12 hours, with no differences seen between the two samples (Figure 4.6 & 
Figure 4.7, open markers). The regression line for H1.X depleted cells is much shallower and 
never resumes cycling therefore it is difficult to ascertain the duration of time in G2/M 
(Figure 4.6 & Figure 4.7). 
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Figure 4.6 – Measurement of G2/M delay over 24 hours 
Exponentially growing, BrdU labelled cells were measured for their entry back in to G1 after a successful mitotic division. Filled markers represent those samples which 
remained un-irradiated and the un-filled markers represent those samples which were exposed to 5 Gy IR. By extrapolating the regression line of the linear part of the 
curve, the G2/M delay can be estimated. The un-irradiated samples all exhibit a 5±1 hour delay, whereas the irradiated samples are delayed much longer. Control MRC5VA 
and LUC siRNA cells exit G2/M after 12±1 hours, whereas it is difficult to determine the delay for H1.X siRNA cells. (n=3 independent experiments; error bars represent ± 
standard error of the mean)  
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Figure 4.7 - Measurement of G2/M delay over 48 hours 
Exponentially growing, BrdU labelled cells were measured for their entry back in to G1 after a successful mitotic division. Filled markers represent those samples which 
remained un-irradiated and the un-filled markers represent those samples which were exposed to 5 Gy IR. By extrapolating the regression line of the linear part of the 
curve, the G2/M delay can be estimated. The un-irradiated samples all exhibit a 5±1 hour delay, whereas the irradiated samples are delayed much longer. Control MRC5VA 
and LUC siRNA cells exit G2/M after 12±1 hours, whereas it is difficult to determine the delay for H1.X siRNA cells. (n=1 independent experiment) 
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4.3.5 siRNA depletion of H1.X leads to a delay in the appearance of 
micronuclei following ionising radiation 
It was noted in a recent paper that, following mitosis, micronuclei formed when cells were 
depleted in H1.X (Takata et al., 2007). Micronuclei form during defective repair following a 
DSB, whereby the unrepaired chromosomal fragment is excluded from the nucleus and 
forms a smaller nuclear body. Cells that are un-irradiated are absent of any micronuclei, 
irrespective of siRNA depletion (data not shown). Following irradiation, cells were analysed 
for their number of micronuclei per binucleate cell after 24 and 48 hours. After 24 hours 
post-irradiation, the MRC5VA, LUC siRNA and H1.2 siRNA transfected control cells all 
exhibited, on average, approximately 0.8 to 1 (± 0.05) micronucleus per binucleate cell, 
whereas in H1.X siRNA transfected cells this number was substantially lower with an average 
of approximately 0.2 micronuclei per binucleate cell (Figure 4.8 & Figure 4.9; p<0.01, 
students’ two-tailed t-test). After 48 hours the MRC5VA, LUC siRNA and H1.2 siRNA 
transfected cells all had approximately 1 micronucleus (± 0.05) per binucleate cell, however, 
in H1.X siRNA transfected cells the number of micronuclei per binucleate cell had increased 
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Figure 4.8 – Cells depleted in H1.X have less micronuclei 24 hours post-irradiation 
Cells were exposed to 5 Gy IR, incubated for 5 hours after which cytochalasin B was added and cells were 
incubated for a further 24 and 48 hours. Following this period the number of micronuclei were counted in 
binucleate cells and plotted as the number of micronuclei per binucleate cell. Levels of micronuclei were 
significantly lower in the H1.X siRNA cells than the controls 24 hours post irradiation. After 48 hours the levels 
of micronuclei were significantly higher in the H1.X siRNA cells than in the controls. Gold stars represent 
statistically significant difference between H1.X siRNA and the MRC5VA, LUC siRNA and H1.2 siRNA controls 
(p<0.01 for 24 hours and p<0.05 for 48 hours, students’ two tailed t-test). (n=3 independent experiments; error 
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Figure 4.9 - Micronuclei seen at 24 and 48 hour post-irradiation 
Micronuclei (labelled with white arrows) are highlighted in all samples at 24 and 48 hours post-irradiation. In 
the MRC5VA, LUC siRNA and H1.2 siRNA control cells there are micronuclei observed 24 hours post-irradiation. 
Cells depleted of H1.X show an absence of micronuclei 24 hours post-irradiation, with them appearing 48 hours 
post-irradiation.  
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4.4 Discussion 
4.4.1 H1.X depletion results in cellular sensitivity to IR 
The initial aim of this chapter was to successfully reduce cellular levels of H1.X protein in 
MRC5VA cells. Using INTERFERin as a transfection reagent, extremely small amounts, 10nM, 
of siRNA was used to achieve specific and efficient knock down. Using other transfection 
reagents, larger amounts of siRNA were needed to be used, which can lead to off-target 
effects whereby the expression of genes involved in cell cycle regulation and apoptosis 
amongst others, have been show to be altered (Semizarov et al., 2003). The expression of 
H1.X was reduced by 99% for a minimum of 5 days, with no noticeable effects on control 
linker and core histones. Further, using siRNA targeted towards LUC there was a noticeable 
decrease in H1.X and H1.2 protein levels after 24 hours, however these returned to normal 
after 48 hours. For this reason all resulting experiments were performed 48 hours post 
transfection with Western blots confirming proteins levels for each experiment (data not 
shown). 
 
Cells depleted in H1.X were assessed for their response to IR using the clonogenic survival 
assay. The clonogenic survival assay aims to determine the ability of a cell to proliferate 
indefinitely (Munshi et al., 2005). Using increasing doses of IR it is possible to determine 
whether the depletion of a certain protein is important for cellular proliferation and survival. 
Cells depleted in H1.X are significantly more sensitive than the control MRC5VA and LUC 
siRNA treated cells. Although the decreased survival seen is not as great as that seen in ATM 
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(Taylor et al., 1975) and XRCC4 (Grawunder et al., 1998) deficient cell lines, it is comparable 
with cells depleted in MDC1 by siRNA (J. Zhang et al., 2005). Chicken DT40 cells with H1.R (a 
chicken specific linker histone variant) knocked out do not show sensitivity to IR. However 
they are sensitive to MMS treatment, which results in stalled replication forks, invoking the 
HR repair pathway (Hashimoto et al., 2007). Interestingly, cells depleted in H1.2 show a 
slight but statistically significant increase in survival at the 8 Gy dose. This is supported by 
another study which shows that using embryonic stem cells deficient in H234 show marked 
resistance to IR, along with MMS and hydroxyurea treatment (Murga et al., 2007). This 
suggests that depletion of H1.2 offers protection to the cell, either by not allowing the 
promotion of an H1.2-stimulated, slower, backup pathway (B-NHEJ; Rosidi et al., 2008), or by 
preventing H1.2-stimulated apoptosis (Konishi et al., 2003). 
  
As cells depleted in H1.X show a marked sensitivity to IR, it was important to ascertain 
whether this had any implications with regards to H2A.X foci which are formed following IR 
(Section 1.1.2.4). It is known that cells deficient in ATM are unable to form H2A.X foci 
(Burma et al., 2001), however, along with the control cells, cells depleted in H1.X are able to 
form H2A.X foci showing that H1.X exerts its effect further downstream than the 
phosphorylation of H2A.X by ATM (Burma et al., 2001). After 30 minutes all cells showed a 
very similar level of H2A.X, therefore H1.X does not promote nor inhibit the propagation of 
the H2A.X signal. Interestingly, H234 cells show an elevated intensity of H2A.X following IR 
which was not directly measured in this study, although the H2A.X foci counts in cells 
depleted in H1.2 are the same as the control cells in this study (Murga et al., 2007). 
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Furthermore, 53BP1, MDC1, BRCA1 and RAD51 have also been shown to be successfully 
recruited to the sites of DSBs in cells depleted in H1.X (Personal communication, Dr. Grant 
Stewart). This suggests that the initial stages of DSB recognition and protein recruitment 
remain intact in the absence of H1.X. 
 
Following IR, a 24 hour period should be enough time for all DSBs to be repaired under 
normal circumstances, which is seen in the control MRC5VA and LUC siRNA cells. Cells 
depleted in H1.X, however, still retain an elevated level of H2A.X foci 24 hours post 
irradiation. Other proteins which form foci which co-localise with H2A.X: 53BP1, MDC1, 
BRCA1 and RAD51 also remain at an elevated level (Personal communication, Dr. Grant 
Stewart). This suggests that although DSB recognition and protein recruitment remain intact, 
the DSB is either not getting repaired, or the H2A.X signal is not being dephosphorylated, as 
seen in cells depleted in protein phosphatase 6 (Douglas et al., 2010). To determine whether 
the breaks are actually being repaired, DNA breaks can be quantified by using either pulsed 
field gel electrophoresis (Whitaker and McMillan, 1992), or the neutral COMET assay (Olive 
et al., 1990). 
 
4.4.2 H1.X depletion invokes the G2 to M cell cycle checkpoint 
Following IR and DSB induction, the cell cycle checkpoints will be activated, allowing the cell 
to repair the damage before it is propagated to the daughter cell. Following the successful 
repair of the DSB the H2A.X signal is removed which is essential for the recovery from the 
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DNA damage induced cell cycle checkpoint (Chowdhury et al., 2005, Keogh et al., 2006, 
Nakada et al., 2008). 
 
Upon exposure to IR, the control MRC5VA and LUC siRNA cells show a G2 to M delay of 12 
hours, a delay typically representative of the time required to repair the DNA DSBs (Konig 
and Baisch, 1980). Cells depleted in H1.X however show an extended delay following IR. The 
increased amount of H2A.X foci and the extended delay in G2/M would be consistent with a 
failure to repair the DSBs incurred. Interestingly, over a 48 hour period, cells depleted in 
H1.X fail to synchronise, unlike the MRC5VA and LUC siRNA populations (data representative 
of one experiment), suggesting that small populations of cells are escaping the G2 to M block 
without the successful repair of the DSB, a phenomenon seen in S. cerevisiae (S. E. Lee et al., 
2001). In the MRC5VA, LUC siRNA and H1.X siRNA cells, phosphorylation of CHK2 on tyrosine 
68 is observed, therefore the activation of the G2 checkpoint remains intact in all 
populations, suggesting that the depletion of H1.X does not affect cell cycle checkpoint 
initiation (personal communication, Dr. Grant Stewart). Unfortunately, cells depleted in H1.2 
were not examined so it is impossible to determine whether the G2 to M delay is truly linked 
with H1.X depletion, or to general linker histone depletion. 
 
A recent study which characterised H1.X as having a role in mitosis, also revealed the 
appearance of micronuclei following mitosis in cells depleted in H1.X (Takata et al., 2007). 
The cells used in the study were human HeLa cells under no genotoxic stress. Micronuclei 
are a marker of unrepaired double strand breaks, therefore, based on the evidence so far, it 
would be expected that cells depleted in H1.X would show elevated levels of micronuclei. 
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Elevated levels were seen, but the micronuclei appeared after 48 hours, 24 hours later than 
they appeared in the controls. It is expected that the delay in appearance of micronuclei is 
due to the extended delay in the cell cycle. Elevated levels of micronuclei are also seen in 
cells depleted for KU70 and RPA (Balajee and Geard, 2004, Vandersickel et al., 2010).  
 













CHAPTER FIVE: THE ANALYSIS OF THE MECHANISM OF 
ACTION OF H1.X IN DSB REPAIR 
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5.1 Introduction and Overview 
The final stage of repair in the NHEJ pathway is performed by the LX complex, in conjunction 
with the recently discovered XLF protein (outlined in more detail in Section 1.1.3.2.3; 
Ahnesorg et al., 2006, Buck et al., 2006, L. Chen et al., 2000). 
 
DNA end ligation by DNA ligase IV has been shown to be significantly stimulated by XRCC4 
and XLF in the in vitro reconstituted ligation reaction (Gu et al., 2007b). Whereas, the KU 
complex is inhibitory when multiple heterodimers are bound to the DNA, however when one 
or two KU heterodimers are bound, the DNA ligase IV mediated ligation reaction is 
stimulated (Kysela et al., 2003). This observation suggests that strict stoichiometric control is 
necessary to achieve stimulation. Previous work has also shown that linker histones also 
inhibit ligation, whereas the packaging of DNA in to nucleosomes with purified core histones 
showed no inhibition at all (Kysela et al., 2005, Rosidi et al., 2008, Yamanaka et al., 2002). 
DNA-PK, on its own, has also been shown to inhibit ligation in a dose-dependent manner. In 
the presence of linker histones and under phosphorylation permissive conditions in the 
presence of ATP, inhibition by DNA-PK is alleviated allowing DNA ligase IV ligation. The linker 
histones incorporated in to the in vitro ligation assay are efficiently phosphorylated and their 
overall DNA binding capacity is significantly reduced (Kysela et al., 2005). 
 
Linker histones, along with the core histones, are generally considered to be a barrier 
preventing access to DNA. There are reports which highlight the effect of phosphorylation of 
the CTD of linker histone variants and the effect this can have on their ability to bind DNA. 
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Altering phosphorylation sites to render the sites un-phosphorylatable (Serine-Alanine), or 
global inhibition of phosphorylation using staurosporine or 5,6-dichloro-1--D-
ribofuranosylbenziminidazole increase the linker histones affinity to DNA (Dou et al., 2002, 
Lever et al., 2000). This suggests a model whereby, un-phosphorylated linker histones have a 
high affinity towards DNA which is alleviated when the linker histones are phosphorylated. 
 
5.2 Aims 
It has been previously shown that H1.X has an important impact in vivo during NHEJ (Chapter 
4), however the mechanism behind this remains to be elucidated. The initial stages of NHEJ, 
including H2A.X phosphorylation and the recruitment of 53BP1, MDC1 and BRCA1 to the 
site of the DSB remain intact, suggesting H1.X is more likely to act further downstream in the 
repair pathway (personal communication, Dr. Grant Stewart). Previous results have shown 
that somatic linker histones have a general inhibitory effect on NHEJ, therefore it is not 
intuitively obvious as to why the absence of H1.X would decrease the efficiency of DSB repair 
and cell survival after exposure to IR. The established in vitro reconstitution techniques have 
been employed to dissect the functional impact of H1.X on DSB repair and its potential 
interactions with components of the NHEJ machinery. 
 
This chapter aims to: 
1. Use an in vitro reconstituted DNA ligation assay to determine the impact of H1.X on 
LX-mediated ligation. 
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2. Examine the binding properties of H1.X and H1.X/LX on DNA using EMSA to elucidate 
if the interaction between LX and DNA is stabilised in the presence of H1.X. 
3. Determine if H1.X can specifically interact with any members of the NHEJ machinery. 
 
5.3 Results 
5.3.1 H1.X stimulates LX mediated ligation of double stranded DNA 
To test whether the presence of H1.X affects the rate of dsDNA ligation, recombinant H1.X 
was added to the ligation system reconstituted in vitro as described previously (Section 2.17) 
(Kysela et al., 2003). As shown in Figure 5.1, the addition of H1.X markedly enhanced the 
rate of LX-mediated DNA ligation when compared to LX alone. LX alone is able to produce 
some high order ligation products (Figure 5.1A Lane 2), however, the addition of H1.X 
dramatically increased the amount of ligated products (Figure 5.1A Lanes 3-16). Amounts of 
H1.X exceeding 157nM begin to decrease the stimulation of ligation, although these are still 
higher than those seen with LX alone (Compare Figure 5.1A lanes 10 and 2). With increasing 
amounts of H1.X up to, and including, 67nM the stimulation increased linearly (Figure 5.1C). 
At the point of stimulation between 34 and 67nM H1.X, approximately equimolar 






Page | 144  
 
 
Figure 5.1 – Recombinant linker histone H1.X stimulates LX-mediated ligation. 
A. Schematic of radio-labelled DNA substrate. Purified recombinant linker histone H1.X was incubated, in 
increasing amounts, with purified LX complex. Increasing amounts of H1.X (lanes 3-16) result in the increasing 
amount of higher order fragment when compared to DNA alone (lane 1), or LX and DNA alone (lane 2). 157nM 
of H1.X (lane 10) results in the majority of ligated products and ligation decreases from 201nM – 390nM (lanes 
11-16), although ligation products remain greater than those seen in the controls (lanes 1 & 2). 
B. Purified recombinant linker histone H1.X was incubated, in increasing amounts, with commercially available 
T4 DNA ligase. T4 DNA ligase alone was unable to ligate DNA fragments (lane 2), and the addition of H1.X failed 
to stimulate ligation (lanes 3-7). 
C. Graphical representation of A, lanes 1-7 and B, lanes 1-7. Converted substrate was calculated as the amount 
of DNA present in ligated products as a percentage of the total DNA present. Stimulation of LX mediated 
ligation by H1.X is clearly linear using these amounts of proteins, whereas T4 DNA ligase shows very minimal 
ligation.  
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To determine whether H1.X mediated stimulation was specific to DNA Ligase IV, ligation 
experiments were repeated, replacing the LX complex with T4 DNA Ligase. T4 DNA Ligase 
alone was not able to stimulate end ligation (Figure 5.1B Lane 2), and with the addition of 
H1.X the stimulation of ligation was not seen (Figure 5.1B Lanes 3-7 and Figure 5.1C). 
 
To determine whether H1.X itself possessed DNA ligase activity on its own, ligation 
experiments were repeated omitting the LX complex. H1.X was shown to possess no DNA 
ligase activity (Figure 5.2 Compare lanes 1 and 2 to lanes 3 and 4). 
 
The original studies, which showed that a somatic linker histone mix inhibited ligation, used 
an increased amount of LX complex, 125nM, coupled with an incubation time of 3 hours 
(Kysela et al., 2005). To confirm that H1.X did not act in an inhibitory manner, its activity was 
assessed under these conditions. Figure 5.3, lanes 2-4, show ligation under stimulatory 
conditions (50nM LX, 30 minute incubation), whereas Figure 5.3, lanes 12-14, show ligation 
under the conditions described previously (125nM LX, 3 hour incubation). Figure 5.3 lanes 5-
11 show the other permutations of incubation times and amount of LX and also show 
ligation. These include 125nM LX complex for 30 minutes (Figure 5.3 lanes 5-7) and 50nM LX 
complex for 3 hours (Figure 5.3 lanes 9-11).  
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Figure 5.2 – Linker histone H1.X does not possess DNA ligase activity. 
Purified recombinant linker histone H1.X was incubated with LX in the presence of DNA resulting in increasing 
amounts of ligated DNA. In the absence of LX, H1.X was unable to ligate fragments of DNA showing it does not 




Figure 5.3 - H1X stimulates ligation under conditions previously shown to inhibit ligation 
Typical stimulatory conditions for ligation require 50nM of LX to be incubated for 30mins. Conditions used in 
the study where a linker histone mix inhibited ligation required 125nM LX to be incubated for 3 hours. To 
assess whether H1.X stimulated ligations under all conditions, it was assessed under all permutations. Ligation 
was seen for all permutations (lanes 4, 7, 11 and 14 compared to lanes 1 & 8), with enhanced ligation when 
incubated for 3 hours (lanes 11 & 14 compared to 4 & 7). This demonstrates that under the same conditions 
which H1 inhibited ligation (125nM of LX for 3 hours), H1.X was still able to stimulate the reaction.  
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5.3.2 H1.X cannot rescue H1-mediated inhibition of ligation 
The commercially available linker histone mix, previously shown to contain H1.0 – H1.5 and 
H1.X (Section 3.3.2), is able to inhibit LX-mediated ligation quite dramatically (Figure 5.4 
Lane 3) whereas H1.X alone clearly stimulates ligation (Figure 5.4 Lane 2). To determine 
whether H1.X was able to rescue the inhibitory phenotype displayed by the linker histone 
mix, H1.X was added to the reaction containing radio-labelled substrate DNA before (Figure 
5.4 Lanes 4-6), after (Figure 5.4 Lanes 7-9), or at the same time (Figure 5.4 Lanes 10-12) as 
the H1 linker histone mix. In all cases DNA ligation was still inhibited showing that under 
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Figure 5.4 - H1.X does not have the ability to rescue H1 mediated inhibition of ligation. 
Purified recombinant linker histone H1.X is able to stimulate LX mediated ligation (compare lane 2 to 1), 
whereas a commercially available linker histone mixture inhibits ligation by LX (compare lane 3 to lane 2). H1.X 
was unable to rescue ligation inhibition by H1 when it was added to the reaction before H1 (lanes 4-6), after H1 
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5.3.3 H1.X and DNA Ligase IV/XRCC4 form protein-DNA complexes. 
H1.X and LX complex were incubated together in the presence of DNA and the absence of 
MgCl2, to stop DNA ligation, and DNA-protein complexes were analysed using EMSA. Alone, 
neither protein was able to form stable DNA-protein complexes (Figure 5.5 lanes 2-9 and 
lane 10). However, two stable DNA-protein complexes are formed when both the LX 
complex and H1.X are present (Figure 5.5 lanes 16-18, indicated by arrows). The lower band 
appears in the presence of 22nM H1.X (Figure 5.5 lane 14) and increases in intensity as the 
amount of H1.X increases (Figure 5.5 lanes 15-18). The higher band appears in the presence 
of 44nM of H1.X (Figure 5.5 lane 16), and also increases in intensity as the amount of H1.X 
increases (Figure 5.5 lanes 17 & 18). It is unclear from the data as to what these bands 
contain. 
 
5.3.4 H1.X interacts with the DNA Ligase IV/XRCC4 complex 
Enhanced stimulation of ligation and the formation of band shifts by H1.X could be due to an 
interaction with either DNA ligase IV or XRCC4. To address the question whether H1.X 
functionally interacts with the LX complex only on a DNA complex, or if it possibly performs a 
complex in vivo co-immuno-precipitation studies using GFP-tagged H1.X proteins were used. 
GFP-H1.X was shown to co-immuno-precipitate endogenous XRCC4 proteins, providing 
evidence for an interaction between H1.X and XRCC4 which is not seen when using GFP 
alone or a control antibody (Figure 5.6). This is not dependent on, or induced by DNA 
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damage since no differences were observed between cells exposed to 30 Gy and un-
irradiated controls (Figure 5.6). 
 
To verify the interaction with endogenous native proteins in a non-over-expressed 
background, co-immuno-precipitation experiments were repeated. Co-immuno-precipitation 
of endogenous proteins with either anti-H1.X or anti-DNA ligase IV antibodies co-immuno-
precipitated the reciprocal protein, suggesting there is an interaction between endogenous 
H1.X and DNA ligase IV which is not seen when using a control antibody (Figure 5.7).  
 
Since both proteins are capable of binding to DNA, albeit with low efficiency, it had to be 
determined if the interaction detected could be the result of both proteins being bound to 
the same DNA fragments present in the lysate, a false positive interaction. To exclude this 
possibility, the intercalating agent, ethidium bromide, was added to the co-immuno-
precipitation buffers (Section 2.19.4) and the endogenous co-immuno-precipitation 
repeated (Lai and Herr, 1992). Increasing concentrations of ethidium bromide were unable 
to disrupt the interaction between H1.X and DNA ligase IV verifying the interaction as a true 
protein-protein interaction, not mediated by DNA (Figure 5.8). 
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Figure 5.5 - H1.X stabilises LX on dsDNA ends. 
Schematic of radio-labelled DNA substrate. Purified recombinant linker histone H1.X was incubated with radio-
labelled substrate DNA, in the absence of MgCl2, and analysed by EMSA. In the absence of LX (lanes 1-9) no 
band-shift was observed when incubated with H1.X up to and including 67nM. In the presence of LX and 22nM 
of H1.X a low band shift becomes apparent (lane 14; lower arrow). As the amount of H1.X increases, as does 
the intensity of this band (lanes 15-18; lower arrow), along with the appearance of a new band shift (lanes 16-
18; higher arrow). 
 
 
Figure 5.6 - Co-immuno-precipitation of XRCC4 with GFP-H1.X 
MRC5VA cells were stably transfected with GFP tagged H1.X. Co-immuno-precipitation experiments show that 
GFP-H1.X interacts with endogenous XRCC4 with and without exposure to 30Gy IR. Co-immuno-precipitation 
experiments using non-specific antibodies do not co-immuno-precipitate any endogenous XRCC4 protein. Co-
immuno-precipitation experiments using cells stably transfected with empty GFP vector do not co-immuno-
precipitate any endogenous XRCC4 protein. IP = Co-immuno-precipitation; IB = Western Blot 
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Figure 5.7 - Co-immuno-precipitation of DNA Ligase IV with endogenous H1.X 
Co-immuno-precipitation of endogenous DNA ligase IV and H1.X from MRC5VA cells using the reciprocal 
antibody shows the two proteins do interact with one another. Control (r/g IgG, either rabbit or goat, 
depending on the antibody used for the co-immuno-precipitation) co-immuno-precipitation experiments failed 







Figure 5.8 - Interaction between H1.X and DNA ligase IV is not disrupted with the addition of ethidium 
bromide. 
Co-immuno-precipitation of endogenous DNA ligase IV and H1.X from MRC5VA cells using the reciprocal 
antibody in the presence of the DNA- intercalator ethidium bromide. Increasing amounts of ethidium bromide 
does not affect the interaction between H1.X and DNA ligase IV, nor does it promote the pull down of DNA 
ligase IV when using a non-specific antibody control. IP = Co-immuno-precipitation; IB = Western Blot   
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5.3.5 H1.X interacts with nucleolin following exposure to IR 
Recombinant H1.X has been shown to interact with two members of the NHEJ pathway, DNA 
ligase IV and XRCC4 and stimulate ligation. It has also been shown that recombinant H1.X 
forms stable complexes with DNA in the presence of LX. The exact location of H1.X on the 
DNA substrate is unknown, however, to interact and stimulate LX-mediated ligation it means 
that H1.X must be close to the site of the DSB. This opens the possibility that H1.X could 
interact with other members of the NHEJ pathway. 
 
To ascertain if there are any other interacting partners for H1.X, co-immuno-precipitation 
experiments were used to immuno-precipitate bound proteins (Section 2.19). Co-immuno-
precipitated proteins were resolved on an SDS-PAGE gel (Section 2.3.2) and bands of interest 
were excised and the protein content analysed by mass spectrometry (Section 2.19.5). 
 
Table 5.1 shows the mass spectrometry results obtained that are of specific interest. 
Interestingly, both DNA-PKCS and KU70 are present in the table, both key members of the 
NHEJ pathway. Also, a 14-3-3 protein is also listed. 14-3-3 proteins interact with CDC25C and 
sequester it to the cytoplasm during the G2-M phase arrest (Dalal et al., 1999; Section 
1.1.1.3). 
 
The highest scoring interacting protein was that of nucleolin. Nucleolin is a nucleolar protein, 
along with H1.X, therefore it is not unsurprising that these two could interact (Lapeyre et al., 
1987). To validate this interaction, GFP-H1.X interacting proteins were co-immuno-
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precipitated, in the presence of ethidium bromide, and, using Western blotting, directly 
probed for nucleolin (Figure 5.9). Interestingly, the interaction was only seen following IR, 
suggesting that the interaction occurs following DNA damage.  
 
Coverage Peptides Score Protein 
38.31 58 1239.10 Nucleolin 
1.81 1 60.70 ATP-dependent DNA helicase 2 subunit 1 (KU70) 
1.16 3 55.76 DNA-dependent protein kinase catalytic subunit 
8.24 2 45.13 14-3-3 protein epsilon 
Table 5.1 - GFP-H1.X interacting partners as determined by mass spectrometry 
GFP-H1.X and interacting partners were co-immuno-precipitated and analysed by mass spectrometry. Proteins 








Figure 5.9 - Co-immuno-precipitation of nucleolin with GFP-H1.X 
MRC5VA cells were stably transfected with GFP tagged H1.X. Co-immuno-precipitation experiments show that 
GFP-H1.X interacts with endogenous nucleolin in response to exposure to 30Gy IR. Co-immuno-precipitation 
experiments using non-specific antibodies do not co-immuno-precipitate any endogenous nucleolin protein. IP 
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5.4 Discussion 
Previous work has shown that linker histone variants are inhibitory to LX-mediated ligation, 
the final step of NHEJ (Kysela et al., 2005). The linker histones used in these experiments 
were a mixture of all the somatic linker histone variants (H1.0 – H1.5 and H1.X). Therefore, it 
is impossible to ascertain whether this effect is contributable to an individual linker histone, 
or the complex interplay between several linker histone variants. 
 
Previous work in this thesis opposes the suggested inhibitory role of linker histones as the 
depletion of H1.X causes a profound impact on DSB repair and cellular survival to IR. Using in 
vitro mechanistical analysis we have provided an important insight in to the possible 
mechanism of action of H1.X in the NHEJ pathway. 
 
Inhibition of LX-mediated ligation was seen both in this study and in other studies when a 
linker histone mix is added to the in vitro reconstitution ligation assay (Kysela et al., 2005). 
Purified recombinant linker histone H1.X, however, stimulates LX-mediated ligation from as 
little as 7nM to as much as 390nM purified recombinant H1.X under the same experimental 
conditions. H1.X is also found in the linker histone mixture used in the previous studies so it 
would suggest that one or more of the other linker histones are able to mask its stimulation. 
Experiments to determine if the formation of H1.X-LX or H1.X-DNA complexes could 
abrogate the inhibitory effect on ligation following the addition of linker histones were 
unsuccessful. This suggests that there is a complex interplay between the individual linker 
histones at the DNA ends of the DSB. 
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The amount of H1.X used in the in vitro reconstituted ligation assay is important for the 
amount of stimulation observed. The greatest stimulation was achieved at approximately 
equimolar concentrations of H1.X to LX complex, with approximately 20 H1.X molecules per 
molecule of DNA. Amounts exceeding 157nM recombinant H1.X, although still stimulating 
the ligation, decrease the stimulation observed. At this concentration of H1.X, there are 
approximately 44 H1.X molecules per DNA molecule. This suggests that amounts of H1.X 
above 157nM could ‘coat’ the DNA in too much protein thereby reducing the accessibility of 
the DNA to the LX complex. This data suggests that there is a stoichiometric relationship 
between H1.X and the LX complex that determines the optimum ligation efficiency, 
something also suggested with the linker histone mix (Rosidi et al., 2008). 
 
Unfortunately, due to problems encountered purifying the other linker histone variants 
(Section 3.3.3), it is impossible to ascertain whether H1.X is unique in its role of stimulating 
the in vitro reconstituted ligation assay. However, commercially available H1.2 and H1.3 
have been recently shown to inhibit LX-mediated ligation over the same range at which H1.X 
stimulates the reaction (personal communication, Dr. Boris Kysela).  
 
Ideally, it would be interesting to see what effect all the linker histone variants have on the 
in vitro reconstituted ligation assay as only then would it be possible to draw conclusions 
regarding the complex interplay which would take place at the DNA ends between the linker 
histone variants. This is highlighted by H1.X stimulating ligation of DNA ligase IV in the 
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conventional NHEJ pathway, whereas H1.2 simulates ligation in the proposed DNA ligase III 
backup pathway (Rosidi et al., 2008). 
 
Linker histone variants have been shown to form stable complexes with the KU complex in 
the presence of DNA (Kysela et al., 2005), and in this chapter, H1.X has formed stable 
complexes with LX in the presence of DNA. Interestingly, H1.X is unable to form a stable DNA 
complex alone. This is likely due to linker histone variants having a shorter residence time on 
DNA than other chromatin binding proteins, such as transcription factors (Lever et al., 2000, 
Misteli et al., 2000, Phair et al., 2004). Also, H1.X lacks the conserved serine and threonine 
residues found in other linker histone variants, which are postulated to enhance DNA 
binding (Hendzel et al., 2004). 
 
The enhanced ligation stimulation and the presence of stable complexes in the presence of 
DNA suggests an interaction between recombinant H1.X and the LX complex. Interestingly, 
H1.X co-immuno-precipitated both DNA ligase IV and XRCC4 implying that this interaction 
occurs in vivo. Using mass spectrometry, H1.X is also suspected to interact with both KU70 
and DNA-PKCS, although not confirmed by co-immuno-precipitation studies. This data 
highlights H1.X having a significant role in DSB repair, interacting with the protein kinase 
DNA-PKCS and the ligation machinery, LX, to enhance the final ligation step. It would be 
interesting to assess whether H1.X’s interaction with DNA-PKCS results in H1.X 
phosphorylation as it has already been determined that H1.X can be phosphorylated by 
DNA-PKCS in vitro (Section 3.3.4). 
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Unfortunately, it is impossible to determine from the co-immuno-precipitation experiments 
as to whether the interaction between LX and recombinant H1.X is direct, or mediated 
through other protein(s). To ascertain this, proteins would need to be produced with 
different tags for purification and assessed using standard pull-down techniques, as both 
H1.X and the LX complex are histidine tagged. Far western blotting could also be used, 
whereby a PVDF membrane is probed with recombinant protein, allowing it to bind to 
potential interacting proteins. The protein is either radio-labelled, or probed with antibodies 
to allow its detection, highlighting proteins which interact. The only potential pitfall of this 
technique as that the proteins on the PVDF membrane will have been denatured and lost 
their tertiary structure which could be important for potential interactions. 
 
Nucleolin was also identified as an interacting partner for H1.X, however, unlike the LX 
complex, this interaction was only detected following DNA damage induced by IR. Nucleolin 
is predominantly a nucleolar protein, although it can be found in the nucleus, the cytoplasm 
and the cell membrane (Borer et al., 1989, Hovanessian et al., 2000). Interestingly, nucleolin 
has already been linked with other types of repair. Nucleolin can accelerate oligonucleotide 
binding, including oligonucleotides which contain mismatches (Hanakahi et al., 2000). 
Nucleolin has also been shown to interact with PCNA, and following exposure to UV, the 
interaction is enhanced having an inhibitory effect on nucleotide excision repair (C. Yang et 
al., 2009). Nucleolin has also been proposed to bind to RAD51 and regulate HR (De et al., 
2006). Also, down-regulation of nucleolin following DNA damage increases the translation of 
p53, helping to initiate the G1 phase checkpoint (De et al., 2006). Further work is required to 
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fully characterise these complex interactions and dissect the role of H1.X and nucleolin in 
response to IR. 
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6.1 Linker Histone Variant, H1.X, and its Role in Double Strand 
Break Repair 
Fundamentally, this project has added to the growing body of evidence showing that linker 
histones are not just structural components of chromatin, and that they have many 
implications in cellular function, specifically DNA repair (Hashimoto et al., 2007, Kysela et al., 
2005, Rosidi et al., 2008). In 1990 a model was proposed that during NHEJ, an alignment 
protein would exist which would bind broken DNA ends to align them, facilitating the end 
joining. It is also proposed that this alignment protein would support and stimulate end 
joining (Thode et al., 1990). One of those end binding proteins, the KU complex, has already 
been characterised in NHEJ (Griffith et al., 1992, Suwa et al., 1994, Taccioli et al., 1994). 
From the evidence provided in this thesis, it is plausible that the linker histone variant, H1.X, 
could act in a similar manner. 
 
Initial studies by Kysela et. al. (2005), proposed that linker histone variants were inhibitory to 
LX-mediated ligation, with the inhibition being relieved following phosphorylation by DNA-
PK (Kysela et al., 2005). Subsequently, the work presented here suggests that although some 
linker histone variants may be inhibitory to LX-mediated ligation, H1.X actually acts to 
stimulate ligation in an in vitro reconstituted assay. 
 
Interestingly, Rosidi et. al. (2008) have also presented a stimulatory role for a linker histone 
variant, H1.2, however stimulating DNA ligase III ligation in the alternative B-NHEJ pathway, 
rather than DNA ligase IV during NHEJ (Rosidi et al., 2008). B-NHEJ has a slower function 
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than NHEJ, is inhibited by DNA-PK and utilises DNA ligase III and PARP (Audebert et al., 2004, 
Perrault et al., 2004, H. Wang et al., 2005a). This observation also suggests that individual 
linker histone variants may fulfil different roles in different pathways of DSB repair, and DNA 
repair generally. 
 
Data in this thesis also suggests that H1.X has a specific role in DSB repair in the NHEJ 
pathway. Although the role is not fully understood yet, it is apparent that in the absence of 
H1.X, the efficiency of LX-mediated ligation is defective. Studies in chicken cells have 
highlighted the need for the avian linker histone variant, H1.R, in the response to DSBs via 
the HR pathway (Hashimoto et al., 2007). Although the authors are unable to ascertain the 
functional significance of H1.R during HR, they hypothesise that there are defects in the 
accessibility or the efficiency of the HR protein machinery in the absence of H1.R protein.  
 
The data in this thesis supports the aforementioned previous findings which together 
suggest a model for the involvement of linker histone variants during NHEJ (Figure 6.1). 
Under normal conditions, linker histone variants are positioned in between nucleosomes in 
an orderly fashion. It is unclear however, how the individual linker histone variants are 
distributed throughout the chromatin. Following DSB induction, the KU complex binds to the 
ends of the damaged DNA, followed by the subsequent recruitment of DNA-PK (Section 
1.1.3.2.1). It is also plausible that after the induction of the DSB, the nucleosomes are 
removed from the DNA and the linker histone variants move in to bind the DNA in the 
vicinity of the break. DNA-PK then phosphorylates linker histones variants, causing them to 
be released from the DNA (Kysela et al., 2005). It is possible that the replication dependent 
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linker histone variants are phosphorylated on the conserved threonine residue (threonine 
152 in H1.1) which is important for high affinity binding to DNA (Hendzel et al., 2004). This 
phosphorylation would reduce the affinity between the linker histone variants and the DNA 
(Dou et al., 2002, Lever et al., 2000). Evidence from this thesis supports this, as threonine 
152 on linker histone variant H1.1 is phosphorylated by DNA-PK in vitro. However, as H1.X 
lacks these residues it is difficult to determine what effect the phosphorylation of H1.X has 
during NHEJ (Section 3.3.4). It has been demonstrated, however, that H1.X can interact with 
the LX complex in vivo, stimulating the end ligation by means of stabilising LX on the DNA 
ends, resulting in efficient ligation (Section 5.3.1 to Section 5.3.4; Figure 6.1A). More 
specifically, this interaction has been demonstrated in over-expressed cell lines and with 
native proteins. It is also not mediated by DNA, suggesting a physical interaction between 
H1.X and the LX complex occurs in vivo. 
 
Under the circumstances where H1.X is depleted from cells, other linker histone variants are 
suspected to compensate (Y. Fan et al., 2003). However, due to the lack of linker histone 
variant H1.X, it is expected that H1.X mediated stimulation of LX does not occur, therefore 
the DNA ends are ligated less efficiently. This is confirmed by H2A.X studies which show 
elevated levels of H2A.X foci following IR in cells depleted for H1.X, but not for H1.2 
(Section 4.3.3). It is also possible that there is a subset of DSBs that may specifically require 
the presence of H1.X to be repaired by NHEJ. Due to the failure to repair a significant 
proportion of DSBs when H1.X is depleted, the G2 to M checkpoint is activated for a longer 
period of time (Section 4.3.4). It is unclear, however, how cells depleted in H1.X escape the 
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G2 to M checkpoint resulting in the persistence of the DSB, leading to the formation of 
micronuclei (Section 4.3.5; Figure 6.1B). 
 
The repair of DSBs is slightly different in cells compromised in NHEJ. For example, in the 
absence of DNA-PK, there is no suppression of B-NHEJ (Perrault et al., 2004). Therefore, H1.2 
is able to activate PARP, and stimulate DNA ligase III specific end joining, resulting in DNA 
ligation by the slower B-NHEJ pathway (Audebert et al., 2004, H. Wang et al., 2005a) (Figure 
6.1C).  
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Figure 6.1 - Model for linker histone variants action during NHEJ 
Three models proposed for the involvement of linker histone variants during NHEJ. A. After DSB induction and DNA-PK recruitment, linker histones are phosphorylated 
resulting in all but H1.X being released from the DNA. H1.X then aids in the recruitment and stimulation of the LX complex. B. In the absence of H1.X there is either reduced 
recruitment or stimulation of the LX complex resulting in no DNA repair. C. In NHEJ defective cells, linker histone variant H1.2 recruits PARP and DNA ligase III to the site of 
the repair, resulting in repair by the slower B-NHEJ pathway. Red circular ‘P’ denotes phosphorylation. L3 represents DNA ligase III. Green circles represent the KU complex.  
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6.2 H1.X and the DSB Specific Interaction with Nucleolin 
Nucleolin has already been linked with the HR pathway due to its interaction with RAD51 
which is believed to regulate HR (De et al., 2006). It has also been shown to interact with 
BRCA1 in the nucleoli, but following exposure to IR, BRCA1 disperses from the nucleoli 
(Tulchin et al., 2010). Interestingly, H1.X has an opposing function, whereby the interaction 
between H1.X and nucleolin is mediated following exposure to IR. This finding, coupled with 
the increase in nucleolar sites following exposure to IR, highlights the importance of this 
interaction, and opens up the possibilities of nucleolin having a role in the DNA damage 
response. It is plausible that H1.X is required specifically for the repair of damaged DNA 
within the nucleolar sites, and that this is mediated by nucleolin, although further 
investigation is required. 
 
6.3 Future Experiments 
This thesis has established the necessity for H1.X during NHEJ, along with the in vitro 
mechanistic analysis. However, how H1.X functions in vivo remains unknown. According to 
the model proposed in Section 6.1, there are still questions that need answering (Figure 6.1). 
 
Primarily, it would be essential to ascertain whether H1.X is phosphorylated in vivo by either 
DNA-PK or ATM following IR, and then to map those phosphorylation sites. If 
phosphorylatable, it would be interesting to determine what effects phosphorylation has on 
H1.X’s activity. Phosphorylation of a linker histone mix by DNA-PK, alleviated its inhibitory 
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effect (Kysela et al., 2005). This could be explained by the conserved threonine 152 and 
serine 183 residues found in the somatic linker histone variants, excluding H1.X (Hendzel et 
al., 2004). These sites are important for high affinity binding, and could be the target of 
phosphorylation to remove the linker histone variants from the DNA. H1.X does not contain 
these residues which could explain the differences between H1.X and the other linker 
histone variants. 
 
It would also be interesting to determine how H1.X is able to stimulate ligation in vivo. H1.X 
could function similar to the KU complex to bridge the DNA ends, facilitating end-joining. 
H1.X could also be involved in the recruitment of LX to the site of the DSB, potentially 
following the PTM of H1.X after DSB induction. Also, the data presented in this thesis 
suggests that H1.X interacts with the LX complex, bringing about stimulation of ligation. It 
would be interesting to map the interacting regions on both H1.X and the LX complex. 
 
The role of nucleolin within the DNA damage response, if any, would need to be established. 
This could be achieved by reducing protein levels by siRNA and assessing the cellular 
response to IR, and subsequently dissecting the interaction between nucleolin and H1.X. 
 
Finally, it would be interesting to study the interplay between different linker histone 
variants at DNA ends. It has already been shown that H1.X stimulates LX-mediated ligation 
and H1.2 and H1.3 inhibit LX-mediated ligation (Section 5.3.1 and personal communication, 
Dr. Boris Kysela). Discovering which of the other linker histone variants stimulate and which 
inhibit LX-mediated ligation would be an important first step. Further characterisation of 
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their role in vivo by siRNA depletion would subsequently help to define the roles linker 
histone variants have during NHEJ.  
 











THE END  
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Appendix A.  






Protein Length Identity Score 
H1.0 194 H1.1 215 34 
H1.0 194 H1.2 213 36 
H1.0 194 H1.3 221 36 
H1.0 194 H1.4 219 40 
H1.0 194 H1.5 226 39 
H1.0 194 H1.X 213 27 
H1.0 194 H1.Foo 345 21 
H1.0 194 H1.t 206 27 
H1.0 194 H1.t2 255 17 
H1.0 194 HILS1 231 9 
H1.1 215 H1.2 213 64 
H1.1 215 H1.3 221 67 
H1.1 215 H1.4 219 72 
H1.1 215 H1.5 226 65 
H1.1 215 H1.X 213 29 
H1.1 215 H1.Foo 345 23 
H1.1 215 H1.t 206 43 
H1.1 215 H1.t2 255 25 
H1.1 215 HILS1 231 18 
H1.2 213 H1.3 221 83 
H1.2 213 H1.4 219 87 
H1.2 213 H1.5 226 76 
H1.2 213 H1.X 213 27 
H1.2 213 H1.Foo 345 28 
H1.2 213 H1.t 206 47 
H1.2 213 H1.t2 255 22 
H1.2 213 HILS1 231 17 
H1.3 221 H1.4 219 86 
H1.3 221 H1.5 226 74 
H1.3 221 H1.X 213 29 
H1.3 221 H1.Foo 345 27 
H1.3 221 H1.t 206 44 
H1.3 221 H1.t2 255 21 
H1.3 221 HILS1 231 19 
H1.4 219 H1.5 226 85 
H1.4 219 H1.X 213 28 
H1.4 219 H1.Foo 345 25 
H1.4 219 H1.t 206 48 
H1.4 219 H1.t2 255 21 
H1.4 219 HILS1 231 15 
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H1.5 226 H1.X 213 30 
H1.5 226 H1.Foo 345 20 
H1.5 226 H1.t 206 45 
H1.5 226 H1.t2 255 20 
H1.5 226 HILS1 231 18 
H1.X 213 H1.Foo 345 29 
H1.X 213 H1.t 206 24 
H1.X 213 H1.t2 255 20 
H1.X 213 HILS1 231 10 
H1.Foo 345 H1.t 206 22 
H1.Foo 345 H1.t2 255 20 
H1.Foo 345 HILS1 231 9 
H1.t 206 H1.t2 255 18 
H1.t 206 HILS1 231 17 
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Appendix B.  
Accession Numbers Used In This Thesis 
Gene Species Accession Number 
H1.0 H. sapiens BI462123 
H1.1 H. sapiens BC069492 
H1.2 H. sapiens BC002649 
H1.3 H. sapiens BC104874 
H1.4 H. sapiens BC099632 
H1.5 H. sapiens BC101581 
H1.X H. sapiens BC010435 
H1.Foo H. sapiens BC047943 
H1.t H. sapiens BC069517 
H1.t2 H. sapiens BC118635 
HILS1 H. sapiens BC033456 
H1.X P. troglodytes XM_526304 
H1.X B. taurus XM_589328 
H1.X M. musculus BC048709 
H1.X R. norvegicus XM_575600.3 
H1.X G. gallus XM_425158.2 
H1.X D. rerio BC047192 
H1.0 P. troglodytes XM_001147037.1 
H1.0 B. taurus BC122613 
H1.0 M. musculus BB661016 
H1.0 R. norvegicus BC061842 
H1.0 G. gallus X00169 
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Appendix C.  
Flow Cytometry Images 
 
Figure 7.1 - Sample dot plot of flow cytometry data 
Sample two parameter dot plot of cells stained with propidium iodide (DNA content, horizontal axis) and FITC 
labelled secondary antibody (BrdU, vertical axis). Four regions are highlighted on the dot plot. The red box, R1, 
contains the BrdU positive cell population. The blue box, R2, contains those cells which are BrdU positive and 
have a singular DNA content representative of cells in the G1 phase of the cell cycle. The orange box, R3, 
contains those cells which are BrdU positive and are currently synthesising DNA and is representative of those 
cells in the S phase of the cell cycle. The green box, R4, contains those cells which are BrdU positive and have 
twice the DNA content of cells in R2 which represents those cells in both G2 and M phases of the cell cycle.   
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Figure 7.2 - Bivariate Cell Cycle Analysis of Un-Irradiated MRC5VA cells.  
MRC5VA cells were incubated in the presence of BrdU for 20 mins. Samples were harvested every 4 hours and 
labelled with fluorescent anti-BrdU and propidium iodide and samples were analysed using FlowJo Flow 
Cytometry Analysis Software (Tree Star, Inc). The red box (8 hours) shows the re-emergence of the G1 
population following mitosis.  
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Figure 7.3 - Bivariate Cell Cycle Analysis of Un-Irradiated MRC5VA cells depleted of LUC.  
MRC5VA cells depleted with control LUC siRNA were incubated in the presence of BrdU for 20 mins. Samples 
were harvested every 4 hours and labelled with fluorescent anti-BrdU and propidium iodide and samples were 
analysed using FlowJo Flow Cytometry Analysis Software (Tree Star, Inc). The red box (8 hours) shows the re-
emergence of the G1 population following mitosis.  
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Figure 7.4 - Bivariate Cell Cycle Analysis of Un-Irradiated MRC5VA cells depleted of H1.X.  
MRC5VA cells depleted of H1.X were incubated in the presence of BrdU for 20 mins. Samples were harvested 
every 4 hours and labelled with fluorescent anti-BrdU and propidium iodide and samples were analysed using 
FlowJo Flow Cytometry Analysis Software (Tree Star, Inc). The red box (8 hours) shows the re-emergence of the 
G1 population following mitosis which is consistent with that seen in the controls (Figure 7.2 & Figure 7.3).   
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Figure 7.5 - Bivariate Cell Cycle Analysis of Irradiated MRC5VA cells.  
Irradiated MRC5VA cells were incubated in the presence of BrdU for 20 mins. Samples were harvested every 4 
hours and labelled with fluorescent anti-BrdU and propidium iodide and samples were analysed using FlowJo 
Flow Cytometry Analysis Software (Tree Star, Inc). The red box (12 hours) shows the re-emergence of the G1 
population following mitosis which is delayed by 4 hours compared to the un-irradiated sample (Figure 7.2).   
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Figure 7.6 - Bivariate Cell Cycle Analysis of Irradiated MRC5VA cells depleted of LUC.  
Irradiated MRC5VA cells depleted with control LUC siRNA were incubated in the presence of BrdU for 20 mins. 
Samples were harvested every 4 hours and labelled with fluorescent anti-BrdU and propidium iodide and 
samples were analysed using FlowJo Flow Cytometry Analysis Software (Tree Star, Inc). The red box (12 hours) 
shows the re-emergence of the G1 population following mitosis which is delayed by 4 hours compared to the 
un-irradiated sample (Figure 7.3).   
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Figure 7.7 - Bivariate Cell Cycle Analysis of Irradiated MRC5VA cells depleted of H1.X.  
Irradiated MRC5VA cells depleted of H1.X were incubated in the presence of BrdU for 20 mins. Samples were 
harvested every 4 hours and labelled with fluorescent anti-BrdU and propidium iodide and samples were 
analysed using FlowJo Flow Cytometry Analysis Software (Tree Star, Inc). The red box (16 hours) shows the re-
emergence of the G1 population following mitosis which is delayed compared to the controls where this occurs 
at 12 hours (Figure 7.5 & Figure 7.6).  
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Appendix D. 
Buffers Used In This Thesis 
Reagent Constituents 
Supplemented DMEM DMEM (containing 1000mg/L glucose) 
10% (v/v) FBS 
2mM L-glutamine 
1mM sodium pyruvate 
1% non-essential amino acids 
 
G418 DMEM As supplemented DMEM, with the addition of 600g/mL G418 
 




0.5% deoxycholic acid 
1% Igepal CA-360 
 




SDS Loading Buffer 65mM Tris/HCl pH8 
10% (v/v) glycerol 
2.3% (w/v) SDS 
0.01 bromophenol blue 
1% dithiothreitol DTT 
 









0.5% Triton X-100 
TBE 89 mM Tris-Base 
89 mM boric acid 
2mM EDTA 
 
X10 DNA Loading Buffer 50% glycerol 
0.05% bromophenol blue 
 
EB Buffer 1.25M NaCl 
50mM Tris/HCl, pH 8.5 
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15% isopropanol (v/v) 
 








Protease inhibitor cocktail (Roche) 
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0.1% Nonidet P-40 
20% glycerol 
 
X10 Ligation Buffer 66 mM Tris/HCl pH 7.5 
5 mM MgCl2 




X10 EMSA Buffer 66 mM Tris/HCl pH 7.5 
1 mM DTT 
1mM ATP 
0.5mg/mL BSA 
IP Lysis Buffer 50mM Tris/HCl pH 7.5 
1mM EGTA 
1mM EDTA 
50mM sodium fluoride 
5mM sodium pyrophosphate 
1mM sodium orthovanadate 
0.27M sucrose 
1% Triton X-100 
0.1% -mercaptoethanol 
Protease inhibitor cocktail 
 
IP Wash Buffer 50mM Tris/HCl pH 7.5 
1mM EGTA 
1mM EDTA 
50mM sodium fluoride 
5mM sodium pyrophosphate 
1mM sodium orthovanadate 
0.27M sucrose 
1% Triton X-100 
0.1% -mercaptoethanol 
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